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PART I: SYNTHESIS OF OLIGOSACCHARIDE MIMETICS BY THE 
DESULFURATIVE REARRANGEMENT OF ALLYLIC DISULFIDES 
 
CHAPTER 1 
INTRODUCTION 
1.1 Carbohydrates, an Ubiquitous Component of Nature 
Living matter is organized into complex structures made of inorganic (water, 
mineral salts, trace elements, etc.) and organic molecules. The organic matter 
comprises four main classes of natural compounds: carbohydrates together with 
nucleic acids, proteins and lipids. Carbohydrates are by far the most abundant 
components on Earth1; they are synthesized directly from carbon dioxide using 
the planet’s primary source of energy, the sun, with more than 4 × 1011 tons of 
carbohydrates produced each year by the process of photosynthesis1. This 
ancient, yet fundamental, chemical transformation, preponderantly undertaken by 
plants and algae, uses water and carbon dioxide to convert sunlight into glucose, 
a form of energy utilizable by all types of living organisms, and releases oxygen. 
Thereafter, this energy is stored by animals and plants as glycogen and starch.  
Carbohydrates are mostly found in Nature in their polymeric forms as oligo- 
and polysaccharides, which are composed of repeated units of monosaccharides 
linked together through O-glycosidic bonds. Naturally occurring monosaccharides 
are also widely distributed, but are of a lesser importance than their 
corresponding condensed forms from a biological point of view. In contrast to the 
other classes of bioconjugates (e.g. lipids, proteins or oligonucleotides), which 
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are only displayed in a linear form, carbohydrates also occur in Nature as highly 
branched polymers.  
Another feature of these molecules is their versatility: carbohydrates are very 
often used as scaffolds for the biosynthesis of other classes of natural 
compounds. Covalently bound carbohydrates are found in Nature attached 
through their reducing end to either lipids, peptides or proteins to form 
respectively glycolipids, glycopeptides and glycoproteins, all of which are 
classified as glycoconjugates2. They are also a key element of the nucleic acids 
whose biopolymers in the form of deoxy-ribonucleic acid, DNA or ribonucleic 
acid, RNA, are the essential carriers of the prokaryotic and eukaryotic genomes. 
In glycobiology, the reaction that covalently binds a glycan to a biochemical 
functional group is called glycosylation and is performed by enzymes. Glycan 
synthesis takes place in cells in the form of post-translational modifications 
(PTMs) of proteins to which the glycan moiety is attached through a O-, N-, C- or 
S- glycosidic linkage, with the O- and N- linkages being the most commonly 
displayed in naturally occurring glycoconjugates, C- and S- are rarely expressed 
in Nature. The glycosylation reaction is fundamental for the regulation and 
modulation of cellular function in higher organisms and different chemical 
aspects of it will be discussed in this manuscript at the appropriate stages.  
 
1.2 Role and Importance of Carbohydrates in Living Organisms 
Until the 1970’s, carbohydrates were mostly perceived as the principal source 
of energy and as structural templates for living organisms. The lack of efficient 
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analytical/physical tools, as well as limited synthetic methodologies, hindered 
development of the field. As a result, determining the structure-relationship 
activity (SAR) of carbohydrate molecules was very difficult, which resulted in a 
relatively poor understanding of the roles that these molecules played in living 
organisms. However, many years have passed since the time carbohydrates 
were only viewed as the fuel of cells and today, it is well established that these 
macromolecules are essential to life processes.  
Nearly all cell surfaces including microbial surfaces comprise carbohydrates 
in the form of glycoconjugates or polysaccharides, which are involved in most or 
part of the cell’s function. Thus, in the past three decades, a large panel of 
important biological processes involving carbohydrate molecules has been 
established3-8, ranging from cell-cell interaction to immune response, intracellular 
signaling or receptors for proteins and viruses. The involvement of carbohydrates 
in the development of autoimmune and proliferative diseases such as cancer has 
also been supported by copious data9-12. The critical roles associated with these 
molecules in numerous life-dependent processes3 have aroused the attention of 
biologists and medicinal chemists who have begun to dismantle the machinery 
behind their functions since they pose as excellent candidates for drug discovery.  
Nonetheless, an important limitation that is most often associated with the 
studies of these molecules is their low availability and purity from natural 
sources13, which makes it hard to isolate them in substantial amounts and 
characterize them14. In contrast with the other classes of macromolecules whose 
biosynthesis is mostly genetically encoded, glycoconjugates and poly- or 
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oligosaccharides are assembled through multi-enzymatic step processes, which 
gives rise to structurally heterogeneous mixture of compounds15. To address this 
problem, chemists have focused their attention on the chemical synthesis of 
structurally homogenous oligosaccharides and glycoconjugates16 to use as 
biological and pharmaceutical probes to elucidate their roles in the cells, with the 
ultimate goal of opening up new pathways to carbohydrate-based vaccines17-20.  
 
1.3 Staphyloccocus aureus and S. epidermidis 
Colonization of solid surfaces by bacteria - frequently medical devices - 
through the formation of biofilms accounts for more than 65% of human 
infections21. Many microorganisms, including bacteria, produce biofilms to 
mediate the parasitic infections through cell-cell adhesion. Once produced by the 
bacteria, this biofilm acts as a shield, keeping the bacteria away from any type of 
antimicrobial agents, which confers them a high resistance against antibiotics as 
well as better resistance to the host’s immune system response22,23.  
Gram-positive Staphylococci especially S. epidermidis and S. aureus are 
some of the most virulent bacteria24. Together, they are responsible for the 
majority of nocosomial infections reported each year25-27. Usually located on the 
skin or in the nose of healthy patients, they coexist in most cases harmlessly in 
the human body, but can lead to diseases when the host’s immune system is 
weakened28. The pathologies associated to their infections vary from mild to very 
severe such as endocarditis or pneumonia, which can potentially lead to death. 
The high resistance developed by these classes of bacteria to various antibiotics 
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has urged the scientific community to develop new potential carbohydrate based-
therapeutics miming the structure of their exopolysaccharide matrices so as to 
prevent their adhesion to host biosurfaces. 
In 1996, Mack29,30 and co-workers isolated and characterized the biofilm 
produced by S. epidermidis and concluded that it mainly consisted of an 
amorphous linear homopolymer of  β-(1→6)-N-acetyl-D-glucosamine (PNAG), 
also referred as to the polysaccharide intercellular adhesin, PIA (Figure 2). PIA is 
produced during the active growth phase of the bacteria and mediates the 
adhesion to biosurfaces29. Immunological studies have depicted PIA as a 
potential immunogen for the development of glycoconjugate vaccines31. A similar 
structure to this glycan backbone was also found in S. aureus32 and other biofilm-
forming bacteria strains for instance, Escherichia coli33.  In the case of S. aureus, 
the polysaccharide antigen expressed in human infections contains N-succinyl 
residues instead of N-acetyl residues and is named poly N-succinyl β-(1→6)-
glucosamine (PNSG)34.  
 
Figure 1: Structure of the polysaccharide intercellular adhesin 
 
 However, both structures, PNSA and PNSG come as mixtures of poly- 
and oligosaccharides when extracted directly from their bacterial sources, with 
O
O
O
NHR
HO
HO
HO
NHR
HO OH
O
H
n
R = Ac or H, PIA, R = succinyl, PNSG
! 6!
each component of these mixtures generating different immunological 
responses35. Clearly, the chemical synthesis of structurally consistent 
homogeneous forms of these exopolysaccharide matrices would be a crucial 
asset for the development of efficient therapeutic means. 
 
1.4  The Glycosylation Reaction, a Central Reaction in Glycochemistry 
Glycosidic bond formation, most commonly known as the glycosylation 
reaction, is the most fundamental reaction in glycochemistry. In a general way, it 
typically involves three components, a glycosyl donor bearing a leaving group at 
the anomeric carbon, a glycosyl acceptor, which displays only one free hydroxyl 
group, and a catalyst or a promoter, until very recently a heterogeneous one, to 
initiate the departure of the leaving group at the anomeric center with, ultimately, 
C-O bond formation. The newly formed glycosidic linkage can have either the 
α or β configuration and be referred to as a 1,2-cis or 1,2-trans glycoside 
(Scheme 1).  
 
Scheme 1: The glycosylation reaction 
 
It was in 1879 that A. Michael36 introduced the first chemical glycosylation 
reaction; the nucleophilic displacement of an anomeric chlorine with potassium 
aryloxides. Not long after his discovery, in 1893, E. Fischer37 proposed a quite 
different methodology by synthesizing a methyl acetal of D-glucose directly from 
O
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O
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O OOO
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or
PGPGPG
α-glycoside
(1,2-cis)
β-glycoside
(1,2-trans)
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an acid-catalyzed condensation of methanol on D-glucose. Then in 1901, 
Koenigs and Knorr38 brought an important contribution to the glycosylation 
reaction by coupling a peracetylated glucosyl bromide with methanol in the 
presence of a heavy metal ion, silver (I) or mercury (I), initially used as an acid 
scavenger (Scheme 2).  
 
Scheme 2: Glycosylation reactions, the debut 
 
Over the decades, the glycosylation reaction has been refined and has 
experienced great advances since the inception of these pioneering works. The 
seminal contribution of Lemieux39 et al., on the subtle understanding of the 
reactivity of halogeno-donors, has led to the introduction of the halide-catalyzed 
glycosylation reaction, providing access to 1,2-cis glycosides. In 1975, Lemieux 
observed that 2-O-benzyl protected α-D-glycosyl bromides anomerized rapidly to 
their highly reactive β-D-anomer, resulting in the formation of the α-D-glycosides, 
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in the presence of a catalytic amount of Et4NBr (Scheme 3)39. This anomerization 
phenomenon was interpreted by Lemieux in terms of a series of ion-pair 
equilibriating through formation of an oxocarbenium ion, cast light on the 
fundamental picture of the glycosylation reaction mechanism39,40. This general 
mechanistic scheme will be presented in Part II of this dissertation.  
 
Scheme 3: Halide ion catalyzed glycosylation reaction 
 
Over the years, diverse glycosyl donors were developed as alternatives to 
the glycosyl halide chemistry, including the versatile thioglycoside donors, or their 
more reactive forms, the thiosulfoxide donors, or the glycosyl imidates, first used 
by Sinaÿ41 then extended by Schmidt42 in the form of the trichloroacetimidates. 
These donors have led to the emergence of various glycosylation protocols, and 
have been, arguably, the most used glycoside donors for the synthesis of 1,2-cis 
or 1,2-trans glycosides. Synthetic carbohydrate chemists have strived to 
reproduce chemically and stereoselectively the wide diversity of glycosidic 
linkages that Nature creates so easily through the help of enzymes43 and as of 
today numerous glycosylation methods have been developed44,45. An adequate 
illustration of this community wide effort is found in Hindsgaul’s46 1995 review, 
which listed over 700 different chemically synthesized glycosidic linkages for the 
year of 1994. A selection of the most commonly used glycosylation reactions is 
listed in Table 145. 
O
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Entry Glycosyl Donors Promoters Linkages 
 
 
1 
 
Thioglycosides 
 
NIS/TfOH, NIS/AgOTf, 
NIS/Sn(OTf)2 or  Cu(OTf)2, 
IDCClO4 or IDCOTf 
NBS/Bi(OTf)3, BSP/Tf2O, 
Ph2SO/Tf2O, BSM/Tf2O 
 
 
1,2-cis and 
1,2-trans 
 
2 
Thioimidates 
 
 
NIS/TMSOTf, AgOTf, 
Cu(OTf)2 MeOTf 
 
1,2-cis and 
1,2-trans 
 
3 
Thiosulfoxides 
 
 
Tf2O/TTBP or 
 Tf2O/DTBMP 
 
1,2-cis and 
1,2-trans 
 
 
4 
Glycosyl imidates 
 
 
TMSOTf, BF3.OEt2, 
Sm(OTf)3, Yb(OTf)3, TBSOTf 
 
1,2-cis and 
1,2-trans 
 
 
5 
Orthoesters 
 
 
 
TrClO4, TMSOTf 
 
 
1,2-trans 
 
6 
Glycosyl phosphates  
TMSOTf 
 
1,2-trans 
O
PG SR
R = Tol, Ph, Et
O
PG S
O
N
O
PG S(O)R
R = Tol, Ph, Et
O
PG O R2
R1N
R1 = H, R2 = CCl3
R1 = Ph, R2 = CF3
O
PG
OO
R
R = OMe, CN
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Table 1: Common glycosylation methods 
 
Various other important aspects of the glycosylation reaction are not 
discussed here but are addressed as appropriate throughout the thesis. Such 
aspects include the nature of the protecting group pattern on both the glycosyl 
donor and acceptor, the type of activating group at C1, along with its promoter 
and additives such as solvents, all of which play role in the control of the 
stereoselectivity of the glycosylation reaction, hence its efficiency. 
 
1.5  Problems in Oligosaccharide Synthesis 
The development of simple, efficient and selective synthetic methods to 
achieve the preparation of complex oligo- and polysaccharides structures has 
been under the spotlight for quite some time in the carbohydrate chemistry field 
and enormous efforts have been devoted towards that end47. Structurally, 
carbohydrates are polyhydroxyl-aldehydes or ketones; they therefore possess a 
high density of functional groups, each of them having different reactivity. Hence, 
it can be fairly said that the chemical synthesis of oligosaccharides is not an easy 
task but actually, rather frequently, a difficult and labor-intensive one. A major 
drawback that has curtailed the endeavors made in this field comes from the lack 
of general and selective methods, unlike the case of peptides and 
O
PG O P OBu
OBu
O
! 11!
oligonucleotides synthesis, and as of today, glycosylation chemistry is still not 
routine46. Consequently, the chemical synthesis of individual oligosaccharides 
needs, in the vast majority of cases, to be investigated independently. Yet, 
important improvements have been made in recent years to enable the rapid 
synthesis of long chains of sugars in the form of convergent syntheses, one-pot 
synthesis48,49 methods and automated oligosaccharide synthesis50,51, to just 
name a few.  
A few years ago, the synthesis of long oligosaccharide chains was perceived 
as a very daunting prospect. Today, with the emergence of new methodologies, 
the preparation of oligosaccharides of complex structures can be conducted in a 
fairly reasonable amount of time. The development of automated tools such as 
the automated synthesis on solid support introduced by Seeberger52 in 2001 
holds promising potential, as illustrated by the synthesis of a branched 
dodesaccharide of the PE  β-glucan in 17 h and in a 50% overall yield. However, 
these methods are still highly substrate specific and necessitate special cocktail 
recipes (protecting group pattern, choice of the anomeric substituent…) limiting 
the applicability of this methodology to the synthesis of quasi-homogenous 
oligosaccharides. Oligosaccharides containing diverse or challenging linkages 
such as 1,2-cis glycosides (α-galactosides, β-mannosides) are not yet amenable 
to solid phase synthesis protocols. Other important drawbacks to a routine 
utilization of automated synthesizers arise from first, the coupling efficiency of 
these reactions, which are not high-yielding, and, second from the difficulty to link 
the sugars together in a completely stereoselective fashion. Similarly, in solution-
! 12!
phase protocols, such as the one-pot synthesis methods, based on multiple 
sequential glycosylations and developed by different groups such as those of Ley 
and Wong50,51 have also shown to be beneficial, using simplified protocols with 
only a single isolation/purification step at the end of the synthesis. However, 
critical aspects of this methodology include the need for complete consumption of 
all the reactants to prevent any side reactions leading to undesirable truncated 
and/or deletion sequences, and low overall yields. 
Central to the synthesis of complex oligosaccharides is the control of the 
stereoselectivity of the glycosidic bond formation. The regioselective construction 
of glycosidic linkages is relatively promptly achieved, albeit time-consuming, 
because it mostly relies on a series of selective protection/deprotection 
manipulation steps. More problematic though, is the stereoselective formation of 
the glycosidic bond at the anomeric carbon C1 for which complete stereocontrol 
is necessary. If 1,2-trans glycosides (e.g.,  β-D-glucosides or α-D-mannosides) 
can generally be properly prepared via neighboring group participation, 
accessing stereoselectively 1,2-cis glycosides (e.g., α-D-glucosides or α-D-
galactosides) is more complex since the presence of a neighboring participating 
group at C2 is excluded and as the glycosylation reaction can occur either 
through SN1 or a SN2-like mechanism. Alternative strategies have been 
investigated and led to the development of novel types of protecting groups to 
dictate the stereochemistry at the anomeric center. These methods have been 
based on various effects, for example, the stereoelectronic demand imposed by 
the 4,6-O-benzylidene53 group or the steric constraints introduced by using silyl 
! 13!
protecting groups such as the 4,6-di-O-tert-butylsilylene54,55 protecting group. Yet 
a further development is the use of chiral auxiliaries56 in semi-classic NPG 
scheme (Scheme 4). Because of these recent advances, it is now as easy to 
synthesize either 1,2-trans or 1,2-cis glycosides in many sugar series.  
 
Scheme 4: Methods for controlling 1,2-cis glycoside formation 
 
Nevertheless, despite the advances made to facilitate the elaboration of 
complex oligosaccharides, most of these methods remain poorly selective in 
solution and especially on solid support, which reduces their applicability (eg. 
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SPS is only suitable for 1,2-trans glycosides). The development of further 
improved methodologies has been hampered by the poor understanding that lies 
behind the mechanism of the glycosylation reaction45, such that  even today it is 
hard, in many cases, to predict and control the outcome of a glycosylation 
reaction57. The synthesis of oligosaccharide mimetics58 can therefore be 
considered as an alternative avenue to this problem. 
 
1.6  Click and Thiol-Ene Click 
1.6.1 “Click” Chemistry 
The term “click chemistry” was first introduced by Sharpless59 a decade 
ago to describe the rapid synthesis of new compounds through heteroatom bond 
formation (C-X-C). This new concept of organic synthesis was developed in 
parallel with the increasing interest of pharmaceutical companies to access 
rapidly large combinatorial libraries. According to Sharpless’ definition, a click 
reaction is a reaction that is i) wide in scope, ii) very high yielding, iii) generates 
only inoffensive byproducts that can be removed by non-chromatographic 
methods, iv) requires mild aqueous or solventless conditions, v) is stable towards 
water and oxygen, vi) is atom economical, vii) is stereospecific and viii) draws on 
a large variety of readily available starting materials. This archetypal concept 
found its first example with the development of the copper(I)-catalyzed azide-
alkyne cylcoaddition (CuAAC), commonly known as “click chemistry”. This 
catalyzed variant of the Huisgen 1,3-dipolar cycloaddition of terminal alkynes and 
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azides was discovered by Sharpless59 and Meldal60 in 2002 and provides access 
to 1,4-disubstituted 1,2,3-triazole derivatives (Scheme 5).  
  
Scheme 5: The Huisgen 1,3-dipolar cycloaddition and the copper(I) variant 
 
Because of its simplicity, mild conditions, high regio- and chemoselectivity, 
and compatibility with a broad range of functional groups, the CuACC chemistry 
has been extensively used as a premier conjugation method in numerous fields 
such as organic synthesis, molecular biology, medicinal chemistry, polymer and 
material science or biotechnology. Over a thousand papers have been published 
on the subject61,62. Many other well-known chemical transformations, which are 
capable of generating a broad range of organic compounds, subsequently have 
been listed as click reactions such as the hetero-Diels-Alder reaction, the 
addition to carbon-carbon multiple bonds for instance, epoxidation, 
dihydroxylation, aziridination or the radical addition of thiols to alkenes, which is 
also known as the thiol-ene coupling reaction (TEC)63-65. 
 
1.6.2 Thiol-Ene Reaction 
Thiols have proven popular targets for chemoselective ligations. The 
relatively weak sulfur-hydrogen bond of thiols (S-H bond dissociation energy = 
N N
N
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R2 H
[CuI] N N
N R1
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Δ
N N
N R1N N
N R1
R2
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340 – 375 kJ.mol-1 vs. 390 to 440 kJ.mol-1 for analogous O-H bonds in alcohols)66 
has been exploited in a large panel of chemical reactions, because of its ease of 
reactivity under mild activation conditions,67 which enables the facile formation of 
different reactive intermediate species such as thiyl radicals, thiolate anions or 
sulfenyl cations. The hydrothiolation of terminal alkenes, which corresponds to 
the addition of thiols across a carbon-carbon double bond or simply “enes”, was 
discover by Posner68 more than a century ago. A vast variety of unsaturated 
functional groups, for instance maleimides, acrylates, and norbornenes or 
unactivated unsaturated substrates, can be reacted with common thiol reagents 
– alkyl thiols, thiophenols, thiol propionates and thiol glycolates – under either a 
photochemically/thermally-induced or base-catalyzed process, to give the sulfide 
adduct, by respectively, a free-radical chain reaction (the TEC reaction) or a 
Michael-type nucleophilic addition (termed the thiol Michael addition), the latter 
being essentially employed on electron poor alkenes (Scheme 6)63.  
 
Scheme 6: Thiol click reactions by a) thiol Michael addition and b) free-
radical addition 
 
The free-radical chain reaction mechanism of the thiol-ene reaction is well 
established and was proposed by Kharasch69 and co-workers in 1938. The 
reaction goes through the formation of a thiyl radical 2 – generated from the thiol 
precursor 1 upon irradiation or in the presence of a radical initiator – which adds 
R1 SH
R2
R2
R1S
a) hν or radical initiator
b) Et3N, solvent
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to the alkene 3 in an anti-Markovnikov fashion to give a carbon centered thioalkyl 
radical 4. Hydrogen radical abstraction of 4 from another molecule of thiol 1 leads 
to the thioether adduct 5 and a new thiyl radical ensuring the propagation of the 
chain (Scheme 7)64. 
 
Scheme 7: Mechanism of free-radical thio-ene coupling reaction 
 
Because of its many attributes as a click chemistry, the robustness of the 
thioether linkage that it generates and the advantages of a photoinitiated 
process, which allows activation at specific times, thiol-ene chemistry has found 
many applications in recent years predominantly in network formation64, polymer 
functionalization and dendrimer synthesis70. Several examples have been 
reported in the glycochemistry arena for instance the synthesis of 
glycoconjugates reported by Davis71 or Dondoni72,73 as displayed in Scheme 8. 
a) S-glycosyl amino-acid synthesis71 
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b) C-glycosylation of nanopeptide 6 with allyl C-galactoside 773 
 
Scheme 8: Examples of the TEC reactions 
 
The alkyne equivalent, the thiol-yne coupling reaction (TYC)65, which 
consists of the addition of two thiol molecules across a carbon-carbon triple 
bond, displays the same characteristics as the TEC reaction and has started to 
emerge in polymer and material science, but has not found yet many applications 
in glycobiology. 
 
1.7 Synthesis of Oligosaccharide Mimetics 
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Because of their facile ability to under chemical and enzymatic hydrolysis, 
poor pharmacokinetics, and low metabolic stability, glycoconjugates or 
oligosaccharides are not directly used as drugs. The chemical synthesis of 
structurally improved oligosaccharide mimics is beginning to emerge as an 
alternative to the preparation of complex oligosaccharides for the production of 
metabolically stable and potentially pharmacologically active molecules74-76.  
 
1.7.1 Triazole-Based Oligosaccharide Mimetics 
In the quest of synthesizing a panel of various functionalized carbohydrate-
based mimetics, different ligation methods have been developed among which 
the CuAAC chemistry77 has been the most widely used in chemical biology61,62,78-
81. The stability of the triazole ring towards enzymatic degradation82 along with its 
potential biological and pharmaceutical activities83,84 supports the synthetic utility 
of the CuAAC reaction in glycochemistry. Soon after its discovery in 2002, 
Wong81 and Santoyo-Gonzáles80 and co-workers were the first to validate the 
applicability of this methodology by linking carbohydrates with non-carbohydrate 
molecules for the synthesis of multivalent glycoclusters anchored to various 
scaffolds. Below, is represented the synthesis of a triazole-based disaccharide85 
11 and a triazole-bazed glycocluster85 13, the latter was obtained by reaction of 
propargyl mannoside 9 with hexakis (azidomethylbenzene) 12 (Scheme 9).  
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Scheme 9: Synthesis of a triazole-based disaccharide and a glycocluster 
 
Various applications of “click” chemistry are described in the literature for the 
synthesis of multivalent saccharide mimetics – in particular, oligomeric structures 
such as glycodendrimers86, glycopolymers87 or glycocusters85 – since it has been 
shown that the affinity between protein receptors and their ligands is higher for 
oligomeric structures owing to the phenomenon known as the “glycoside cluster 
effect”88,89.  
  
1.7.2 Sulfur-Based Oligosaccharide Mimetics 
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Another approach to the synthesis of glycomimetics involves the 
preparation of non-natural glycosidic bonds, such as C-90,91 or S-glycosides67, 
which are of much interest because of their better stability towards enzymatic 
degradation than their natural analogs O- or N-glycosides91 as well as their 
compatibility with many biological systems.  
 Various synthetic routes have been employed for the synthesis of thio-
linked oligosaccharides mimetics including the thiol-ene reaction72, Michael-type 
additions or by S-alkylation reactions92. Some of these examples are highlighted 
in the scheme below. 
a) β-(1→6) Thiodisaccharide synthesis by thiol-ene reaction72 
 
b) S-Alkylation and base-promoted S-glycosylation92 
 
Scheme 10: Examples of sulfur-based disaccharide mimetics 
 
1.7.3 Phosphonate-Based Oligosaccharide Mimetics 
Phosphonosugars or phostones93-98 – sugars in which the anomeric 
carbon has been substituted by a phosphonate group – have shown promising 
biological results as potential glycosidase inhibitors and as mimetics of the 
glycosidic bond95,97,99. Very recently, Crich100 described a novel approach to 
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synthesizing phostone-based glycomimetics by coupling P-chiral ammonium 
phosphonite-borane analogs of glucose or mannose with various carbohydrate- 
or non-carbohydrate-derived primary alcohols. The coupling reactions proceeded 
with high diastereoselectivity and, in the case of the mannose series,  the α- or β- 
coupling products can be selectively induced depending on the reaction 
conditions used. Tervalent P(III) phosphonite compounds 15 are masked in the 
form of their borane adducts 16 to prevent oxidation at the phosphorus center101 
and to block the H-phosphinate in its more reactive tervalent configuration rather 
than in its tetra-coordinated P(IV) form102 14 (Scheme 11). 
 
Scheme 11: Tautomeric forms of H-phosphinates and their borane 
complexes 
 
The borane complex is reacted with the primary alcohol in the presence of a 
nucleophilic catalyst, either 3-nitro-1,2,4-triazole (NT) or DMAP to give the 
corresponding phophonite-borane adduct, which is subsequently oxidized to its 
more stable phosphonate form to give the actual glycomimetic. Examples of such 
disaccharide glycomimetics are outlined in the Scheme below, in the mannose 
20 and in the glucose 24 series100. 
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Scheme 12: Synthesis of (1→6)-disaccharide phosphonate mimetics 
 
Ultimately, the synthesis of oligosaccharide mimetics is an attractive 
alternative to circumvent the high level of stereocontrol needed at the anomeric 
carbon during standard O-glycosylation reactions and therefore facilitates the 
elaboration of complex mimetics of otherwise inaccessible oligosaccharides 
and/or glycoconjugates. 
 
1.8 Disulfide Ligation, Principles and Problems 
Thiol-based ligation reactions have primarily been used in the 
functionalization of biopolymers, especially peptides and proteins, when they rely 
on the exploitation of the high nucleophilicity of the sulfhydryl group in cysteine 
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residues for the formation of either stable thioether or amide linkages or for the 
installation of more labile disulfide bridges. Examples of thiol-based ligations, 
such as the disulfide ligation or the native chemical ligation (NCL)103, which 
enables the formation of native cysteine-containing peptide bonds in aqueous 
media, demonstrate the use of the sulfhydryl group as a powerful chemoselective 
ligation device.  
The disulfide ligation, one of the oldest ligation methods, allows the 
formation of mixed disulfides under mild conditions. Indeed, the method is 
encountered in Nature, when enzymes join together two cysteine-containing 
peptide chains under oxidative conditions with the formation of a cystine bridge. 
Several chemical methods have been reported for the synthesis of mixed alkyl or 
aryl disulfides that rely on, for instance, alkylsulfenyl thiocyanates 25104 or aryl 
disulfides 26 as disulfide precursors when exposed to a thiol molecule (Scheme 
13).  
 
Scheme 13: The disulfide ligation reaction 
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R1 = CH3(CH2)5, R2 = CH2COCH3
R = C6H5CH2, R2 = tBu
25
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A different variant of the disulfide ligation, introduced by the Davis group, 
uses selenosulfide derivatives as the disulfide for the attachment of proteins to 
sugar units (Scheme 14)105.  
 
Scheme 14: Selenosulfide-mediated glycoprotein ligation 
 
Besides the modifications of peptides and proteins, the practicality of the disulfide 
ligation has made it a valuable tool for the generation of dynamic combinatorial 
libraries (DCLs), which take advantage of the reversible nature of the disulfide 
bond. However, the advantages of the disulfide ligation are offset by the 
impermanence of S-S bonds, which are labile to reducing agents and which 
undergo facile thiol-disulfide exchange processes.  
 
1.8.1 Thiol and Disulfide Exchange 
 Mixed alkyl or aryl disulfides can undergo disulfide exchange in the 
presence of a free thiol to give rise to new mixed disulfide derivatives. This 
phenomenon, the thiol-disulfide exchange, is encountered in biological systems 
and is believed to take place during the denaturation of proteins by urea. The 
reaction occurs reversibly under mild basic conditions (pH 7-9) and requires only 
a catalytic amount of the thiolate to proceed106. In 1920, Lecher observed that the 
reaction between a thiol and a disulfide proceeded via an ionic exchange. 
However in some cases, a free-radical mechanism with homolytic scission of the 
sulfur-sulfur bond, giving rise to a short-lived sulfenyl radical may also be 
O
HO SHProtein S SePh
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involved. Under acidic conditions or in media free of thiols, the thiol-disulfide 
exchange does not occur. 
The thiol-disulfide exchange reaction is the main limitation of the disulfide 
ligation and has prompted the development of alternatives, more permanent 
sulfur-based ligation methods in the Crich group. 
 
1.9 Allylic Disulfide Rearrangement 
Early studies carried out by Moore107-109 and Greenwood110 showed that 
symmetrical dialkenyl disulfides reacted with triphenylphosphine upon heating in 
dry benzene to give dialkenyl monosulfides and triphenylphosphine sulfide 
almost quantitatively. Similarly, mixed disulfides for instance alkenyl-alkyl 
disulfides undergo the same transformation and yield alkenyl-alkyl monosulfides 
along with triphenylphosphine sulfide. Interestingly, dialkyl-, diaryl, and diaralkyl 
disulfides remained unreactive under similar conditions. Following up on these 
observations, Baldwin rationalized these results by demonstrating that  α-
substituted allylic disulfides 27 and 28 rearrange at room temperature in benzene 
to their thermodynamically more stable isomers 31 and 32 through an 
intramolecular double [2,3]-sigmatropic rearrangement111. This equilibrium 
proceeds via the formation of a thiosulfoxide intermediate 29 and 30 (Scheme 
15). 
! 27!
 
Scheme 15: Double [2,3]-sigmatropic rearrangement of diallyl disulfides 
 
Conversely, mixed alkyl-allyl disulfides were found to be thermally stable upon 
the same treatment and isolation by distillation was even possible111. However, in 
the presence of a phosphine reagent and upon heating, the equilibrium is driven 
forward to desulfurization and formation of the corresponding thioether product 
(Scheme 16).  
 
Scheme 16: Desulfurative rearrangement of mixed allylic disulfides  
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Kinetics studies revealed that this transformation followed a pseudo-first-order 
reaction profile with rate constant values indicating that the 2,3-sigmatropic 
rearrangement is dependent on the substitution pattern111 as previously observed 
by Moore and Trego108. In the case of mixed alkyl-allyl disulfides, increasing the 
steric hindrance of R3, R4 and R5 substituents significantly decreases the rate of 
formation of 35-c by disfavoring the formation of the thiosulfoxide intermediate 
34-c. On the other hand, the trend goes the opposite way for substitution at the 
 α carbon. Thus, the rate of thioether formation is enhanced as the size of R1 and 
R2 substituents increases and spontaneous desulfurization was observed for 
compounds 33e and 33f. Further, in line with previous results, Baldwin also 
noted that increasing the solvent polarity had an effect on the rate of the allylic 
rearrangement as the formation of the thiosulfoxide intermediate was favored. 
Mechanistically, a close analogy with the well-known Mislow-Evans 
rearrangement112 of allylic sulfoxides can be made.  In 1968, Mislow and 
coworkers reported that enantiomerically pure allylic sulfoxides 36 racemized in 
either benzene or p-xylene upon heating through the formation of a sulfenate 
ester 37 via a [2,3]-sigmatropic rearrangement. Evans then broadened this 
transformation to the formation of allylic alcohols by trapping the allylic sulfenate 
ester intermediate using a thiophilic reagent enabling the reversible 1,3-
transposition of allylic sulfoxides and allylic alcohol functionalities (Scheme 17). 
 
Scheme 17: Mislow-Evans rearrangement of allylic sulfoxides 
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 In a similar manner, Sharpless113 reported in 1972 the first example of the 
analogous [2,3]-sigmatropic rearrangement of diallylic diselenides and noticed 
that the selenoallylic rearrangement proceeded faster than its thioallylic 
counterpart. This was characterized by the difficulty to prepare and isolate 
diallylic diselenide compounds of which the digeranyl diselenide 39 represented 
the only example of this type reported in the literature.  Treatment of 39 with an 
excess of triphenyl phosphine at 25 °C in chloroform afforded the corresponding 
rearranged product with loss of selenium and gave the geranyl linalyl selenide 
product 41 in a matter of hours (Scheme 18). The half-life reported for this 
transformation was of 2.5 h at 25 °C. 
 
Scheme 18: Deselenylative rearrangement of digeranyl diselenide 
 
A few years ago, the Crich group114-117 investigated the scope and limitation 
of the disulfide rearrangement with the objective of rendering the ligation of thiols 
permanent, by developing a new method that could proceed at room temperature 
and in protic media and more importantly, that could benefit biological system 
studies. For this, the amount of triphenyl phosphine used was cut down to a 
minimum excess instead of the large excess used in the previous work of Höfle 
and Baldwin111. Screening studies showed that mixed disulfides more specifically 
allylic Bunte salts 42114 (S-allyl thiosulfonates) were the most suitable substrates 
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to meet all of these criteria.  The weakness of the Se-S bond was exploited to 
drive the reaction in the forward direction and facile loss of selenium was 
observed at room temperature with or without a phosphine reagent, enabling the 
development of a new, permanent chemical ligation method from the 
deselenative rearrangement of Se-allylic selenosulfides114 (Scheme 19).  
 
Scheme 19: Formation and rearrangement of Se-allylic selenosulfides 
 
Primary Se-allylic selenosulfates like compound 42, were obtained according to 
known protocols118-120 starting with formation of potassium selenosulfate by 
reaction of potassium sulfite with selenium powder.  Then, potassium 
selenosulfate was heated in the presence of either allylic bromide or allylic 
chloride gave the expected product compound 42 (Scheme 20). 
 
Scheme 20: Synthesis of primary Se-allylic selenosulfates 
  
However, it turned out that this synthesis was only suited for the introduction of 
tertiary allylic sulfides from primary selenosulfides. The preparation of secondary 
and tertiary Se-allylic selenosulfates did not proceed as required as the standard 
methodology used to prepare primary Se-allylic selenosufates failed to give the 
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desired compounds. These results were in accordance with Sharpless’113 earlier 
observations when attempting the synthesis of secondary allylic diselenides, 
which he described as undergoing a fast 1,3 shift to their isomeric primary 
selenides (Scheme 21). 
 
Scheme 21: [1,3] shift of secondary allylic selenides 
 
Faced with the instability of secondary allylic selenides, the Crich group 
redirected their investigation towards the allylic disulfide rearrangement using 
Baldwin’s early conclusions on the great influence of the substituents at the  α 
carbon R1 and R2 on the rate of this transformation, noticing that secondary and 
tertiary allylic disulfides conversion proceeded more than 200-fold faster in 
benzene at 60 °C than that of their primary conterparts (Scheme 9)111. The Crich 
group therefore postulated that the desulfurative rearrangement of allylic 
disulfides could then take place at room temperature and in protic solvents as 
was demonstrated to stabilize the dipolar thiosulfoxide intermediate121, provided 
that the proper substituent pattern was employed115,116.  
 Secondary and tertiary allylic thiols were synthesized from primary allylic 
thiocarbonyl derivatives via a thermal [3,3]-sigmatropic rearrangement then the 
allylic thiol 49 were reacted with either 2,2’-dipyridyl disulfide, 2,2’-di(5-
nitropyridyl) disulfide or 2,2’-di(1,3-benzothiazolyl) disulfide to give the 
XSe
SeX
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corresponding S-allyl S’-heteroallyl disulfides 50116 as presented in the scheme 
below. 
 
Scheme 22: Preparation of secondary and tertiary allylic disulfides 
 
Subsequent to this point, sulfenyl transfer of 50 to the target thiol was followed 
with [2,3]-sigmatropic rearrangement and desulfurization occurred upon addition 
of a thiophilic reagent at room temperature in either methanol or acetonitrile, as 
anticipated (Scheme 23). 
 
Scheme 23: Desulfurative rearrangement of secondary and tertiary allylic 
disulfides 
 
To conclude, this novel chemoselective ligation is a mild, electrophile-free 
transformation that enables the permanent modification of thiols and cysteine 
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residues. Similarly to “click” reactions, the reaction takes place at room 
temperature, in polar media and proceeds with high stereoselectivity. The 
chemoselectivity of this ligation allows the coupling of protecting-group free 
substrates. 
 
1.10 Goals of Part I 
 The work presented in this part of the thesis aims to demonstrate the 
applicability of the 2,3-sigmatropic rearrangement of allylic disulfides as a new 
ligation method for the synthesis of thioether-linked carbohydrate derivatives, and 
provides thereby entry to a novel type of oligosaccharide mimetics. Ultimately, 
the goal is to carry out the ligation step with unprotected sugar building blocks in 
polar media. The further goal is to apply this method to the synthesis of β-(1→6)-
oligo-glucosamine mimetics taking advantage of a building block assembly 
strategy to ensure maximum convergency. 
 
 
 
 
 
 
 
 
 
! 34!
CHAPTER 2 
SYNTHESIS OF  β-(1→6) GLUCOSAMINE MIMETICS OF 
STAPHYLOCOCCUS EPIDERMIDIS BY DESULFURATIVE 
REARRANGEMENT OF ALLYLIC DISULFIDES 
2.1 Introduction 
β-D-(1→6) Oligo-glucosamines are important motifs of bacterial surface 
polysaccharides29,30,34. Surprisingly, the linear synthesis of these compounds has 
not drawn much attention and to date, only a few related papers are found in the 
literature122-129.  The first chemical synthesis of a β-(1→6) hexa- and a 
nonasaccharide of N-acetyl-glucosamine was reported by Yang122,123 and 
coworkers in 2002, following a convergent blockwise approach. Different 
strategies have been used for the elaboration of β-(1→6) oligo-glucosamine 
derivatives, such as the solid phase synthesis developed by the Seeberger 
group125, or the one-pot synthesis adopted by the Baasov group124 (Scheme 1). 
In this context, herein will be described the synthesis of β-D-(1→6) oligo-
glucosamine mimetics based on the desulfurative rearrangement of allylic 
disulfides, in a blockwise assembly fashion130.  
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A. Convergent blockwise synthesis of a hexasaccharide123 
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B. Automated synthesis of a trisaccharide125 
 
C. One-pot synthesis of a tri- and a tetrasaccharide124 
 
Scheme 24: Examples of oligo β-(1→6) glucosamine syntheses  
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The application of the desulfurative rearrangement of allylic disulfides to 
the synthesis of glycomimetics involves the coupling of a saccharide building 
block bearing a thiol functionality, in this case at the C6 position of the sugar, with 
another saccharide building block functionalized with an allylic sulfenyl moiety at 
the anomeric carbon (Figure 2).  
 
Figure 2: Building blocks for the construction of the glycomimetics 
 
The linear chemical synthesis of the β-D-(1→6) glucosamine di- and tetra-
saccharide mimetics was designed using a building block assembly approach; 
the glycoligation reaction would be performed at room temperature and in protic 
polar medium according to the protocol developed in the Crich laboratory114-117. 
In order to enable this key transformation to proceed smoothly in protic solvent, 
the saccharide building blocks were fully deprotected prior to the ligation step. 
Several factors had to be taken into consideration in designing the synthetic 
routes for the preparation of the building block moieties such as the choice of the 
anomeric substituent, the nature of the protecting groups and the glycosylation 
method, in order to minimize the number of protection/deprotection steps and not 
defeat the whole purpose of the protecting group-free glycoligation strategy. As 
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part of this streamlining effort, only one set of glycosylation conditions was to be 
used with the same anomeric substituent, the thiosulfoxide for the glycosyl donor 
and the thioglycoside precursor for the glycosyl acceptor. The protecting groups 
would thus be chosen accordingly in view of performing the deprotection reaction 
in a one-pot manner. Furthermore, as is generally the case in glucosamine 
derivatives, the β-stereoselectivity of the glycosylation reaction would easily be 
accommodated using the participating group at the C2 position; when this would 
not be possible - in case of the azide chemistry - then additives such as solvents 
would be used to control the stereoselective outcome of the glycosylation 
reaction. Finally, the intention was to explore different protecting groups at the 
nitrogen in the glucosamine series to further test the functional group 
compatibility of this key ligation reaction. 
Overall, the stereoselective synthesis of oligo-β-(1→6)-glucosamine 
mimetics required the glucosamine building blocks to bear a temporary protecting 
group at O-6 that can be removed under mild conditions, permanent orthogonal 
protecting groups stable under glycosylation conditions at O-3 and O-4, and 
ideally, a participating protecting group at the amine to control the formation of 
trans β-(1→6) linkages (Figure 3).  
 
Figure 3: Strategy for the synthesis of β-(1→6) linkages 
 
2.2.2 Synthesis of the Disaccharide Mimetics 
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2.2.2.1 Synthesis of the Allylic Thiocarbonate Acceptor 
The preparation of the acceptor 82, developed previously in the Crich 
group131, is presented in Scheme 25. 
 
Scheme 25: Preparation of the the allylic thiocarbonate acceptor 82 
 
Thus, the essential allylic thiocarbonate moiety 82 was synthesized in a 
straightforward manner starting with the conversion of the monosilylated cis-but-
2-ene-1,4-diol 79 to its corresponding phenyloxythiocarbonate compound 80 by 
reaction with phenyl chlorothionocarbonate in presence of catalytic DMAP in 
pyridine. Upon heating in refluxing toluene compound 80 underwent a [3,3]-
sigmatropic rearrangement to give the TBDMS-protected acceptor 81. 
Desilylation of crude compound 81 with p-toluenesulfonic acid monohydrate 
(pTsOH.H2O) gave the desired acceptor 82 in a 70% yield over 3 steps. 
 
2.2.2.2 Preparation of the Unprotected Monosaccharide Disulfide Donor 
 The synthesis of β-(1→6)-oligo-glucosamine mimetics was first envisioned 
in their biologically relevant form29,30 starting from N-acetyl-D-glucosamine. The 
preparation of oligosaccharides containing 2-acetamido-2-deoxy-D-glucose 
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(GlcNAc) is an important task in synthetic carbohydrate chemistry132-137. 
Common glycosylation reactions in this series fail to give the desired coupling 
product as they proceed with neighboring-group participation leading to the 
formation of a stable oxazolinone, compound 85 as the main product (Scheme 
26)138.  
 
Scheme 26: Oxazolinone formation mechanism 
 
As a result, the efficiency of glycosidic coupling reactions involving N-acetyl-
glucosamine donors is significantly lower than that of other glycosides, because 
of the poor reactivity of the oxazolinium intermediate 84. Significant effort has 
been directed towards the development of efficient glycosylation methods using 
the oxazolinone as the glycosyl donor, for the formation of the required β-
glycosides139,140. However, the low reactivity of 84 requires relatively harsh 
conditions for it to be activated, for instance, p-toluenesulfonic acid in refluxing 
toluene132,140, which causes decomposition of both the glycosyl donor and the 
forming  β-glycoside. In regard to these results, mild activation conditions were 
investigated instead and Wittmann138 and Lennartz138 reported that the treatment 
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of the oxazolinone in refluxing chloroform, in the presence of either anhydrous 
cupric bromide (CuBr2) or chloride (CuCl2) enabled the formation of the desired 
 β-glycosides of N-acetyl glucosamines in moderate to good yields. Then, 
Jensen141 and co-workers showed that rare Earth metal triflates such as 
scandium triflate (Sc(OTf)3) were also good Lewis acid catalysts for the formation 
of the oxazolinone from N-acetyl galacto- and glucosamines.  
Following this methodology, the synthesis of the monosaccharide disulfide 
donor 91 was carried as outlined in Scheme 27.  
 
Scheme 27: Synthesis of the unprotected disulfide monosaccharide 91 
 
The synthesis started from the commercially available N-acetyl-D-glucosamine, 
which was first peracetylated in the usual manner to give compound 88. 
Oxazolinone 89 was obtained in an almost quantitative yield, by reaction with 
peracetylated N-acetyl-glucosamine 88 and trifluoromethanesulfonic acid 
(TMSOTf)139 in 1,2-dichloroethane at 50 ºC. Although not a high-yielding 
reaction, the coupling of 89 with the acceptor 82 in the presence of an excess of 
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CuCl2 turned out to be an efficient way to allow the direct formation of the desired 
1,2-trans  β-glycoside 90. The anomeric configuration was confirmed by a 1H 
NMR experiment centered on the value of the vicinal coupling constant 3J 
between the H1 and H2 protons. This coupling constant, 3J, is correlated to the 
dihedral angle H1-C1-C2-H2  (ω) through the Karplus plot. Theoretically, an 
axial-axial vicinal coupling constant for an antiperiplanar H1-C1-C2-H1 
conformation (ω = 180º) observed in 1,2-trans glycosides is usually between 7 Hz 
and 10 Hz. On the other hand, in the case of 1,2-cis glycosides the axial-
equatorial vicinal coupling constant, which corresponds to a dihedral angle ω of 
60º is between 1 to 4 Hz. The 3J1,2 value for compound 90 was found to be 9.3 
Hz, which is in agreement with the theoretical values given from the Karplus plot. 
The subsequent steps, concomitant saponification of the thiocarbonate 
functionality and the acetate groups as well as the sulfenyl transfer reaction 
proceeded as expected. Compound 90 was hydrolyzed using a 1M solution of 
potassium hydroxide (KOH) in dry methanol at 0 ºC131, which was followed by 
sulfenyl transfer upon treatment with 2,2’-dipyridyl disulfide, giving rise to the 
targeted unprotected sulfenyl donor 91 as a 1:1 mixture of diastereomers.  This 
mixture was deliberately not separated since the chirality at the allylic carbon is 
lost during the rearrangement step. 
 
2.2.2.3 Preparation of the Based-Thiol Monosaccharide Moiety 
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 The second part of this [1+1] coupling reaction consisted in the 
preparation of the 6-deoxy-6-thiol monosaccharide unit. The synthesis of 95 was 
set following a straightforward process as shown in Scheme 28.  
 
Scheme 28: Synthesis of the based thiol monosaccharide  
 
The methyl  β-glycoside 92 was obtained under the same standard glycosylation 
conditions as previously described138 in this series but in a significantly higher 
yield than that of the coupling of acceptor 82, underlining the relatively low 
reactivity of 82 towards the oxazoline glycosyl donor. The  β-stereoselectivity of 
the coupling reaction was confirmed by 1H NMR (3J1,2 = 8.0 Hz). Deacetylation of 
92 using Zemplén conditions gave methyl N-acetyl-β-D glucosaminide 93. 
Introduction of the thioacetate functionality at the C6 position was readily 
achieved in a one-step fashion, by a chemo- and regioselective Mitsunobu142 
reaction. The primary alcohol was thus selectively converted to its 6-thioacetate 
derivative without the need of protecting groups at the remaining free secondary 
alcohols. Care was required for the handling of the free primary thiol 95, which 
was prone to oxidation to its disulfide counterpart. Therefore, the hydrolysis step 
was carried out under oxygen-free conditions, which necessitated the preparation 
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of a fresh solution of sodium methoxide (NaOMe) in degassed methanol. 
Unprotected 6-thio-glycoside 95 was then ready to be subjected to the ligation 
reaction. 
 
2.2.3 The Ligation Reaction: Coupling of the Unprotected Monosaccharide 
Moieties 
 With the two monosaccharide building blocks in hand, attention was then 
focused on the key step of this synthesis, which consisted of the conjugation of 
the monosaccharide thiol 95 with the anomeric disulfide monosaccharide donor 
91. 
 
Scheme 29: Ligation of disaccharyl sulfenyl donor 91 and thiol 95 
 
 As discussed in section 1.8, the standard protocol for this transformation was 
developed in polar media and at room temperature115,116,131. According to the 
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conditions set forth, the first step of this transformation – the sulfenyl transfer – 
was carried out in regular methanol and proceeded smoothly as anticipated. The 
sulfenyl transfer reaction could easily be followed by naked eye as the side-
product, the pyridyl-thiol, is characterized by a persistent yellow color. However, 
the advancement of the reaction was followed by TLC and electrospray mass 
spectrometry to ensure the complete consumption of the based-thiol 
monosaccharide 95. At this point, the disulfide disaccharide intermediate 96 was 
ready to undergo the final step of this two-step process, which consisted of a 
[2,3]-sigmatropic rearrangement followed by phosphine-mediated desulfurization 
leading to the incorporation of an allylic thioether bond between the sugar 
moieties. 
Initially developed in the presence of a phosphine reagent116, the 
desulfurization step was first promoted by triphenylphosphine as the thiophilic 
reagent. Previous studies undertaken in the Crich laboratory showed that the use 
of a more nucleophilic phosphine, for instance a trialkylphosphine, was 
accompanied by the formation of undesired coupling products, due to competitive 
reaction between the phosphine and the pre-formed disulfide intermediate115,116. 
Given these observations, the choice of the phosphine reagent was then limited 
to the triarylphosphine series rather than the alkylphosphines, despite their low 
solubility in polar solvents. Thus, because of the poor solubility of 
triarylphosphines in polar solvents, another alternative, the use of silver nitrate 
salts,143 has also been investigated and developed in the Crich laboratory as a 
replacement for triphenylphosphine reagents. Studies indicated that the silver 
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nitrate salts were more reactive towards the desulfurative rearrangement of allylic 
disulfides than their triphenylphosphine counterparts, allowing the transformation 
of unreactive substrates while fulfilling the same reaction criteria; the reaction 
proceeds in a few hours at room temperature, in polar solvents and with high E-
selectivity.  
The coupling reactions proceeded in good yield, independently of the 
thiophilic reagent used.  The installation of the 2-butenyl linker took place with 
complete trans-selectivity (3Jtrans = 16.8 Hz) giving rise to the formation of the E-
isomer exclusively in both cases (PPh3 and AgNO3 conditions), as was expected 
with respect to related [2,3]-sigmatropic rearrangements, such as the Mislow-
Evans rearrangement112 as was discussed in section 1.9 or the [2,3]-Wittig 
rearrangement144. A proposed mechanism for this transformation is shown in 
scheme 30. 
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Scheme 30: [2,3]-Sigmatropic rearrangement mechanism 
 
By analogy with similar rearrangements, the mechanism of this transformation 
was expected to proceed via an envelope-like transition state, where two 
different patterns could be drawn, with regard to the relative orientation of the 
homoallylic methylene group, either endo or exo to the five-membered ring; the 
exo-mode being the more favorable as it displays less unfavorable interactions.  
 
2.2.4 Synthesis of the Tetrasaccharide Mimetics 
 Seeking to apply the scope of this facile [2,3]-sigmatropic rearrangement 
of allylic disulfides to the synthesis of oligosaccharide mimetics, the preparation 
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of two tetrasaccharide mimetics was carried out following the same building block 
approach strategy used for the synthesis of the monosaccharide mimetic 97.  
 
2.2.4.1 The First Approach: The NHAc Series 
2.2.4.1.1 Preparation of the Unprotected Disulfide Disaccharide Building 
Blocks 
 Following the initial approach, the synthesis of the disulfide disaccharide 
building block started with the N-acetyl glucosamine series. The synthesis of the 
target disaccharide building blocks was envisioned as schematized in the 
retrosynthetic scheme below. 
! 49!
 
Scheme 31: Retrosynthetic analysis (NHAc series) 
 
Given the satisfactory results obtained from the coupling reactions using the 
oxazolinone 89 as the glycosyl donor, the construction of the disaccharide 
moieties was undertaken according to that same synthetic route (Scheme 32). 
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Scheme 32: Attempted construction of building block 99 
 
Disaccharide 105 was obtained under standard Cu (II) conditions138 and in a 
good yield, with respect to the reported yields found in the literature for coupling 
reactions made in the NHAc series. The oxazolinone disaccharide 101 was 
prepared from 105, in 54% yield, via in-situ formation of the corresponding 
anomeric bromide using TMSBr, BF3Et2O and 2,4,6-collidine under anhydrous 
conditions. Unfortunately, the coupling of the oxazolinone disaccharide donor 
101 with acceptor 82 gave results far below expectations and yielded an 
inseparable, complex mixture of products along with the desired coupling 
product, which was observed by electrospray mass spectrometry. These results 
were in line with what was observed earlier and confirmed the low reactivity of 
the allylic thiocarbonate acceptor towards oxazolinone donors. A further reason 
for the low efficiency of these coupling reactions may be the use of multiple 
electron-withdrawing protecting groups on the glycosyl donor which significantly 
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lowers its reactivity – a manifestation of the “disarmed” effect of the O-acetyl 
groups, a phenomenon that was described by Fraser-Reid145, and which is also 
referred as to the “armed/disarmed” principle. This notion will be presented in 
part II of this dissertation. Given these considerations, the use of acetate as a 
protecting group at the nitrogen and as a C2-stereodirecting, participating group, 
was considered no to be suitable for the synthesis of the tetrasaccharide 
mimetic. The strategy was therefore redirected towards the azide chemistry and 
the avoidance of disarming protecting groups.  
 
2.2.4.2 The Second Approach: The Azido Series 
2.2.4.2.1 Strategies for the Synthesis of the Tetrasaccharide Mimetic 
The synthesis of the tetrasaccharide mimetic was next attempted in the 2-
azido-2-deoxyglucose series as envisaged in the retrosynthetic scheme shown 
below. 
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Scheme 33: General retrosynthetic scheme (N3 series) 
 
  Different protecting groups at the nitrogen133 of glucosamine derivatives 
have been investigated to prevent the formation of the oxazolinone while keeping 
neighboring group assistance to ensure the formation of 1,2-trans glycosides, 
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trichloroethoxycarbonyl (Troc)148-150. The 2-azido group42,151-153, which is distinct 
in that it is not capable of neighboring group participation, has also been used for 
this purpose, especially when  α-glycosides were required. The absence of  β-
directing neighboring group participation needed for the synthesis of β-glycosides 
can be overcome through use of the nitrile effect42,154,155.  
The influence of solvents on anomeric stereocontrol is a well known 
phenomenon156. Ether and nitrile solvents such as acetonitrile can exert a 
stereodirecting effect on the outcome of the glycosylation reaction, also referred 
as to the ether effect151,157 and the nitrile effect respectively. In the nitrile effect, 
after activation and departure of the leaving group (LG), the forming 
oxocarbenium ion intermediate is trapped, by acetonitrile via the formation of a 
covalent  α-acetonitrilium ion 116, leaving the  β-face open for attack by the 
incoming glycosyl acceptor, which displaces the latter in a SN2 fashion to give the 
β-glycoside 117 (Scheme 34).   
 
Scheme 34: The nitrile effect 
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The installation of the azido group at the C2 position was envisaged under 
Stick’s158 conditions, using imidazole-1-sulfonyl azide hydrochloride 118 as the 
diazotransfer reagent, whose synthesis is reported in Scheme 35.  
 
Scheme 35: Preparation of the imidazole-1-sulfonyl azide hydrochloride 
 
 In order to optimize the reactivity of the glycosyl donor and considering the 
strong electron-withdrawing character of the 2-azido group, armed protecting 
groups such as ethers were employed, to mask the hydroxyl functionalities. 
Following this logic, the p-methoxybenzyl ether (PMB) was selected on the basis 
of its anticipated orthogonality with the 2-azido group and the acceptor 82 – 
unlike the more commonly used benzyl ether group. The regioselective 
functionalization at the 6-position would be ensured by using the Ley’s 
cyclohexane diacetal (CDA)159,160 protecting group since it is highly efficient for 
the protection of the trans-diequatorial-1,2-diol functionality in carbohydrate 
chemistry. Moreover, both the PMB and CDA protecting groups are acid labile, 
suggesting a one-pot deprotection step. Only one set of glycosylation conditions 
was used, whose choice was conditioned by the presence of the acid-sensitive 
PMB groups, which are cleaved under mild acidic conditions (e.g 5 to 10% TFA), 
and the allylic disulfide functionality. Based on these considerations, Kahne’s161-
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163 sulfoxide glycosylation method was selected. This method uses a glycosyl 
sulfoxide as the donor and trifluoromethanesulfonic anhydride as the promoter; 
leading to the formation of a covalent glycoside triflate as the intermediate 
species, as identified in pioneering work done by Crich and coworkers164,165.  
The synthesis of the tetrasaccharide mimetic is presented in the next two 
sections. 
 
2.2.4.2.2 Preparation of the Unprotected Disaccharide Disulfide 107 
The synthesis of the disulfide disaccharide moiety started with the 
preparation of both the glycosyls donor 38 and acceptor 39 as outlined in 
scheme 36.  
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Scheme 36: Preparation of glycosyl donor 112 and acceptor 113 
 
A common path was used for the synthesis of compounds 112 and 113, 
beginning with commercially available N-acetyl-D-glucosamine. The synthesis 
started with installation of the chloride at the anomeric position, followed by 
peracetylation upon treatment with acetyl chloride, giving rise to a mixture of α/β 
chloro peracetyl N-acetylglucosamine. The subsequent synthesis was conducted 
only with the β-chloro compound 119 because of the low reactivity of the  α 
anomer. Compound 119 was converted to its corresponding thioglycoside 120 by 
reaction with thiophenol166 in 92% yield (3J1,2 = 10.4 Hz). Thioglycoside 120 was 
fully deprotected in the presence of 1 M NaOH166 prior to installation of the azido 
group at the 2-position by reaction with imidazole-1-sulfonyl azide 
hydrochloride158 118 to give the 2-azido β-thioglycoside 121 in 70% yield over the 
two steps. Then, from compound 121, a one step reaction using trimethyl 
orthoformate and butane-2,3-dione in presence of a catalytic amount of CSA 
afforded glycosyl acceptor 113159 in 83% yield. Installation of the PMB groups at 
the 3-, 4-, and 6-positions was carried out under standard conditions167 to give 
compound 122 in 84% yield, which was finally oxidized in presence of m-
CPBA168 to give the β-glycosyl sulfoxide donor 112 as an equal mixture of 
diastereomers and in 91% yield.   
With the glycosyl donor and acceptor in hand, the synthesis was carried 
out through the formation of the unprotected disulfide disaccharide moiety as 
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depicted in Scheme 37 proceeding first with the coupling of compounds 112 and 
113 using Kahne’s glycosylation conditions161-163.  
 
Scheme 37: Synthesis of the unprotected disaccharide disulfide precursor 
107 
 
The glycosyl sulfoxide donor 112 was activated with Tf2O in presence of the 
glycosyl acceptor 113, in a 4:3 mixture of CH2Cl2:MeCN. An excess of a non-
nucleophilic base, TTBP*169, was used in order that the PMB groups would 
withstand the glycosylation conditions. The use of Kahne’s sulfoxide 
methodology allowed the activation of the thiosulfoxide donor 112 in presence of 
the thioglycoside 113 in the reaction medium, as described for related 
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compounds by the van Boom group162,170. The glycosylation reaction was 
conducted at low temperature (- 80 ºC) because of the high reactivity of the 
sulfoxide donor 112, which was easily prone to react at higher temperatures, in 
an intramolecular fashion via neighboring group participation of the ether group 
at O-6 to form a 1,6-anhydro by-product171. The stereoselectivity of the 
glycosylation reaction was controlled by the nitrile effect42,154,155. Disaccharide 
123 was thus obtained with high diastereoselectivity in favor of the  β-anomer 
(α/β > 1/20) and in 62% yield. The β-selectivity of the reaction was confirmed by 
1H NMR experiments (3J1,2 = 7.6 Hz). The resulting disaccharide was then 
oxidized to its sulfoxide counterpart using m-CPBA168, to further allow the 
introduction of the acceptor 82 at the anomeric position. The coupling reaction 
between 109 and 82 proceeded with complete β-stereoselectivity (3J1,2 = 8.8 Hz) 
and afforded the disaccharide disulfide precursor 124 in 63% yield. Hydrolysis of 
124 took place upon treatment with aqueous trifluoroacetic acid (TFA)172 in 
presence of thioanisole, and afforded the fully deprotected disaccharide 125. 
Finally, saponification of 125 was followed by treatment with 2,2’-dipyridyl 
disulfide131 to give the target compound 107 as a 1:1 mixture of diastereomers 
and in 65% yield over the two steps.  
 
2.2.4.2.3 Preparation of the Unprotected Based-Thiol Disaccharide Building 
Block 108 
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The synthesis of 108 was carried out in a straightforward manner from 
intermediates 110 and 111. The synthesis of the thiosulfoxide donor 110 was 
conducted as schematized below (Scheme 38). 
 
Scheme 38: Synthesis of the thiosulfoxide donor 110 
 
Functionalization at the 6-position proceeded first with introduction of the tosyl 
group173, giving rise to compound 126 in a quantitative yield. This was followed 
by displacement of the tosyl group by potassium thioacetate173, which gave the 
desired 6-thioacetate precursor 127 in 67% yield. Finally, compound 127 was 
treated with m-CPBA under the usual conditions to give the glycosyl sulfoxide 
donor 110 in 70% yield and as a single diastereomer. 
 
The glycosyl acceptor 111 was synthesized on the same basis as glycosyl 
acceptor 113 as shown in Scheme 39. 
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Scheme 39: Synthesis of the glycosyl acceptor 111 
 
After complete hydrolysis of the acetate groups, the azido functionality was 
installed at the 2-position158 to give compound 129 in 90% overall yield. Finally, 
protection of the 3- and 4- hydroxyl groups with the CDA protecting group159 
afforded the target glycosyl acceptor 111 in 81% yield. 
Elaboration of the disaccharide based-thiol was then completed as 
presented in Scheme 40. 
 
Scheme 40: Synthesis of the deprotected based-thiol disaccharide 108 
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The glycosyl donor 110 and acceptor 111 were coupled under Kahne’s 
glycosylation conditions161-163, in a 3:1 mixture of CH2Cl2:MeCN and yielded 
disaccharide 130 as a 1:6  α/β mixture of anomers in a moderate yield. The 
mixture was subjected to aqueous TFA in dichloromethane to give the 
deprotected disaccharide 131 as a 1:10 mixture of α/β anomers, from which the 
β-anomer (3J1,2 = 7.8 Hz) was purified by column chromatography. Hydrolysis of 
the 6-thioacetate to give the 6-primary thiol completed the synthesis of the 
disaccharide based-thiol building block 108. The reaction was carried out under 
neutral conditions under an oxygen-free atmosphere in dimethylformamide, by 
reaction with hydrazine acetate. Because of sensitivity to aerial oxidation, the 
resulting deprotected disaccharide 108 was not isolated and was used in crude 
form in the final step of the synthesis. 
 
2.2.4.2.4 The Ligation reaction: Conjugation of Unprotected Disaccharide 
Moieties 107 and 108 
 With the two disaccharide building blocks in hand, the final step of the 
synthesis of the tetrasaccharide mimetic 106 were carried out by coupling both 
unprotected disaccharide building blocks 107 and 108 as shown in Scheme 41.   
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Scheme 41: Ligation of disaccharyl sulfenyl donor 107 and thiol 108 
 
The transformation took place smoothly as expected, under the standard 
conditions previously described116,131 and gave the target tetrasaccharide 
mimetic 106 in moderate yield. The desulfurization step was carried out with 
silver nitrate143 to ensure retention of the azide functionality at the 2-position, and 
proceeded with complete E-selectivity giving rise to compound 106 as the only 
isomer detected, in 52% yield. 
 
2.2.4.3 The Third Approach: The NHTroc Series 
The last example targeted to test the applicability of this methodology 
centered on the use of the N-Troc-protected glucosamine series. Both 
disaccharide moieties were synthesized according to a similar strategy as the 
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in the next two sections. An overall retrosynthetic scheme is presented below 
(Scheme 42). 
 
Scheme 42: General retrosynthetic scheme (N-Troc series) 
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 The synthesis started with the construction of the disulfide disaccharide 
unit 133, for which the synthesis of the corresponding glycosyl donor 138 and 
acceptor 139 is outlined in the scheme below. 
 
Scheme 43: Synthesis of glycosyl donor 138 and acceptor 139 
 
The synthesis of compounds 138 and 139 was quite straightforward and started 
from commercially available D-glucosamine hydrochloride 140. Installation of the 
carbamate functionality at the 2-position followed by peracetylation under the 
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α/β mixture. Functionalization of the anomeric position by introduction of 
thiophenol175 gave the thioglycoside 142, whose β-selectivity was ensured by 
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single diastereomer, and in 88% yield. Deacetylation of compound 142 under 
Zemplén conditions followed by Ley’s176 CDA protection of the 4- and 6-positions 
gave the targeted thioglycosyl acceptor 139 in 72% yield. 
The synthesis of the first disaccharide building block 133 was undertaken as 
follows (Scheme 44).  
 
Scheme 44: Synthesis of the unprotected disulfide disaccharide moiety 133 
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was then advanced with the introduction of the essential allylic acceptor 82 at the 
anomeric position, which took place after the thioglycoside 144 was oxidized to 
its thiosulfoxide counterpart 135. The disaccharide disulfide precursor 145 was 
obtained with total β-stereoselectivity (3J1,2 = 9.6 Hz) and in 65% yield. Hydrolysis 
of the CDA protecting group under aqueous TFA conditions afforded compound 
146 in 68% yield. Finally, the synthesis of the unprotected disulfide disaccharide 
133 was achieved by the standard deacetylation of intermediate 146 upon 
treatment with 1 M KOH in MeOH, followed with installation of the disulfide 
functionality by reaction with 2,2’-dipyridyl disulfide, to give the target compound 
133 as a 1:1 mixture of diastereomers. 
 
2.2.4.3.2 Preparation of the Unprotected Based-Thiol Disaccharide Building 
Bloc 134 
 The last step toward the elaboration of the tetrasaccharide mimetic in the 
N-Troc series consisted of the synthesis of the based-thiol disaccharide moiety, 
which was prepared from the glycosyls donor 136 and acceptor 137 as 
schematized in Scheme 45. 
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Scheme 45: Synthesis of glycosyl donor 136 and acceptor 137 
 
Compound 142 was used as the starting material for the synthesis of the glycosyl 
acceptor 137, which was obtained in three steps starting with introduction of the 
methoxy group at the anomeric position. The coupling of thioglycoside 142 with 
methanol under N-iodosuccinimide (NIS)/trifluoromethanesulfonic acid (Tf2O) 
conditions177 gave the corresponding methyl glycoside 147 in excellent yield and 
stereoselectivity (3J1,2 = 9.2 Hz). Hydrolysis of 147 under Zemplén conditions was 
followed by installation of the CDA protecting group159 at the 3- and 4-positions to 
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Scheme 46: Synthesis of the based-thiol disaccharide 134 
 
The coupling efficiency of the glycosylation reactions in the N-Troc series was 
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precautions were used for the hydrolysis of 151, which was achieved with 
hydrazine acetate at room temperature. The resulting disaccharide was directly 
engaged in the final step of the synthesis without further purification. 
 
2.2.4.3.3 The Ligation Reaction: Conjugation of Unprotected Disaccharide 
Moieties 133 and 134 
 Finally, the key step of this synthesis, the ligation reaction, completed the 
construction of the tetrasaccharide mimetic in the N-Troc series. The two 
disaccharide building blocks were assembled under the standard conditions and 
the transformation took place uneventfully, giving rise to the last tetrasaccharide 
mimetic 132 in 54% yield. The desulfurative rearrangement was promoted under 
triphenylphosphine conditions for purification reasons. 
 
Scheme 47: Ligation of disaccharyl sulfenyl donor 133 and thiol 134 
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2.3 Conclusion 
 This chapter presented a novel approach for the preparation of 
oligosaccharide mimetics by the means of a recently developed [2,3]-sigmatropic 
rearrangement of allylic disulfides. Two pre-assembled sugar units were attached 
together via a small, thioether linkage, whose installation proceeded with 
complete chemoselectivity. The features of this facile transformation were 
exploited to construct these glycomimetics without protecting groups. The use of 
the azide and the trichloroethoxycarbonyl groups demonstrated the compatibility 
of this transformation with diverse functionalities. This method could then been 
used as an alternative for the construction of large, linear oligosaccharide 
mimetics from pre-assembled small sugar units.  
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PART II: STEREOELECTRONIC INFLUENCE OF C-O BONDS ON C- AND O-
GLYCOSYLATION 
 
CHAPTER 3 
INTRODUCTION 
3.1 The Glycosyl Oxocarbenium Ion: a Transient Intermediate 
 As briefly introduced in section 1.4, the glycosylation reaction is a complex 
phenomenon that involves numerous components and the mechanism that lies 
behind it has not yet been fully understood. Unless anchimeric assistance by a 
NPG at C2 of the sugar occurs, the mechanism of the glycosylation reaction is 
not clear-cut. Two extreme schemes can be readily drawn going from a direct 
bimolecular SN2 displacement of the anomeric substituent, which corresponds to 
an associative mechanism, to an unimolecular SN1 reaction via the formation of a 
glycosyl oxocarbenium ion, in which case a dissociative pattern is involved. Yet, 
it has been commonly accepted that a cationic intermediate, the putative 
oxocarbenium ion, was, at some point of the reaction, involved in the mechanistic 
scheme of the glycosylation reaction. Although conventionally drawn out in 
almost all the mechanistic patterns in carbohydrate chemistry involving the 
forming or the breaking of bonds at the anomeric carbon, in reality, evidence of 
the actual existence of the oxocarbenium ion has still to be proven 
experimentally179,180. To address this issue, indirect methods most commonly 
computational or NMR spectroscopic studies, have served as tools to gain better 
inside into the general features of this supposedly key intermediate. 
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If oxocarbenium ion is an intermediate in glycosylation processes, the 
abundance of carbohydrate molecules in higher organisms implies that many 
biological processes proceed via the formation of oxocarbenium ion 
intermediates. Biological mechanisms that consider to include oxocarbenium ion 
intermediates are encountered for instance, in the biosynthesis of cyclic ADP-
ribose (cADP), an important intermediate for intracellular calcium signaling and, 
of more interest for carbohydrate chemists, glycosidases, enzymes involved in 
the breakdown of glycosidic bonds. As a result, understanding the chemical and 
physical properties of the oxocarbenium ion goes to the heart of glycochemistry 
and glycobiology.  The hydrolysis of glycosidic bonds, which is in fact the inverse 
reaction of the glycosidic bond formation, has been subjected to a tremendous 
amount of work, in both mechanistic enzymology, whose mechanisms first were 
proposed by Koshland181 in 1953 and then revisited over the years182, and in 
carbohydrate chemistry. This is especially true for the acid-catalyzed hydrolysis 
of glycopyranosides183 whose mechanism will be discussed in Chapter 5. 
Mechanistically, it has been generally accepted by both communities, chemists 
and enzymologists, that the breaking of the glycosidic bond involves the 
formation of a species exhibiting a high degree of oxocarbenium ion character. 
Indeed, the strategy adopted by enzymologists in the concept of glycosidase 
inhibitors, seeks to mimic the transition state of the hydrolysis of the glycosidic 
bond, which is believed to go through an exploded transition state, in other 
words, to mimic the structure of the oxocarbenium ion, by miming its positive 
charge and/or geometry184 (Figure 4).  
! 73!
 
Figure 4: Proposed transition state during the glycosidic bond cleavage 
 
Failing to observe the glycosyl oxocarbenium ion experimentally, 
structurally related, but more stable species than the oxocarbenium ion have 
been studied as probes. Falling into this category, examples such as simple 
alkoxycarbenium ions, prepared first by Meerweein then observed and described 
experimentally by NMR spectroscopy in superacids by different research groups, 
such as the Olah group, have rendered plausible the idea that comparable 
intermediates could be envisaged in the mechanistic pattern of the glycosylation 
reaction. Some NMR spectroscopy characteristics of several of these 
intermediates are outlined in Figure 5.  
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In line with this, Woerpel185 provided complementary information by investigating 
the characteristics of polysubstituted cyclic dioxocarbenium ions, for which he 
determined that the orientation of alkoxy substituents on the half-chair 
conformation are governed by electronic interactions with the electron deficient 
cyclic oxocarbenium ion,  thus forcing the alkoxy substituents to occupy pseudo-
axial positions, unlike their alkyl counterparts, which prefer to sit at the equatorial 
positions of the half-chair conformation (Scheme 48)186,187. 
 
Scheme 48: Preferred orientation of alkoxy and alkyl substituents on a 
cyclic dioxocarbenium ion 
 
Clearly, the geometry of the oxocarbenium ion is a crucial piece of 
information that is needed in order to understand the stereoselective outcome of 
glycosylation reactions. Computational studies remain a powerful, indirect 
method to provide theoretical explanations for experimental observations. 
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energies, which are presented in a 3D spherical representation along with the 
chair, boat and skew boat conformers that link them (Figure 6).  
 
Figure 6: Conformational representations of glycopyranosyl ring 
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question of whether or not an entity of this type could have a real existence in the 
typical organic medium used in glycosylation reactions, mostly dichloromethane, 
was raised rightly a few years ago by Sinnott192, who pointed out that if aqueous 
solutions cannot sustain a good charge separation of such polarized species, 
then a fortiori solvents like dichloromethane ( ε = 8.93 at 25 °C), with a dielectric 
constant far less than water (ε = 78.30 at 25 °C) cannot do so. From this 
reasoning another question arises as to the actual lifetime of the oxocarbenium 
ion? Jencks180 and coworkers estimated the lifetime of the glycosyl 
oxocarbenium ion to be around ∼ 10-12 s at room temperature and in an aqueous 
solution devoid of nucleophiles – the half-life of bond vibration being ~10-13 s. 
This estimated lifetime in aqueous solution is very different from the lifetime 
evaluated by Yoshida193-196, of simple alkoxycarbenium ions, which he found to 
be on the scale of minutes in dichloromethane, at – 80 °C and the absence of a 
strong nucleophile.  
On this basis, any firm conclusions will be hard to draw and subjective 
because of the indirect nature of all of these experiments. However, many 
consistent data such as the evidence of glycosylation reactions exhibiting 
unimolecular kinetics197,198 lean towards the acceptation of the postulate of the 
transient existence of a glycosyl oxocarbenium intermediates. 
  
3.2 General Chemical Glycosylation Mechanism 
Mechanistically, the glycosylation reaction corresponds to an acetal 
formation, which in itself involves one of the most empirical concepts of organic 
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chemistry, C-O bond formation and yet, one of the most puzzling mechanisms. 
The focus of this section will be to give a general overview of the mechanism of 
the glycosylation reaction by bringing its key intermediates into perspective, with 
a particular emphasis on one class of glycosylation reaction, the 4,6-O-
benzylidene-directed glycopyranosylation reaction. 
The nature of the protecting group at the C2 position of the glycosyl donor 
can influence the mechanistic scheme of the glycosylation reaction and thereby, 
its outcome. When a participating group is present at C2 – most commonly O- or 
N-acyl groups – the departure of the activated leaving group can be assisted by 
this later, leading to the formation of an acyloxonium ion, which temporarily 
blocks one face of the sugar, giving rise to the 1,2-trans glycosides as the major 
product (Scheme 49)57. 
 
Scheme 49: Mechanism of the glycosylation reaction in presence of a NPG  
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one with a broad tray of possible mechanistic schemes. Details have been added 
onto the picture first advanced by Rhind-Tutt and Vernon197, followed by the work 
of Lucas and Schuerch199, and finally revisited in the seminal contribution of 
Lemieux39 et al. According to this picture the glycosyl donor exists in a series of 
equilibria of more or less loose ions pairs that stretch from its activation until its 
transformation into the desired glycoside, with the position of the equilibrium as 
well as the population of each intermediate species being functions of the 
conditions set. The general scheme of these equilibria depicted by Lemieux is 
presented in Scheme 50. 
 
Scheme 50: Lemieux ion-pair glycosylation mechanism 
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at  α-oxygen-substituted carbon are all factors that disfavor a SN2 mechanism. It 
is therefore not surprising that most glycosylation reactions are considered to 
proceed via a dissociative mechanism, and the difficulty to achieve complete 
anomeric stereocontrol in absence of a NPG follows from these mechanistic 
assumptions. Glycosyl halides, introduced first by Koenigs and Knorr38 as 
glycosyl donors, have been one of the class of substrates for which a pure SN2 
pattern has been observed197.  
Although, many glycosylation reactions proceed via a dissociative 
mechanism, insight into the details of SN1-like glycosylation mechanism is still 
limited,200 therefore examples of such reactions will not be presented here. 
Instead, attention will be paid towards the mechanistic scheme of a glycosylation 
mechanism more relevant to the work presented here, the 4,6-O-benzylidene 
directed glycosylation reaction. 
 
3.2.1 4,6-O-Benzylidene-Directed Glycosylation Reaction 
 Groundbreaking studies undertaken in the Crich201,202 laboratory to 
unravel the mechanism of the glycosylation reaction, more specifically the ones 
involving 4,6-O-benzylidene protected donors, started with the solution of the 
challenging problem of the formation of β-mannosidic linkages. In 1996, Crich201 
discovered that the 4,6-O-benzylidene protecting group was a determining factor 
in controlling the β-selectivity of the mannopyranoside reaction. Long dreaded by 
carbohydrate chemists, a facile access to  β-mannosides has been paved from 
Crich’s seminal papers on sulfoxide glycosylation method162,203 – initially 
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introduced by the Kahne group161 – wherein he identified by low-temperature 
NMR experiments in CD2Cl2, that  α-covalent glycosyl triflates were the key 
intermediate species in glycosylation reactions involving trifluoromethanesulfonic 
anhydride (Tf2O) as the promoter165. When 4,6-O-benzylidene- α-D-
mannopyranosyl sulfoxide donors react with Tf2O, in the presence of ether-type 
non-participating protecting groups at O2 and O3, the coupling reaction results in 
the formation of β-D-mannosides204. On the basis of the established reaction 
protocol, the β-mannosylation reaction typically involves a two-step process. The 
sulfoxide donor is first pre-activated with Tf2O at low temperature to promote the 
formation of the covalently bound α-mannosyl triflate, which is followed by 
addition of the acceptor to give the β-mannoside product, with typically high yield 
and high selectivity. The scope of this reaction was later on expanded to  α- and 
β-D-mannopyranosyl thioglycoside205 donors, which were also found to be 
excellent substrates for the induction of α-mannosyl triflates by the means of the 
electrophilic BSP/Tf2O combination178 (Scheme 51). 
 
Scheme 51: Synthesis of  β-D-mannopyranosides 
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mechanism of the  β-mannosylation reaction was most likely governed by an 
unimolecular nucleophilic substitution, until very recently, complementary studies 
on primary 13C kinetic isotopic effects207 (higher magnetic field, 200 MHz for 13C) 
supported by DFT calculations showed that the β-mannosylation mechanism as 
well as the  α- and β-glucosylation reactions were associative in nature (SN2 like)  
going via the intermediacy of an exploded transition state where the incoming 
alcohol displaces the triflate group from the opposite face (Scheme 52)207.  
 
Scheme 52:  Exploded transition state 
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Scheme 53: Mechanism of  α- and β- gluco and mannopyranosides 
formation with 4,6-O-benzylidene protected donors as determined by KIE 
measurements 
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glycosyl donors as well as in the stereochemical outcome of the glycosylation 
reaction. The ability to tune the reactivity of glycosyl donors and acceptors 
through the modification of protecting groups, is a direct application of the 
seminal “armed-disarmed” concept introduced by Fraser-Reid145 and is a major 
focus for the improvement of oligosaccharide synthesis. The past two decades 
have witnessed an increase in the understanding of the effect of protecting 
groups on anomeric reactivity, providing the basis for the development of efficient 
methods and strategies for the synthesis of oligosaccharides such as, the one 
pot synthesis,50,176 and the automated solid phase synthesis52 discussed 
previously in Chapter 1.  
First noted by Paulsen151 in 1982, Fraser-Reid145,208 observed a few years 
later that the nature of the substituent at O2 had a considerable influence on the 
rate of hydrolysis of glycosyl donors. This was followed by his early observation 
that 2-O-akylated pentenyl glycosides reacted faster than their 2-O-acylated 
counterparts, in presence of a halonium ion source, for instance, iodonium 
dicollidine perchlorate (IDCP) when no evidence of self-condensation of the 
pentenyl glycoside acceptor was detected145. In other words, benzylated pentenyl 
glycosyl donors react faster than their acetylated counterparts  (Scheme 54)208.  
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Scheme 54: “Armed-disarmed” principle 
 
This difference in reactivity was ascribed to a difference in the electron-
withdrawing character of the protecting group, from which Fraser-Reid145 
stipulated that, an armed glycosyl donor was defined as one bearing electron 
donating groups, such as ether groups, most often, benzyl groups. On the other 
hand, a disarmed glycosyl donor was defined as a system bearing electron-
withdrawing groups such as ester groups, most commonly benzoyl or acetate 
groups. A similar observation was noted for cyclic acetal protecting groups such 
as 1,3-dioxanes or 1,3-dioxalanes, which, as Fraser-Reid209 also reported, 
affected anomeric reactivity, although the origin of this disarming effect is rather 
different in nature than the one encountered in acyclic protecting groups, as 
discussed further in the next section.  A mechanistic rationale was advanced to 
explain this disparity in reactivity based on electronic factors according to which 
the partial or full forming positive charge at the endocyclic oxygen/anomeric 
carbon in the course of the glycosylation reaction, is either stabilized or 
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destabilized by, respectively, the electron-donating or electron-withdrawing 
nature of the protecting group at C2 (Scheme 55)208. 
 
Scheme 55: Rationale for the “armed/disarmed” effect in glycosyl donors 
  
With this in mind, Fraser-Reid demonstrated that benzylated donors could 
be activated selectively in presence of an equimolar amount of the benzoylated 
donor when competing with one equivalent of the promoter ICDP and in 
presence of an excess of methanol, to give the corresponding benzylated methyl 
glycoside. However, modifying the reaction conditions by changing the nature of 
the promoter for example, the N-iodosuccinimide (NIS)/triethylsilyltriflate 
(Et3SiOTf)210,211 combination, led to the activation of the disarmed donor 161 and 
gave a 5:1 mixture of both methyl glycosides (Scheme 56).  
 
O
OBn
X
E
Karm
HO
O
OBn
X
HO
E
O
OBn
HO
fast
O
OAc
X
E
Kdisarm
HO
O
OAc
X
HO
E
O
OAc
HO
slowδ+δ+
δ+
- XE
- XE
O
OBn
OR
HO
O
OAc
OR
HO
ROH
ROH
Armed glycosyl donor
Disarmed glycosyl donor
O
OR O
160: R = Bn 
161: R = Bz
OR
RORO
MeOH (6 eq)
promoter (1 eq)
CH2Cl2
O
BnO OMe
OBn
BnO
BnO
O
OBz
OMe
OBz
BzO
BzO
IDCP
NIS/Et3SiOTf
162 (α/β) = 1:2 163: not observed
162 (α/β)/ 163 = 5:1
! 86!
Scheme 56: Competition reaction between an armed and a disarmed 
glycosyl pentenyl donors 
 
From these observations, Fraser-Reid was able to exploit his armed/disarmed 
concept and use it as the basis for the elaboration of a one-pot synthesis of a 
trisaccharide145,212 based on a chemoselective synthesis strategy (Scheme 57). 
 
Scheme 57: Fraser-Reid’s one-pot trisaccharide synthesis 
 
3.4 Cyclic Acetal Protecting Groups 
 Cyclic acetals such as the 4,6-O-benzylidene 165 or either cyclic 
carbamates 165 or carbonates 167 as shown in Figure 7, are commonly 
employed in oligosaccharide synthesis strategy as temporary protecting groups, 
for their chemoselectivity as well as their directing effect in glycosylation 
reactions. However, the origin of the disarming effect that they exert on glycosyl 
reactivity is unclear, which impedes any type of mechanistic rationale and makes 
predictions on the glycosylation stereochemistry hard to make. Extensive 
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computational studies has been done by Whitfield188,190 and al. to understand the 
somehow unusual behavior of these protecting groups, by predicting the different 
theoretical conformational geometries adopted by the pyranose ring in the course 
of the glycosylation reaction, in different sugar series.  
 
Figure 7: Examples of cyclic acetal protecting groups 
 
 Fraser-Reid209, who was the first to notice the rather slow rate of 
hydrolysis of trans-fused acetal protecting groups over acyclic protecting groups, 
eg, the 4,6-O-benzylidene protected glucose vs. its tetra-benzylated counterpart, 
proposed a “torsional disarmament” explanation for this phenomenon, explaining 
that trans-fused protecting groups inhibit the flattening of the ring that is imposed 
by the planar geometry about the C2-C1-O5-C5 bond angle of the glycosyl 
oxocarbenium intermediate. This argument was quick implemented by Ley159,160 
and co-workers in their pioneering work on the protection of trans vicinal diols 
with 1,2-diacetals such as the cyclohexane-1,2-diacetal (CDA) encountered in 
Chapter 2 or the butane-2,3-diacetal (BDA), protecting groups that have found 
widespread application in carbohydrate chemistry. Ley also suggested that 1,2-
diacetals induce torsional strain because of the rigidity that the bicyclic system 
imparts on the pyranose ring.  The slower reactivity of glycosyl donors bearing 
cyclic protecting groups compared to that of classical glycosyl donors has 
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similarly been exploited towards chemoselective glycosylation as another 
example of the “armed/disarmed” principle. 
 Another cyclic acetal protecting group of particular interest is the 4,6-O-
benzylidene acetal. The discovery of its  β-directing effect in 
mannopyranosylation reactions and of its determining factor for the highly 
stereoselective installation of the  β-mannosidic linkage, has led several groups 
to further study the singular properties of this protecting group, either 
experimentally53 or computationally188,213. The exact role of the 4,6-O-
benzylidene acetal, as well as its reactivity profile is not well understood and 
several explanations have been advanced to explain its behavior, among which 
is Crich’s164 suggestion that the benzylidene group “serves to shift an entire 
series of CIP/SSIP equilibria toward the covalent glycosyl triflates”. An important 
contribution in the understanding of the origin of the disarming effect of the 
benzylidene group was made by Bols53 and co-workers who attributed this 
phenomenon to the locking of the C6-O6 bond in its most disarming 
conformation, the trans-gauche (tg) conformation, in which C6-O6 is 
antiperiplanar to C5-O5 when the electron-withdrawing character of the C6-O6 
bond is maximized, leading to the destabilization of the electron deficient 
oxocarbenium intermediate. This aspect will be extensively discussed later in 
Chapter 5 of this thesis. 
 
3.5 Problems to be Addressed in this Part 
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The next two chapters of this thesis are dedicated to the study of the effect 
of C-O bonds on the anomeric reactivity, by first looking at the influence of the 
C3-O3 bond on the stereochemical outcome of C-glycoside formation in 4,6-O-
benzylidene protected donors in the D-mannose as well as in the D-glucose 
series. Later on in Chapter 5, the focus will be directed towards the 
understanding of the effect of the 4,6-O-benzylidene group on galactose 
reactivity by probing the disarming influence of the trans-gauche conformation of 
the C5-C6 bonds. 
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CHAPTER 4 
EFFECT OF THE C3-O3 BOND IN C-GLYCOSYLATION REACTIONS WITH 
4,6-O-BENZYLIDENE PROTECTED 3-DEOXY GLUCO- AND 
MANNOPYRANOSIDE DONORS 
4.1 Introduction ! C-Glycosides are natural mimics of O-glycosides; they occur when the 
exocyclic oxygen of the glycosidic bond is replaced by a carbon atom. 
Comparatively to their O-counterparts, C-glycosides are rarely found in Nature 
and are not biosynthesized by higher organisms. A number of naturally occurring 
C-glycosides have been isolated from their natural resources and examples are 
presented in Figure 8214,215.  
 
Figure 8: Examples of naturally occurring C-glycosides 
 
Because of the ease of alkoxy substituents to act as good leaving groups when 
they are protonated, O-glycosides are very labile to acidic and enzymatic 
hydrolyses. Such a mechanism is not applicable in the case of a C-C bond and 
as a result C-glycosides exhibit a greater stability to metabolic degradation. Other 
distinctive physical properties that derive from the C-glycosidic linkage are, for 
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instance, the inability to form a hydrogen bond and the absence of an anomeric 
effect. Owing to their attractive chemical and physical properties, a growing 
interest in the chemistry of C-glycosides has thus emerged from the scientific 
community whose consequent efforts have been directed toward their use as 
scaffolds for the development of potential glycosidase inhibitors.  
The study described in this chapter was undertaken with a view to 
determining the factors that govern the stereoselectivity in the formation of C-
glycosides, with a particular emphasis on the influence of the C3-O3 bond on the 
outcome of the glycosylation reaction. The synthesis of C-glycosides according 
to a standard protocol from 3-OBn- as well as 3-deoxy-4,6-O-benzylidene-
protected donors will be described in both the glucose and the mannose series. 
The coupling reactions described make use of one set of glycosylation 
conditions, the standard BSP or/DPSO/Tf2O activation cocktail. 
 
4.1.2 C-Glycoside Formation 
Various approaches have been reported in the literature for the 
preparation of C-glycosides214,215. The most commonly used method – parallel 
with the preparation of O-glycosides – consists of the direct addition of the 
carbon-based nucleophile on the electrophilic glycosyl oxocarbenium ion. The 
first reaction of this type was reported by Hanessian216 et al., in the early 1970’s 
and concerned the synthesis of C-nucleosides. The Lewis-acid mediated attack 
of silyl enol ether 170 on protected glucofuranoside 168 afforded the 
corresponding β-C-nucleoside 171 in 95% yield (Scheme 58).  
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Scheme 58: Synthesis of a C-nucleoside 
 
 About a decade later, Kishi217 et al., extended this approach to the 
pyranoside series, by reacting a silicon-based nucleophile, allyltrimethysilane 173 
with the 2,3,4,6-tetra-O-benzyl-D-glucopyranoside derivative 172 in the presence 
of a Lewis acid, boron trifluoride etherate (BF3Et2O). The reaction resulted in the 
formation of the corresponding α-C-allyl-glucoside 174, with high 
diastereoselectivity (α/β = 10:1) (Scheme 59). 
 
Scheme 59: Synthesis of a C-allyl-glycopyranoside 
 
The high α-selectivity observed in the product was interpreted by Kishi217 et al., in 
terms of pseudo-axial attack of the nucleophile on the half-chair conformation of 
the oxocarbenium ion as schematized below (Scheme 60). 
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Scheme 60: Pseudo-axial attack of the nucleophile on an oxocarbenium ion 
 
Kishi’s observations were supported by Woerpel’s218-221 extensive studies 
towards the determination of the factors involved in controlling the selectivity of 
C-glycoside formation. Toward this end, he investigated the different 
conformational preferences of five- and six-membered ring, mono- or 
polysubstituted oxocarbenium ions toward carbon-based nucleophiles along with 
the interactions that are responsible for them. Several conclusions were drawn 
from these studies. A recurrent observation pointed out the importance of 
stereolectronic factors in directing the axial attack of the nucleophile on the 
preferred conformation of the oxocarbenium ion, leading to the formation of the 
product in its most stable 4C1 chair conformation221.  These observations will be 
further discussed in the results and discussion section of this chapter. 
 
4.1.3 The Glucose/Mannose Paradox 
 When phenyl 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside S-
oxide was reacted with Tf2O in the Crich laboratory, unexpected results were 
obtained. The α-coupling product was obtained indicating that the 4,6-O-
benzylidene protecting group is α-directing in the glucose series, rather than β-
directing as in the mannose series222,223. Logically, Crich reasoned that this 
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difference in stereoselectivity observed between the two series might involve the 
change in the orientation of the substituent at C2. Following this hypothesis, a 
series of experiments were conducted in the 2-deoxy and in the 3-deoxy series 
as well as in the 2-deoxy-fluoro and the 3-deoxy-fluoro glucose and mannose 
series 12-15, to probe the influence of the C2-O2 and C3-O3 bonds (Figure 
9)224,225. 
 
Figure 9: Deoxy and deoxy-F gluco- and mannopyranosyl donors 
 
These modifications resulted in a loss of α- and β-selectivity in the glucose and 
the mannose series respectively, confirming the importance of the C2-O2 and 
C3-O3 bonds in controlling the selectivity in O-glycosylation reactions with 4,6-O-
benzylidene-protected donors.  
The presence of the 4,6-O-benzylidene protecting group clearly restricts 
the pyranose moiety ring flip, imposing very similar conformations on the glucosyl 
and mannosyl oxocarbenium ions. Whitfield, Nukada, and co-workers computed 
that the glycosyl oxocarbenium ion in 4,6-O-benzylidene-protected donors, 
adopts a B2,5 boat conformation in the mannose series and a 4E envelope in the 
glucose series, besides the common 4H3 chair conformation190,213. Thus, different 
factors must be responsible for this reversal of selectivity. Ultimately, Crich225 and 
coworkers identified the C2-O2-C3-O3 torsional angle as a key factor in directing 
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the stereoselective outcome in the glycosylation reaction. In the case of the 
mannose series, the conversion from a 4C1 ground state conformation in the 
covalent α-mannosyl triflate to a 4H3 half-chair conformation results in a 
compression of the C2-O2-C3-O3 dihedral angle, which is thermodynamically 
unfavorable since it increases steric strain between the O2 and O3 substituents. 
On the other hand, the value of the C2-O2-C3-O3 torsional angle remains 
unchanged when the oxocarbenium ion adopts a B2,5 boat conformation. An 
opposite trend is observed in the glucose series. As the covalent triflate 
fragments into either of the oxocarbenium ion geometries, i.e, the 4H3 half-chair 
or the 4E envelope conformations, the O2-C2-C3-O3 torsional angle relaxes from 
60° to either 75° or 90° respectively, reducing therefore the energy requirement 
for the oxocarbenium ion formation (Scheme 61).  
 
Scheme 61: Evolution of the O2-C2-C3-O3 torsional angle in the mannose 
and glucose series on oxocarbenium ion formation 
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Consequently, the formation of the oxocarbenium ion in 4,6-O-benzylidene-
protected donors is more disfavored in the mannose than in the glucose series.  
On this basis, it was suggested that the oxocarbenium ion is more readily 
populated in the glucose than in the mannose series, resulting in a shift in the 
key equilibria (Scheme 53) further toward ion pairs than is the case in the 
mannose series, which more strongly favors the covalent glycosyl triflate.  
 More recently, studies undertaken in the Crich laboratory207 led him to 
propose an alternative mechanism for the formation of 4,6-O-benzylidene-
protected α-glucosides.  Primary 13C KIE studies demonstrated that the formation 
of α-glucosides proceeds via a β-glucoside triflate intermediate, and follows a 
Curtin-Hammett kinetic scheme207. Finally, although the mechanism of the 
glycosylation reaction in 4,6-O-benzylidene-protected donors has been clarified 
in the glucose and the mannose series, the origin of the reversal of selectivity 
observed between glucose and mannose remains unknown. 
 
4.2 Results and Discussion 
4.2.1 Preliminary Studies 
Crich226 and Sharma showed that the formation of C-glycosides in 4,6-O-
benzylidene-protected glycosyl donor systems followed the same selectivity 
pattern as that of O-glycosides, namely α-C-glycosides are formed in the glucose 
series and β-C-glycosides in the mannose series, implying that carbon-based 
nucleophiles behave in a similar fashion as alcohols. This same trend of 
selectivity between O- and C-glycoside formation was also observed when the 
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screening of protecting groups at the O3 position of the glycosyl donor was 
investigated. The change to a 3-O-carboxylate protecting group from a 3-O-
benzyl ether group resulted in a reversal of selectivity in C227- and O228-glycoside 
formation in the mannose series. Consequently, Crich hypothesized that the 
formation of C- and O-glycosides likely follows a common mechanistic pathway.  
Computational calculations carried out by Whitfield and later by Pratt 
suggested, on the other hand, that the stereocontrolled formation of O-glycosides 
in the 4,6-O-benzylidene-directed  β-mannopyranosylation reactions might result 
from a hydrogen bond between O3 of the glycosyl donor and the hydrogen of the 
incoming alcohol acceptor, directing the attack of the acceptor on the β-face of 
the glycosyl triflate intermediate. In the case of glucose, a hydrogen bond was 
observed computationally between O2 of the glycosyl donor and the alcohol 
acceptor, promoting therefore the formation of the α-glucose product (Scheme 
62). 
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Scheme 62: Rationalization of the hydrogen bonding hypothesis in the 
mannose and the glucose series 
 
Such a hypothesis is moot in the case of the formation of C-glycosides. The 
studies reported in this chapter were undertaken aiming to probe the influence of 
the C3-O3 bond on the stereoselectivty of C-glycoside formation with a view to 
shedding further light on the mechanisms of O- and C-glycoside formation. 
 
4.2.2 Syntheses of the 4,6-O-Benzylidene Protected Glycosyl Donors 
4.2.2.1 In the Glucose Series 
 The 4,6-O-benzylydene protected glucopyranosyl donor 182 was prepared 
by known methods222, starting from commercially available D-glucose 179 as 
outlined in Scheme 63.  
 
Scheme 63: Preparation of the glucosyl donor 182 
 
Peracetylation of D-glucose 179 under standard conditions was followed by 
introduction of thiophenol at the anomeric carbon and gave compound 180 in 
95% yield. Deacetylation of 180 using Zemplén conditions and installation of the 
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benzylidene acetal gave compound 181 in 80% yield. Finally, the hydroxyl 
groups at O2 and O3 were masked as benzyl ethers giving rise to the target 
donor 182 in 91% yield.  
 
4.2.2.2 In the Mannose Series 
  The 2,3-di-O-benzyl-4,6-O-benzylidene-protected  β-D-mannopyranosyl 
donor229 183 was not synthesized since it was available in the laboratory. Its 
synthesis will therefore not be presented here. 
 
Figure 10: 2,3-di-O-benzyl-4,6-O-benzylidene protected mannosyl donor 183 
 
4.2.3 Syntheses of the 2-O-Benzyl-4,6-O-Benzylidene Protected 3-Deoxy 
Glycosyl Donors 
 The 3-deoxy glycosyl donor analogs 190 and 192 were prepared 
according to known procedures224, from a common synthetic pathway. Their 
syntheses are outlined in the next two sections. 
 
4.2.3.1 In the Glucose Series 
 The synthesis of glycosyl donor 190 was carried out as depicted in 
Scheme 64. 
OO
OBn
SPh
OPh
BnO
183
! 100!
 
Scheme 64: Synthesis of the 3-deoxy glucosyl donor 190 
 
Di-acetone-D-glucose 184 was converted to the iodo derivative 185 in a two-step 
sequence starting first with esterification in presence of Tf2O and pyridine in 
dichloromethane then, displacement by iodine, which gave 185 in 64% yield over 
the two steps. Hydrolysis of the acetonide groups under acidic conditions was 
followed by peracetylation affording 186 in its pyranose form predominantly and 
in 82% yield over the two steps. Then treatment of 186 in presence of tributyltin 
hydride (HSnBu3) and azobisiosobutyronitrile in hot toluene led to radical 
diodination, giving rise to the 3-deoxy glycoside 187 in 73% yield. Subsequent to 
this point, a series of standard steps were carried out starting with introduction of 
thiophenol at the anomeric position followed with deacetylation under Zemplén 
conditions then 4,6-O-benzylidene protection, which gave the target donor in a 
1:3 α/β mixture, of which only the β anomer 189 was carried on further in the 
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synthesis. Finally, benzyl protection of O2 under the usual conditions gave the 
target 3-deoxy thioglycoside donor 190. 
 
4.2.3.2 In the Mannose Series 
 The synthesis of the last donor 192 was achieved in three steps starting 
from the common 3-deoxy intermediate 189 (Scheme 65) 
 
Scheme 65: Synthesis of the 3-deoxy mannosyl donor 192 
 
Dess-Martin periodinane oxidation of 189 was followed by reduction of the 
resulting ketone with L-selectride and gave a α-D-glucose/β-D-mannose mixture 
from which compound 191 was isolated in 43% yield over the two steps. Finally 
benzyl protection of O-2 gave the final target compound, the 3-deoxy mannosyl 
donor 192 in 83% yield. 
 
4.2.4 Coupling Reactions: Formation of the C-Glycosides 
 With all the glycosyl donors in hand, attention was given to the coupling 
reactions. A single set of glycosylation conditions was used for all the sugar 
series, i.e, the standard BSP or DPSO/TTBP/Tf2O activation method with pre-
activation of the glycosyl donor at – 65 °C in CH2Cl2 followed by addition of an 
excess of the nucleophile (Nu-M), allyltrimethysilane, allyltributylstannane or α-
trimethylsiloxystyrene. A general scheme is presented below. 
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Scheme 66: C-glycoside formation protocol 
 
4.2.4.1 In the 3-O-Benzylated Series 
 In order to verify the previous published work from the Crich laboratory the 
coupling reactions in the normal mannose and glucose series were conducted.  
The results of these studies are presented below (Table 2)230. 
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Table 2: C-glycoside formation in the mannose and glucose series 
 
The results obtained from this first set of coupling reactions confirm Crich's226 
earlier observations that the formation of C-glycosides is β-selective in the 
mannose series and  α-selective in the glucose series. The stereochemical 
assignments at the anomeric carbon were confirmed by nuclear Overhauser 
effect 1D NMR experiments, which displayed the diagnostic correlations 
indicated in Figure 11. 
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Figure 11: Determination of the anomeric stereochemistry of the C-
glycosides by NOE 
 
The C-glycosides 193, 196, 197 and 198 were obtained with complete 
stereoselectivity in both, the mannose and the glucose series and in moderate to 
good yields. A significant amount of double adduct 199 was formed from the 
reaction of glycosyl donor 182 with α-trimethylsiloxystyrene 195 highlighting here 
the ambident character of this nucleophile, with possible attack from both ends, 
either via the vinylic carbon or the oxygen atom. The O-glycoside 199 was 
formed with high α-selectivity and isolated as a single anomer. Adduct 198 and 
the double adduct 199 were obtained in an equimolar ratio and 80% overall yield. 
The formation of the O-glycoside derivative did not occur in the case of the 
mannose series and reaction of mannosyl donor 183 with nucleophile 195 took 
place uneventfully, with formation of a single product, compound 196 in 76% 
yield.  
 
4.2.4.2 In the 3-Deoxy Series 
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 A similar series of experiments were conducted in the 3-deoxy glucose 
and mannose series from which comparable results were obtained as 
summarized in Table 3230. 
Entry Donor Nucleophile Product Yield 
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Table 3: C-glycoside formation in the 3-deoxy mannose and glucose series 
 
The C-glycosides were formed again with complete stereoselectivity in the 
mannose as well as in the glucose series, with moderate to good yields. An 
interesting by-product 192α arose from the reaction of 3-deoxy-mannosyl donor 
192 with the least nucleophilic acceptor, allyltrimethylsilane 173, along with the 
expectedcoupling product 200. The β-mannosyl donor 192 isomerized to its α 
anomer in the course on the glycosylation reaction, corroborating the greater 
reactivity of the 3-deoxy-mannose donor 192 compared to its normal series 183. 
Formation of a double adduct 204 was also observed in the 3-deoxy glucose 
series, from the reaction of 3-deoxy-glycosyl donor 190 with α-
trimethylsiloxystyrene 195.  Compounds 203 and 204 were formed with complete 
α-selectivity and only a single isomer was isolated in each of the cases.   
The double adducts 203 and 204 were both formed as single 
diastereomers at the newly formed remote stereogenic center and, although the 
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stereochemistry of this center has not been rigorously proven, it is predicted to 
be (R)-on the basis of the mechanistic rationale presented in Scheme 67. The 
formation of double adducts 203 and 204 is consistent with previous results 
obtained in the Crich laboratory wherein reaction of donors 182 or 183 with 
pinacolone trimethylsilyl enol gave similar double adducts, also predominantly in 
the glucose series226. 
 
Scheme 67: Stereoselective formation of adducts 199 and 204 
 
Assuming the adoption of the oxo-anomeric effect preferred conformation about 
the glycosidic bond in the initial adduct, the proposed mechanism considersthe 
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two possible rotamers 205/207 and 206/208 in each of the glucose series (3-OBn 
and 3-deoxy) about the vinyl-O bond of which the former is preferred for steric 
reasons. Trapping of the vinyl glycoside with phenyl sulfenyl triflate – a side-
product arising from the activation of the thioglycoside donor with Tf2O and BSP 
– from the more exposed face gives riseto two oxocarbenium ions with opposite 
geometry, E- or Z-, of which the E-isomer is expected to predominate based on 
the greater population of the vinyl glycoside rotamer 205/206. Assuming the 
continued operation of the exo-anomeric effect, reaction of the E-oxocarbenium 
ions 209/210 on its more exposed face with a second equivalent of silyl enol 
ether leads to the preferential formation of the observed products 199 and 204 
(Scheme 67). This analysis closely resembles those adopted in the literature to 
explain the face selectivity of Dields-Alder reaction of glycosyl dienes231-233. An 
interesting feature of the formation of the double adducts 199 and 204 concerns 
the reactivity of the oxocarbenium ions 209 and 210, which necessarily suffer 
attack by external nucleophiles more quickly than they undergo fragmentation to 
a ketone (phenylthioacetophenone) and a glycosyl oxocarbenium ion. Similar O-
glycosyl oxocarbenium ions to 209-212 studied in the Crich laboratory also 
showed a preference for nucleophilic addition over decomposition to their 
corresponding glycosyl oxocarbenium ion and a carbonyl derivative – in that case 
formaldehyde234. 
 
4.2.4.3 Mechanistic Rationale for the Stereoselectivity of C-Glycoside 
Formation 
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 It is clear from comparison of Tables 2 and 3 that the C3-O3 bond in 4,6-
O-benzylidene-protected glycosyl donors is not the control element in the 
stereoselective formation of C-glycosides, unlike for the formation of O-
glycosides. The stereoselective outcome in the formation of C-glycosides may be 
interpreted by considering the preferred conformational geometry of the 
oxocarbenium ion, as well as the steric interactions that arise in the course of the 
attack of the nucleophile. 
 
4.2.4.3.1 In the Mannose Series 
 The stereoselective formation of the C-glycoside adducts is explained as 
depicted in Scheme 68, by using the oxocarbenium ion model. 
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Scheme 68: Proposed mechanistic rationale for C-mannoside formation 
 
The spherical representation of the different pyranoside ring conformations 
(Figure 6) shows that the B2,5 conformation is intermediate between two other 
conformers, the OS2 215/216 and the 1S5 217/218 skew boat conformers, to 
which it distorts by attack on the α-face and the β-face respectively. Assuming 
the oxocarbenium ion model, the β-selectivity observed in the mannose series 
can be explained by the pseudo-axial attack of the incoming nucleophile on the 
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β-face of the B2,5  conformation of the mannopyranosyl ion, positioning thereby 
the nucleophile in a pseudo-axial orientation in the resulting  1S5 skew boat 
conformation 217/218. The unfavorable 1,3-diaxial-type interaction between the 
incoming nucleophile and the C3-X bond in the course of the reaction is reduced 
as the reaction proceeds and the pyranose ring distorts to the 1S5 skew boat – 
this interaction does not therefore play a major stereodeterming role in this 
process. Rather the key interaction appears to be an unfavorable steric clash 
between the incoming nucleophile and the C2-H2 bond on the α-face of the 
oxocarbenium ion, which retards attack on the α-face. This interaction is best 
visualized with the aid of a Newman projection (Figure 12). 
 
Figure 12: Newman projections about the C1-C2 bond showing the attack 
of the nucleophile on the 4,6-O-benzylidene-protected mannosyl 
oxocarbenium ion 
 
Finally, the C2-H2 bond of the glycosyl donor appears to be a determining factor 
in controlling the stereoselective formation of β-C-mannosides. 
 
4.2.4.3.2 In the Glucose Series 
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 A comparable model was also proposed for the 4,6-O-benzylidene-
protected glucose series as presented in Scheme 69. 
 
Scheme 69: Proposed mechanistic rationale for C-glucoside formation 
 
Pseudo-axial attack of the nucleophile on the α-face (the bottom face) of the 
preferred 4H3 half-chair conformation of the 4,6-O-benzylidene-protected glucosyl 
oxocarbenium ion 223 or 224, leads to the direct formation of the α-glycoside, in 
its most stable 4C1 chair conformation. Nucleophilic attack on the β-face of the 
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oxocarbenium ion gives rise to a higher energy 1S3 skew boat conformer 225 or 
226, in which an unfavorable torsional interaction is again observed between the 
C2-H2 bond and the incoming nucleophile. A Newman representation of the 
unfavorable C2-H2 torsional interaction in the case of glucose is presented in 
Figure 13. 
 
Figure 13: Newman projections about C1-C2 showing the attack of the 
nucleophile on the 4,6-O-benzylidene-protected glucopyranosyl ion 
 
The results obtained in the glucose series follow the same conclusions than the 
ones made in the mannose series. The C2-H2 bond seems to be a crucial 
element in directing the attack of the nucleophile toward one face of the 
oxocarbenium ion.   
 
4.2.5 Comparison with O-Glycoside Formation 
 The reaction of alcohol acceptors with 4,6-O-benzylidene-protected 3-
deoxy mannoside donors is slightly α-selective in the formation of O-mannosides, 
whereas the formation of C-glycosides takes place with complete β-
stereoselectivity. Moreover, unlike for O-glycosides, the stereoselectivity in the 
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formation of C-glycosides is not altered on going to the 3-deoxy series. Assuming 
that C-glycosides are formed via the intermediacy of a glycosyl oxocarbenium 
ion, just as it was proven for the formation of α-O-mannosides, then different 
factors might have to be invoked to account for the loss of selectivity in O-
glycoside formation.  
 The loss of α-selectivity observed in the formation of O-glycosides cannot 
be explained in terms of hydrogen bonding since computational studies indicates 
a hydrogen bond between O2 of the donor and the incoming alcohol acceptor 
and O2 is retained in the 3-deoxy series. Rather, a change in mechanism for the 
formation of O-glycosides in the 3-deoxy series to that of the normal glucose 
series (3-OBn) is proposed. As discussed previously, KIE studies suggest that 
the formation of the α-O-glucosides proceeds via an associative SN2 mechanism 
with a concerted displacement of a transient β-glucosyl triflate207. For the 3-deoxy 
glycosides, gluco- and manno-, a dissociative oxocarbenium ion-based 
mechanism is more likely owing to the absence of the electron-withdrawing C3-
O3 bond164,235. As an sp3 oxygen-centered nucleophile (0.55<A-value<0.75)236 is 
considerably smaller than a sp2 vinylic carbon-centered nucleophile (1.49<A-
value<1.68)236, the type of interactions proposed in Figures 5 and 6 to explain the 
face selectivity of C-glycoside formation are much reduced for O-glycoside 
formation resulting in the loss of selectivity in the case of the O-glycosides. The 
difference in steric bulk of alcohols and allyl-metal-based nucleophiles and the 
corresponding reduction in the importance of the nucleophile/C2-H2 interaction 
are best appreciated with the Newman projection of Figure 14. 
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Figure 14: Newman representations of the transition states for 
antiperiplanar attack by a) π-type C-nucleophiles and b) alcohols on the 
disfavored face of the glycosyl oxocarbenium ions 
 
The difference in the bulkiness of an alcohol nucleophile and a vinyl nucleophile 
adequately accounts for the loss of α-selectivity observed in the formation of O-
glucosides as compared to C-glucosides for attack on a common oxocarbenium 
ion.  
 
4.3 Conclusion 
 The C-glycosides were formed with complete  α- and β-stereoselectivity in 
the glucose and the mannose series respectively, regardless of the substituent 
(H or OBn) at C3, demonstrating the lack of influence of the C3-O3 bond in C-
glycosides formation, as opposed to the O3 substituent selectivity-dependence 
that Crich observed in the formation of O-glycosides. 
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CHAPTER 5 
TOWARD THE UNDERSTANDING OF THE α-DIRECTING EFFECT OF THE 
4,6-O-BENZYLIDENE GROUP IN THE GALACTOSE SERIES 
 
5.1 Introduction 
 Literature data indicate that the reaction of 4,6-O-benzylidene-protected 
galactopyranosyl donors carrying ether-type non-participating protecting groups 
at O2 and O3 are predominantly α-directing in their coupling with non-hindered 
alcohol acceptors237-239. In presence of a participating group at the C2 position of 
the glycosyl donor, the glycosylation reaction takes place, as commonly 
expected, with β-selectivity240,241. However, several instances showed, in similar 
4,6-O-benzylidene-protected galactopyranosyl systems, that neighboring group 
participation failed to proceed with complete β-selectivity, leading in some cases 
to the formation of the α-coupling product as the major product242,243, if not as the 
only product54. The latter situation was observed when the 4,6-O-di-tert-
butylsilylene protecting group, developed in the Kiso laboratory, was used in 
place of the 4,6-benzylidene acetal. Thus, Kiso54,55,244 found such a silylene-
protected system to be highly α-selective independently of the nature of the 
substituent used at C2 of the glycosyl donor. Two different explanations have 
been invoked to account for the observed α-directing effect of the 4,6-O-
benzylidene or the DTBS protecting group in the galactose series, an electronic 
and a steric hypothesis. The former hypothesis is built around the supposed 
stabilization of the 4,6-O-acetal-protected oxocarbenium ion by the benzylidene 
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acetal242, whereas the proponents of the steric hypothesis claim that the 
apparent α-selectivity is a result of the shielding of the β-face of the 
oxocarbenium ion by the acetal54. 
The fact that 4,6-O-acetals exert a disarming effect in glycosides reactivity 
is a well-accepted phenomenon209,245. Their effect on reactivity in the galactose 
series is, on the other hand, far less known and an acceptable explanation for it 
has still to be proposed. In this context, a study of the reactivity of 4,6-O-acetals 
in the D-galactose series was undertaken with the emphasis on probing the 
disarming influence of the trans gauche conformation of C5-C6 bonds with the 
aim of gaining better insights into the observed α-directing effect of 4,6-O-acetal-
protected donors in galactopyranosylation reaction. The results of this study are 
presented in this chapter. 
 
5.1.1 Preliminaries Studies  
5.1.1.1 The Electronic Hypothesis 
5.1.1.1.1 The Electronic Effect of the Hydroxylic Substituent 
 The effects of the substituents on reactivity have been studied extensively 
by Bols246-248 and co-workers in their seminal work on the acidity of 
polyhyddroxylated piperidinium246 compounds, as a study model for 
oxocarbenium ions. Bols found that stereoisomers having axial hydroxyl 
substituents were consistently less acidic (higher pKa values) than their 
equatorially oriented counterparts, regardless of their position on the piperidinium 
ring (Figure 15)246.  
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Figure 15: Relative acidity of stereoisomeric piperidinium ions 
 
This observation was rationalized in terms of the electron-withdrawing character 
of the hydroxyl substituent, which Bols247,249 postulated to be lower for an axial 
than for an equatorial substituent. Later on, Bols applied this postulate to 
carbohydrate derivatives, to explain the disparities in the rate of hydrolysis of 
methyl-D-glycopyranosides (Figure 16)248.   
 
Figure 16: Relative rate of hydrolysis of methyl α-D-glycopyranosides 
 
The fact that the rate of hydrolysis of stereoisomeric glycosides is function of the 
number of axial hydroxyl substituents – the greater the number of axial hydroxyl 
substituents, the faster the rate – had been observed by Armstrong and Glover250 
back in 1908. However, it was only in 1955, that the first explanation to this 
phenomenon was proposed by Edwards251, who termed it “the relief of the steric 
strain” to refer to the unfavorable 1,3-diaxial interactions present in the ground 
state of the glycoside being released as the pyranose ring distorts to the 
oxocarbenium geometry. This steric hypothesis was later displaced by an 
electronic explanation advanced by Withers252 known as “the field effect”. As 
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shown in Figure 16, the rate of hydrolysis of guloside 231 is faster than the rate 
of hydrolysis of galactoside 232, which is in turn faster than the rate of hydrolysis 
of glucoside 233. The exact cause of this effect in carbohydrates has not been 
clearly understood, but it was postulated that a charge-dipole interaction249 
between the axial hydroxyl substituent and the cationic oxocarbenium ion is most 
likely responsible for the relative difference in the rate of hydrolysis observed 
between sugar series186,248,253 (Figure 17)249. 
 
Figure 17: Charge-dipole hypothesis 
 
As shown in Figure 17, when the dipole formed by the hydroxyl substituent at C4 
is oriented away from the electron-deficient center (as is the case in the glucose 
series) it results in destabilization, whereas a perpendicular orientation (observed 
in galactose derivatives) leads to a greater stabilization. 
 
5.1.1.1.2 The Through-Space Hypothesis 
The systematic enhancement of reactivity observed in the hydrolysis of 
methyl-α-D-galactopyranosides as compared to their glucose counterparts has 
been rationalized in an elegant manner by Deslongchamps186, who demonstrated 
that the rate of acetolysis of methyl α-D-glycopyranoside was dependent on the 
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electron-donating ability of the C4 substituent, which is large in the galactose 
series, but much less appreciable in the glucose series (Figure 18)186.  
 
Figure 18: Relative acetolysis rate of methyl α-D-glycopyranosides 
 
To account for the large kinetic effect observed in the galactose series, 
Deslongchamps argued against the possibility of a through bond interaction 
stabilization (inductive effect) as observed in the glucose, but instead pointed to a 
stronger effect such as a through space donation from the axially oriented 
substituent at C4 and the incipient oxocarbenium ion. This interaction, which 
destabilizes the ground state conformation of galactopyranoside derivatives due 
to electrostatic repulsion, becomes stabilizing as the oxocarbenium ion forms186 
(Scheme 70).  
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Scheme 70: “Through-space” interaction between the substituent at C4 and 
the developing oxocarbenium ion 
 
Such an interaction is geometrically not possible in the glucose series because of 
the equatorial orientation of the hydroxyl substituents on the pyranose ring. 
Deslonchamps supported his “through-space” interaction hypothesis with ab-
initio calculations.  
 
5.1.1.2 The Steric Hypothesis 
 Another rational, the steric hypothesis, has been proposed by Kiso54 et al., 
after the discovery, in the Kiso laboratory, of the 4,6-O-DTBS acetal as a 
determining element in the formation of α-(1,2-cis)-galactopyranosides54,55. In 
terms of conformation, the DTBS group is comparable to the benzylidene acetal. 
Both of these protecting groups lock the O4 and O6 of the donor in a six-
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membered ring system, except that the di-tert-butylsilyl group 239 is more 
hindered than the phenyl ring 240 (Figure 19).  
 
Figure 19: Di-tert-butylsilyl and benzylidene acetals 
 
However, a drastic change of selectivity was observed in the coupling of 4,6-O-
di-tert-butysilyl- 242 and 4,6-O-benzylidene-protected galactosyl 243 donors with 
acceptor 241, under the NIS/TfOH glycosylation conditions. The α-coupling 
product was obtained stereoselectively when using donor 242, despite the 
presence of the N-participating group at C2. The 4,6-O-benzylidene-protected 
galactosyl donor 243 gave the β-galactopyranoside 245 exclusively (Scheme 
71)54. 
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Scheme 71: Examples of galactopyranosylation reaction with 4,6-O-
protected DTBS and benzylidene 
 
The considerable steric bulk of the DTBS group was used by Kiso54 to explain 
the observed α-directing effect in galactosylation reactions using 4,6-O-di-tert-
butysilyl-protected donors. While building his hypothesis on Deslongchamps’ 
through-space interaction theory186, Kiso advanced that ab-initio calculations 
showed that the interatomic distance between the tBu groups and the anomeric 
center was shortened in the course of the glycosylation reaction. The through 
space interaction observed between the axially oriented substituent at C4 with 
the electron-deficient oxocarbenium ion in the galactose series resulted in a 
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decrease in the interatomic distance between those two. X-Ray crystallographic 
analysis showed that the introduction of a di-tert-butylsilylene group resulted in 
the flattening of the C4-C5-C6 bond because of the sofa-like conformation 
adopted by the pyranose ring. As a result, the β-face of the galactoside is 
shielded by the tBu group, which leaves the α-face as the only possible face of 
attack by the acceptor (Scheme 72)54.  
 
Scheme 72: The steric hypothesis 
 
A similar steric explanation was also advanced earlier by Jacquinet254 who 
postulated that the phenyl ring of the benzylidene group shielded the top face of 
the sugar in galactose series thereby favoring the α-glycoside over the β-
glycoside. 
 
5.1.1.3 The Disarming Effect of the 4,6-O-Benzylidene Group in the Glucose 
series 
In D-aldohexopyranoses, the conformation of the hydroxymethyl 
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abundant rotamer observed in hexopyranosides) and the gauche-trans 
conformation (gt), which correspond to three minima on the plot of the potential 
energy surface of rotation about the C5-C6 bond255. In this formalism, the first 
letter describes the dihedral relationship between O6 and O5 and the second 
letter refers to the relationship between O6 and C4 (Figure 20). Factors such as 
the 1,3 syn-diaxial interaction, the gauche-gauche effect, hydrogen bonding and 
the solvent effect, have been shown to influence the C5-C6 rotameric 
population256.  
 
Figure 20: Staggered conformers of the exocyclic C5-C6 bond in D-
aldohexopyranoses 
 
Based on the charge-dipole hypothesis, the tg conformer is expected to be 
the least reactive because of the antiperiplanar orientation of the C6-O6 bond 
with respect to the C5-O5 bond, leading to the destabilization of the forming 
oxocarbenium ion.  
A few years ago, Bols53 and co-workers investigated the origin of the 
disarming effect of 4,6-O-benzylidene derivatives in the D-glucose series, by 
evaluating the contribution of the electronic effects coming from the locking of the 
C5-C6 bond in the deactivating trans-gauche conformation (tg), with respect to 
the torsional disarmament. Thus, Bols conducted a series of kinetics studies in 
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which he altered the conformation about the exocyclic C5-C6 bond in a range of 
glycopyranoside systems, in order to determine which factors were responsible 
for the disarming effect of the 4,6-O-benzylidene group in the glucose series 
(Figure 21)53.  
 
Figure 21: Conformationally constraint glucopyranoside probes 
 
These models were all designed to incorporate the same type of trans-decalin 
skeleton as in the 4,6-O-benzylidene-protected glucopyranosides and so, to have 
the same torsional constraints while allowing systematic variation of the 
orientation of the C6-O6 bond.  The conclusions drawn by Bols53 highlighted first 
of all, a significant destabilization arising from the locking of the C5-C6 bond in 
the tg conformation, resulting in a maximization of the electron-withdrawing ability 
of the C6-O6 bond and therefore, an overall destabilization of the glycosyl 
oxocarbenium ion. Finally, the torsional strain was also shown to equally 
contribute to the observed disarming effect encountered in 4,6-O-benzylidene 
protected glucopyranoside systems. 
 
5.1.2 Reactivity of the Benzylidene Acetal in the Galactose Series: A 
Logical Reactivity Pattern 
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Given on all these considerations, electronic and kinetic, one might expect 
that a different reactivity pattern would be expected in 4,6-O-benzylidene-
protected galactoside derivatives as compared to the perbenzyl analogues. 
Unlike their glucose counterparts, 4,6-O-benzylidene-protected galactosides are 
locked in a cis-fused system, where the C5-C6 bond is held in the favorable gg 
conformation. Thus, based on the “through-space” space interaction observed by 
Deslongchamps186 characteristic of galactoside derivatives, it was hypothesized 
that a similar interaction could also emanate from the optimal orientation of the 
C6-O6 bond in 4,6-O-protected acetal galactosides. Following up on this logic, 
the 4,6-O-benzylidene protecting group should have an arming effect on 
galactosyl reactivity, by anticipation of the larger through-space interaction 
arising from the favorable positioning of both, the C4-O4 and the C6-O6 bonds, 
held perpendicular to the C5-O5 bond and thereby maximizing the through-space 
stabilization onto the oxocarbenium ion (Figure 22). 
 
Figure 22: Oxocarbenium stabilization in 4,6-O-acetal-protected systems 
 
5.2 Results and Discussion 
 Adapting Bols’53 model study to the galactose series, similar 
conformationally locked probes were synthesized and carried through acidic 
O
O
O
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O
Ph
glucose galactose
"through space"
stabilization
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hydrolysis measurements in the case of the methyl α-D-galactopyranoside 
derivatives and spontaneous hydrolysis as for the dinitrophenyl 
galactopyranoside probes. The results of this investigation are detailed in the 
following sections starting first with the chemical synthesis of probes 247, 254R, 
254S, 255, 256R, 256S and 263. 
 
5.2.1 Synthesis of α-Methyl and β-Dinotrophenyl Galactoside Substrates 
5.2.1.1 Preparation of the Methyl Galactoside Substrates 
5.2.1.1.1 Synthesis of Methyl 2,3,4,6 –Tetra-O-Methyl –α-D-
Galactopyranoside 247 
 A one-step synthesis staring from commercially available methyl α-D-
galactoside 246 afforded the monocyclic reference substrate 247. Thus, 
permethylation of 246 by reaction with sodium hydride and methyl iodide gave 
the monocyclic probe 247 in 80% yield. 
 
Scheme 73: Synthesis of monocyclic methyl galactopyranoside probe 247 
 
5.2.1.1.2 Synthesis of (6R) and (6S)-Methyl 4,8-Anhydro-7-Deoxy-2,3,6-tri-O-
Methyl-Glycero-D-Galacto-Octopyranosides 254R and 254S 
 Bicyclic diastereomers 254R and 254S were synthesized as set out in 
Scheme 74. 
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Scheme 74: Synthesis of methyl α-D-galatopyranosides 254R and 254S 
 
The synthesis started from commercially available methyl α-D-galactoside 246 
with installation of the benzylidene protecting group at the O4 and O6 positions in 
the usual manner, followed by methylation of the resulting O2 and O3 positions 
to give dimethyl ether derivative 249. Regioselective reductive ring opening of the 
4,6-O-benzylidene acetal was carried out in presence of borane-tetrahydrofuran 
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complex and scandium triflate257 giving rise to the corresponding 4-O-benzyl 
ether compound 250 in 96% yield. Swern oxidation of the primary alcohol 250 
afforded the corresponding aldehyde, which after addition of allyl magnesium 
bromide in anhydrous THF gave a 2:1 diastereomeric mixture of separable 
adducts 251R and 251S, in 61% overall yield over the two steps. The 
stereochemistry of compounds 251R and 251S was assigned after the formation 
of the bicyclic derivatives 254R and 254S. Subsequent to this point, the 
syntheses of compounds 251R and 251S were carried out independently to give 
the respective final bicyclic compound 254R and 254S as shown in Scheme 74, 
pathways A and B. Secondary alcohol 251R was methylated and gave the 
corresponding methyl ether adduct 252R. Oxidative cleavage of terminal alkene 
252R by ozonolysis was followed by in-situ reduction of the corresponding 
aldehyde, affording 253R in 73% overall yield. Tosyl protection of the resulting 
primary alcohol was followed by hydrogenolysis of the benzyl ether functionality. 
Finally, in-situ displacement of the tosyl group by iodine occurred prior to the ring 
closure by SN2 displacement of the iodide by the alcoholate, giving rise to the 
corresponding target bicyclic compound 254R. The same procedure was 
followed for the diastereomeric compound 254S. The stereochemistry at C6 was 
confirmed by 1D NOE correlation between protons H6ax and H4eq in the case of 
diastereomer 254R. This correlation is absent in compound 254S, for which a 
NOE correlation between protons H6eq and H8eq was observed. 
 
5.2.1.2 Preparation of 2,4-Dinitrophenyl Galactoside Substrates 
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5.2.1.2.1 Synthesis of 2,4-Dinitrophenyl 2,3,4,6-Tetra-O-Methyl-β-D-
Galactopyranoside and 4,8-Anhydro-7-Deoxy-2,3,6,tri-O-Methyl Glycero-D-
Galacto-Octopyranosides 255, 256R and 256S 
 The preparation of the 2,4-dinitrophenyl probes 255, 256R and 256S was 
carried out in a straightforward manner as outlined in Scheme 75. 
 
Scheme 75: Synthesis of 2,4-dinitrophenyl probes 255, 256R and 256S 
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Probes 255, 256R and 256S were synthesized according to the same synthetic 
scheme starting from their corresponding methyl α-D-galactoside derivates. The 
synthesis involved first the acetolysis of the methyl glycosides using 70% 
perchloric acid in presence of acetic anhydride. This was followed by hydrolysis 
of the corresponding anomeric acetate derivative on reaction with hydrazine 
acetate. Finally, the introduction of the 2,4-dinitrophenyl group was performed by 
reaction of the resulting hemiacetal with 1-fluoro-2,4-dinitrobenzene, in presence 
of a nucleophilic base, DABCO. The β-configuration of each of the probes was 
confirmed by NMR data (3J1,2 = 7.2-7.5 Hz). 
 
5.2.1.2.2 Synthesis of 2,4-Dinitrophenyl 2,3-di-O-Methyl-4,6-Methylidene-β- 
D-Galactopyranoside 263 
The last compound of the series was synthesized following standard 
manipulations as depicted in Scheme 76. 
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Scheme 76: Synthesis of 2,4-DNP-4,6-O-methylene galactopyranoside 263 
 
D-galactose was peracetylated in the usual manner prior the functionalization of 
the anomeric position by introduction of thiophenol. β-Thioglycoside (3J1,2 = Hz) 
258 was deacetylated under Zemplén conditions after which acid catalyzed 
treatment with benzaldehyde dimethyl acetal gave the corresponding 4,6-O-
benzylidene protected donor 259 in 80% yield. Methyl ether protection of the 
remaining alcohols afforded galactoside 260. Subsequent acidic hydrolysis of the 
benzylidene group was followed by the installation of the methylene acetal at the 
O4 and O6 positions upon treatment with formaldehyde dimethyl acetal in the 
presence of a catalytic amount of CSA, provided compound 261 in 41% yield. 
Conversion of the anomeric thioglycoside to the corresponding acetoxy derivative 
was carried out under the NIS/AcOH glycosylation conditions within an hour, 
affording compound 262 in 70% yield. Finally hydrazine acetate-mediated 
deacetylation of 262 was followed by the introduction of the 2,4-dinitrophenyl 
moiety at the anomeric position, giving rise to the target bicyclic methylene acetal 
probe 263 in 40% overall yield. 
 
5.2.2 Kinetic Studies 
5.2.2.1 Spontaneous Hydrolysis of 2,4-Dinitrophenyl Galactopyranosides 
5.2.2.1.1 General Mechanism 
 Cocker and Sinnott258 demonstrated in their early work that the 
spontaneous hydrolysis of 2,4-dinitrophenyl β-D-galactopyranosides obeys a first-
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order rate reaction and is pH independent at 25 °C between pH 1.6 and 8.4, 
above which a specific base-catalyzed reaction rapidly takes place. Thus, the 
rate of liberation of 2,4-dinitrophenolate is uncatalyzed within this pH range and 
will therefore not be affected by protonation equilibria. Accordingly, the departure 
of the 2,4-dinitrophenolate can only be assisted by the lone pair of the endocyclic 
oxygen – provided that the reaction is conducted in non-nucleophilic media – 
giving rise to the transient glycosyl oxocarbenium ion in the rate determining 
step. Finally, the glycosyl oxocarbenium ion is trapped by water to give an 
α/β mixture of D-galactose as shown in Scheme 77.  
 
Scheme 77: Mechanism of the spontaneous hydrolysis of 2,4-DNP-
galactopyranosides between pH 1.6 and 8.4 
 
5.2.2.1.2 Kinetic Measurements 
 The kinetic parameters were obtained by measuring 
spectrophotometrically in dilute solutions, the rate of formation of 2,4-
dinitrophenolate at λ = 400 nm. The solvolyses of probes 255, 256R, 256S and 
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263 were easy to follow experimentally since the 2,4-dinitrophenyl glycoside 
derivatives and the 2,4-dinitrophenolate anion, the two chromophores present in 
solution, absorbe light at different wavelengths, around λ = 280-290 nm and λ = 
400 nm respectively, therefore giving rise to distinct UV spectra. Each 
measurement was recorded under the same conditions. 
 
5.2.2.1.2.1 Protocol for the Spontaneous Hydrolysis of 2,4-Dinitrophenyl 
Galactopyranosides 
The rate of spontaneous hydrolysis of the 2,4-dinitrophenyl β-D-
galactosides were measured in a phosphate buffered saline solution (pH = 6.5, c 
= 25 mM, CKCl = 0.4 M KCl) to which was added dioxane to ensure full solubility 
of the substrates. The absorbance was recorded at 400 nm over different periods 
of time. In order to obtain reliable data, the measurements were not stopped until 
the reaction had reached at least five times the half-life of the compound. Then, 
each reaction was repeated three to four times for consistency. Finally, the rate 
constants were measured at five different temperatures (42 °C, 50 °C, 60 °C, 68 
°C and 75 °C) and at a single concentration (C = 0.5 mM) for each compound. 
The kinetic data obtained in this manner are presented in the following sections. 
 
5.2.2.1.2.2 First Order Rate Constants Determination 
 The graphs of absorbance as a function of time A = f(t), were plotted for 
each compound at T = 42 °C, 50 °C, 60 °C, 68 °C and 75 °C and the rate 
constants k were calculated for each temperature from the slopes. An example of 
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one of the plots obtained for a given temperature is shown in Graph 1, and the 
remainder are presented in the appendix. 
 
Graph 1: Formation of 2,4-dinitrophenolate as a function of time at λ = 400 
nm and T = 68 °C 
 
A summary of the averaged k values obtained for each compound for this set of 
temperatures is presented in Table 4.  
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49 
 
57 (gg) 
 
50R (gt) 
 
50S (tg) 
 
T = 315 K 
1.85 x 10-5 
± 4.65 x 
10-8 s-1 
8.06 x 10-6 
± 2.54 x 
10-8 s-1 
4.61 x 10-6 
± 1.13 x 
10-8 s-1 
3.55 x 10-6 
± 8.50 x 
10-9 s-1 
 
T = 323 K 
4.90 x 10-5 
± 1.19 x 
10-7 s-1 
2.23 x 10-5 
± 7.02 x 
10-8 s-1 
1.32 x 10-5 
± 5.30 x 
10-8 s-1 
1.04 x 10-5 
± 3.00 x 
10-8 s-1 
 
T = 333 K 
1.57 x 10-4 
± 2.27 x 
10-7 s-1 
7.20 x 10-5 
± 3.88 x 
10-7 s-1 
4.85 x 10-5 
± 1.16 x 
10-7 s-1 
3.90 x 10-5 
± 1.23 x 
10-7 s-1 
 
T = 341 K 
3.82 x 10-4 
± 5.76 x 
10-7 s-1 
1.85 x 10-4 
± 7.27 x 
10-7 s-1 
1.22 x 10-4 
± 3.69 x 
10-7 s-1 
9.84 x 10-5 
± 4.49 x 
10-7 s-1 
 
T = 348 K 
7.64 x 10-4 
± 9.96 x 
10-7 s-1 
3.83 x 10-4 
± 1.55 x 
10-6 s-1 
2.60 x 10-4 
± 8.08 x 
10-7 s-1 
2.12 x 10-4 
± 7.88 x 
10-7 s-1 
 
Table 4: Averaged rate constants calculated for compounds 255, 263, 256R 
and 256S at different temperatures 
 
5.2.2.1.2.3 The Arrhenius Equation 
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 The Arrhenius equation correlates the rate constant k to the temperature, 
in the form  
                                                       k = Ae-Ea/RT                                              (Eq 1) 
where A is the frequency, or pre-exponential factor, Ea, the activation energy, R, 
the gas constant and T, the temperature. 
The plot of ln k versus the inverse temperature (1/T) provides the activation 
energy value from the slope of the curve and the pre-exponential factor from the 
y intercept. 
The entropy of activation ΔS‡ was calculated from equation 2259 as follows  
                                    !∆!‡!".!" = log ! – !10.753!– log! + !"!".!"!                          (Eq. 2)  
  
where k represents the rate constant at a given temperature T. 
The Arrhenius plot was then constructed for each compound on the basis of the 
averaged k values (Table 4) obtained at these five different temperatures.  
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Graph 2: The Arrhenius plot of 2,4-DNP galactoside probes  
 
The kinetic parameters for each compound are summarized in Table below. 
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263 
 
 
 
- 8.87 
 
5.00 
× 10-4 
 
108 
 
4.33 
× 10-6 
 
0.43 
 
256R 
 
 
 
- 8.48 
 
3.35 
× 10-4 
 
113 
 
2.50 
× 10-6 
 
0.23 
 
256S 
 
 
+ 4.54 
 
2.75 
× 10-4 
 
114 
 
1.85 
× 10-6 
 
0.17 
 
Table 5: Experimental kinetic parameters for the sponotaneous hydrolysis 
of 2,4-DNP galactosides 255, 263, 256R and 256S 
 
Comparisons of the relative rates of hydrolysis of monocyclic compound 255 with 
bicyclic compounds 263, 256R and 256S as probes for the gg, tg and gt 
conformers show that cis-fused systems also suffer from a torsional disarming 
effect regardless of the orientation of the C6-O6 bond. In other words, the 
presence of a cis-fused ring slows down the distortion of the pyranose ring to the 
geometry imposed by the oxocarbenium ion, resulting in a slower release of 2,4-
dinitrophenolate. The electronic influence of the C6-O6 bond parallels that 
predicted by the charge-dipole hypothesis, namely that the gg conformer, 
compound 263, is the most reactive one and the tg conformer, compound 256S, 
the least reactive and hence the most disarmed, as shown from the relative rate 
of hydrolysis of compound 256S being about six times slower than that of 
monocyclic probe 255. A clear arming effect arises from the additional axially 
O
MeO
OMe
ODNP
O
O
O
MeO ODNP
MeO
O OMe
O
MeO ODNP
MeO
OMeO
! 141!
oriented C6-O6 bond as anticipated; the gg conformer 263 is more reactive than 
either the gt or tg conformer. However, the overall stabilizing interaction of the 
two axial C4-O4 and C6-O6 bonds is not sufficient to compensate the disarming 
effect coming from the locking of the rings (k49 = 2 x k57). Thus, Table 5 points to 
the torsional disarming effect as the preponderant factor affecting the reactivity of 
conformationally restrained galactopyranosides. This disarming effect is revealed 
in the form of the increased activation energy Ea needed for the reaction to 
overcome the formation of high energy intermediates in the transition state, on 
going to the formation of the products (ΔEa = 10 kJ/mol between monocyclic 
probe 255 and the tg conformer 256S).  
 
5.2.2.2 Acid Catalyzed Hydrolysis of Methyl Glycosides!
5.2.2.2.1 General Mechanism 
 The acid catalyzed hydrolysis of alkyl or aryl glycopyranosides has been 
thoroughly studied and many related papers can be found in the literature183. The 
assumed, or most commonly well-accepted mechanism is one that is believed to 
proceed by exocyclic protonation of the glycosidic oxygen atom followed by 
unimolecular heterolysis of the glycosyl-oxygen bond, leading to a 
glycopyranosyl oxocarbenium ion and the aglycone. The rate-determining step 
occurs at the breaking of the glycosidic bond, in other words, on the formation of 
the oxocarbenium ion. The protonation of the exocyclic oxygen is the fast step of 
the reaction (Scheme 78, pathway A). 
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a) Exocyclic protonation 
 
b) Endocyclic protonation 
 
 
Scheme 78: Acid catalyzed hydrolysis of methyl α-D-glycopyranosides via 
a) exocyclic and b) endocyclic protonation 
 
Evidence such as, the oxygen isotopic effect determined in 18O-enriched water or 
the existence of a linear free energy relationship between the acid-catalyzed 
hydrolysis of alkyl glycoppyranosides and spontaneous processes giving rise to 
the same cyclic oxocarbenium intermediate, has been used to support this 
mechanism. Methyl α-D-glycopyranosides were shown to predominantly 
hydrolyze by this mechanistic route. An alternative pathway, protonation at the 
endocyclic oxygen, has also been considered as a plausible mechanism in the 
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hydrolysis of pyranosyl acetals and proofs of it taking place in polar solvents and 
even water have been documented.  In this later hypothesis, a higher energy 
intermediate is formed due to the opening of the pyranose ring, leading to the 
formation of an acyclic oxocarbenium ion (Scheme 78, pathway B) 
 
5.2.2.2.2 Kinetic Measurements 
 The acidic hydrolysis experiments were conducted by following the 
change in the optical rotation value over the course of time polarimetrically. Each 
compound was measured according to the same protocol. 
 
5.2.2.2.2.1 Protocol for the Acid Catalyzed Hydrolysis  
The acidic hydrolysis of the methyl α-D-galactosides 247, 254R and 254S 
was conducted at the same concentration C = 33 mM and in aqueous perchloric 
acid (c = 2.0 M). The optical rotation values were recorded until no further 
change was observed. The measurements were stopped once no more starting 
material was detectable by mass spectrometry (MS ES+). The experiment was 
repeated three times for each compound, to ensure the consistency of the data 
obtained. 
 
5.2.2.2.2.2 First Order Rate Constant Determination 
The recorded optical rotation values were analyzed with the aid of an 
equation of the type A(t) = (α(t) – α(inf))/ (α(0) – α(inf)) where α(inf) represents 
the optical rotation value at the end time, then fitted as an exponential curve in 
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the form of y(t) = yo + a  × exp (-bt) with the b value representing the first-order rate 
constant k of the reaction. Examples of the curves obtained from these 
experiments are showed in Graph 3 and the full set of plots is given in the 
appendix. 
 
Graph 3: Acid catalyzed hydrolysis of methyl α-D-galactopyranosides  
 
After extraction of the rate constant k, an average of these values was calculated 
within experimental errors. The results of these experiments are summarized in 
Table 6.  
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Compound 
 
Structure 
 
k × 105 s-1 (T = 82 
°C) 
 
Relative 
hydrolysis rate 
 
 
247 
 
 
 
 
13.5 ± 0.28  
 
 
1 
 
 
254R 
 
 
 
 
 
10.5 ± 0.23  
 
 
 
0.78 
 
 
254S 
 
 
 
 
 
10.7 ± 0.22  
 
 
 
0.79 
 
Table 6: Rate constants for the acid catalyzed hydrolysis of methyl α-D-
galactosides 247, 254R and 254S 
 
Analogous with the results observed in the spontaneous hydrolysis of the 2,4-
dinitrophenyl substrates, the presence of a fused system retards the formation of 
the oxocarbenium ion and the rate of acidic hydrolysis is faster in the case of 
monocyclic probe 247 than bicyclic probes 254R or 254S. Surprisingly, it seems 
that the orientation of the C6-O6 bond has no apparent effect on the reactivity of 
the oxocarbenium ion since the acidic hydrolysis of 254R and 254S occurs at 
same rates within experimental errors (kgt ≈ ktg), whereas the charge-dipole 
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theory would have predicted a slower rate for the hydrolysis of the tg conformer 
as it was observed by Bols53 in the acid hydrolysis of methyl α-D-glucopyranoside 
derivatives. From comparison of Tables 2 and 3, it is obvious that the trend 
observed for the relative spontaneous hydrolysis of constraint 2,4-dinitrophenyl 
galactopyranosides does not hold anymore in the case of the acidic hydrolysis of 
similar methyl α-galactopyranoside probes. Clearly, there is no free energy 
relationship relating the spontaneous hydrolysis of 2,4-DNP galactosides to the 
acid catalyzed hydrolysis of α-methyl counterparts. These results suggest that a 
different mechanism is most likely involved in the acidic hydrolysis of 
conformationally locked methyl α-galatopyranoside systems that does not include 
the intermediacy of a cyclic oxocarbenium ion, pointing therefore toward an 
endocyclic protonation mechanism. Yet, since a difference in the relative rate of 
hydrolysis between 247 and 254R/254S is noted, an exocyclic protonation 
pathway cannot be excluded, but is no longer favored. The hypothesis of an 
endocyclic protonation confirms what was observed during the spontaneous 
hydrolysis of compounds 255, 263, 256R and 256S, namely that the formation of 
the oxocarbenium ion is a high energy process - due to the disarming effect 
coming from the bridging of O4 and O6. This effect is overridden in the acid-
catalyzed hydrolysis reaction by a switch to the endocyclic protonation pathway. 
A counter-argument to this hypothesis arises from the fact that such a 
mechanism has not been observed in similar reactions in the glucose series and 
because an endocyclic protonation is not stereoelectronically favored for methyl 
α-D-glycopyranosides260. Going back to Deslongchamps’186 hypothesis, the 
! 147!
ground state of galactopyranosides is characterized by a 1,3-syn diaxial 
electronic interaction (electrostactic repulsion) between the axial substituent at 
C4 and the axial lone pair of the endocyclic oxygen. This unfavorable interaction 
should be relatively stronger in conformationally restrained molecules such as 
compounds 254R or 254S, since the freedom of rotation about the C4-O4 bond 
is lost, leading to a closer positioning between O4 and O5. Consequently, the 
protonation step in the acid catalyzed hydrolysis of bicyclic galactopyranoside 
systems is most likely assisted by the lone pairs of both oxygen atoms O4 and 
O5 via hydrogen bonding, directing thereby the site of protonation at the 
endocyclic oxygen while relieving the LP/LP interaction observed in the ground 
state of galactopyranoside systems (Scheme 79). 
 
Scheme 79: Endocyclic protonation hypothesis 
 
5.3 Conclusion 
 The results obtained from this set of kinetic studies confirmed what 
Fraser-Reid observed about twenty years ago, namely that 4,6-O-acetals exert a 
disarming effect on glycosides reactivity. In the case of the galactose series, the 
origin of this disarming effect appears to be mostly torsional, affecting directly the 
glycosyl oxocarbenium ion by retarding its formation.  However, this disarming 
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effect is tempered by the favorable electronic interactions arising from the 
through-space donation of the two axially oriented C4-O4 and C6-O6 bonds into 
the developing oxocarbenium ion. From these results, it seems that the α-
directing effect observed in 4,6-O-acetal-protected galactopyranosyl donor might 
most likely be due to thermodynamic rather than kinetic controls. 
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CHAPTER 6 
OVERALL CONCLUSION 
 The applicability of a novel ligation method between a disulfide and a thiol 
functional to the preparation of oligosaccharide mimetics was demonstrated in 
the first part of this thesis through the chemical synthesis of linear  β-(1→6)-N-
acetyl glucosamine mimetics. Large oligosaccharide mimetics can be generated 
from small, pre-assembled sugar building blocks, by linking them together with a 
small thioether linkage via the desulfurative rearrangement of allylic disulfides. 
This facile transformation takes place at room temperature under mild conditions 
and is favored in polar media, allowing the manipulation of polar molecules 
without the need of protecting groups. This methodology is suitable for the 
modification of thiols and cysteine residues and is highly compatible with a wide 
range of functional groups, which supposes potentials application across 
carbohydrate chemistry field. 
 Different mechanistic aspects of the glycosylation reaction were brought 
into light by investigating the stereoelectronic influence of the proximal C-O 
bonds in 4,6-O-benzylidene-protected glycoside systems. In contrast with the 
formation of O-glycosides, C-glycosides are formed stereoselectively in the 
glucose and the mannose series, independently of the nature of the substituent 
at C3 in other words, the C3-O3 bond was found to have no discernible effect on 
the outcome of C-glycosylation reaction, whereas it had been previously shown 
to have a major effect on the outcome of O-glycosylation. A different mechanistic 
scheme was proposed to account for this change in selectivity based on the 
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changing face of selectivity of an oxocarbenium ion intermediate according to the 
nature of the nucleophile.   
4,6-O-Acetal-protected galactopyranosides were shown to suffer from a 
torsional disarming effect despite the cis-fused conformation of the rings. 
However, this effect is lesser in the galactose series than in the glucose series 
because of the favorable electronic interactions arising from the two axially 
oriented C4-O4 and C6-O6 bonds. 
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CHAPTER 7 
EXPERIMENTAL SECTION 
General 
The reactions were all conducted under inert atmosphere of either argon or 
nitrogen. All solvents were dried and distilled by standard procedures. All the 
reagents were purchased from commercial sources and used as received, unless 
otherwise stated. The products were purified by silica gel (60 Å, 230 × 450 mesh) 
column chromatography. The optical rotation values were recorded on an 
Autopol III automatic polarimeter in CHCl3 unless otherwise stated. NMR 
experiments were recorded on either a Mercury 400 MHz or a Varian 500 MHz 
instruments for 1H and 13C spectra. Melting points were measured on a 
Barnstead electrotermal (9100) instrument and are uncorrected. Electrospray 
mass spectra were recorded on a Waters Micromass LCT premier XE mass 
spectrophotometer in conjuction with the Waters Acquity UPLC. The absorbance 
was measured on a Varian Cary-Bio 50 UV/Visible spectrophotometer using a 
stoppered quartz cuvette. 
Only data for new compounds are provided here. 
 
General Protocols: 
A. General Procedure for Saponification of Phenoxycarbonylthioxybutenyl 
Groups and Installation of the Pyridyl Disulfide Moiety. To a solution of the 
glycosyl thiocarbonate (0.5 mmol) in MeOH (2.5 mL) was added, dropwise at 0 
ºC a freshly prepared solution of 1M KOH (2.3 mmol, 1.5 eq per group to be 
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saponified). The resulting mixture was stirred for 0.5 h then neutralized by careful 
addition of Amberlyst-15 resin and then filtered. The filtrate was added dropwise 
to a solution of 2,2’-dipyridyl disulfide (0.7 mmol) in MeOH at 0 ºC. The resulting 
mixture was allowed to warm to room temperature and stirred for 4 h. The 
solvent was removed in vacuo and the residue was purified by silica gel column 
chromatography to give the desired products. 
B. General Procedure for the Preparation of Cyclic Bisacetals. 
Camphorsulfonic acid (0.34 mmol) was added to a stirred solution of the 
glycoside (3.4 mmol) in methanol (32 mL) at room temperature. Then, trimethyl 
orthoformate (18.5 mmol) and butane-2,3-dione (4.0 mmol) were added and the 
mixture was heated at reflux for 14-16 h. The mixture was then basified to pH = 8 
by addition of triethylamine and the solvents were removed under reduced 
pressure. The residue was purified by silica gel column chromatography to give 
the desired bisacetals. 
C. General Procedure for the Preparation and Isolation of Tosylates. p-
Toluenesulfonyl chloride (4.86 mmol) and tetramethylethylenediamine (4.86 
mmol) were added sequentially to a stirred solution of the glycoside (0.24 mmol) 
in acetonitrile (25 mL) at room temperature. The mixture was stirred for 2-5 h 
then, poured into ice and extracted twice with dichloromethane. The combined 
organic layers were dried, filtered and concentrated in vacuo. The residue was 
purified by silica gel chromatography. 
D. General Procedure for the Introduction of the 6-Acetylthio Group from 
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the Corresponding Tosylates. To a solution of tosylate (2.12 mmol) in DMF (28 
mL) was added potassium thioacetate (4.24 mmol). The reaction mixture was 
heated to 80 ºC (50 ºC in case of the disaccharide) for 18-36 h then concentrated 
in vacuo. The residue was taken up in dichloromethane and washed with water. 
The aqueous phase was extracted twice with dichloromethane. The combined 
organic layers were dried, filtered and concentrated and the 6-acetylthio 
derivatives were isolated by silica gel column chromatography. 
E. General Procedure for the Oxidation of Thioglycosides to Glycosyl 
Sulfoxides. To a stirred solution of thioglycoside (1.06 mmol) in dichloromethane 
(30 mL) was added dropwise at -80 ºC a freshly prepared solution of m-
chloroperoxybenzoic acid (1.04 mmol) in dichloromethane (3.8 mL). The resulting 
mixture was stirred at -80 ºC for 0.5-1.5 h then quenched by addition of saturated 
aqueous NaHCO3. The resulting mixture was allowed to warm to room 
temperature and the aqueous phase was extracted twice with dichloromethane. 
The combined organic layers were dried, filtered, concentrated and purified by 
silica gel column chromatography to yield the desired glycosyl sulfoxides. 
F. General Procedure for Glycosylation under NIS/TfOH conditions. The 
glycosyl donor (0.56 mmol) and glycosyl acceptor (0.73 mmol) were stirred in 
dichloromethane (4 mL) at room temperature in presence of activated 4Å 
powdered molecular sieves for 0.5 h before the reaction mixture was cooled to –
35 ºC. Then, N-iodosuccinimide (1.12 mmol) and trifluoromethanesulfonic acid 
(0.34 mmol) were added sequentially and the resulting mixture was stirred for 2 
h. The reaction was quenched by addition of 20% Na2S2O3 and allowed to warm 
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to room temperature and the aqueous phase was extracted twice with 
dichloromethane. The combined organic layers were dried, filtered, concentrated 
and purified by silica gel column chromatography to yield the desired product. 
G. General Procedure for Deprotection of 2-(Phenyloxycarbonylthioxy)-3-
butenyl Disaccharides with Trifluoroacetic Acid. To a stirred solution of the 
disaccharide (0.14 mmol) and thioanisole (1.35 mmol) in dichloromethane (8 mL) 
was added an aqueous solution of trifluoroacetic acid, TFA/H2O (19:1) (4mL), at 
room temperature. The resulting mixture was stirred for 0.5 to 1 h at room 
temperature, taken up in toluene and then evaporated. The deprotected 
disaccharide was isolated by silica gel column chromatography. 
H. General Procedure for the Triphenylphosphine-Promoted 
Rearrangement of Allylic Disulfides. A solution of acetylthio sugar (0.20 mmol) 
in methanol (1.7 mL) was sparged with nitrogen before a freshly prepared 
solution of 1M sodium methoxide in degassed methanol (0.2 mL) was added. 
The resulting mixture was stirred for 0.5 h, quickly neutralized by addition of dry 
Amberlyst IR 120 resin, filtered and then directly added to a stirred solution of the 
allylic sulfenyl donor (0.24 mmol) in methanol (2 mL) at room temperature. The 
resulting mixture was stirred at room temperature until TLC showed complete 
consumption of the thiol (14 h). Then, triphenylphosphine (0.24 mmol) was added 
at room temperature and the resulting mixture was stirred for an additional 16 h. 
The mixture was evaporated in vacuo and subjected to chromatographic 
purification eluting with dichloromethane/methanol (15:1). 
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I. General Procedure for the Formation of C-glycosides under the Standard 
Glycosylation Method using the BSP or DPSO/TTBP/Tf2O Systems 
To a stirred solution of donor (1 equiv), BSP or DPSO (1.2 equiv), TTBP (1.5 
equiv) and 4 Å molecular sieves in dichloromethane (0.05 M) was added at -65 
ºC Tf2O(1.2 equiv). The resulting mixture was stirred for 0.75 h before a solution 
of the acceptor (5 equiv) in dichloromethane (0.20 M) was slowly added. The 
resulting mixture was stirred at – 65 ºC for 3 to 12 h. The reaction was quenched 
at - 65 ºC by adding a saturated solution of NaHCO3. The temperature was 
allowed to warm to room temperature naturally. The mixture was taken up in 
dichloromethane and the molecular sieves was filtered through celite before 
phase separation. The organic phase was washed with a saturated solution of 
NaHCO3, dried over Na2SO4, filtered and concentrated. Purification by column 
chromatography eluting with hexanes/ethyl acetate 15:1 unless otherwise stated 
afforded the desired C-coupling products. 
 
2-(Phenyloxycarbonylthioxy)-3-butenyl 2-acetamido-3,4,6-tri-O-acetyl-2-
deoxy-β-D-glucopyranoside 90. 
To a stirred solution of the oxazolinone (2.5 g, 7.6 mmol) and 2-
(Phenoxycarbonylthioxy)-3-butenol (425 mg, 1.9 mmol) in chloroform was added, 
at room temperature, copper chloride (1.5 g, 11.4 mmol). The resulting mixture 
was heated at reflux for 14 h. The reaction mixture was allowed to warm to room 
temperature before saturated aqueous NaHCO3 was added. The resulting 
mixture was filtered through celite and washed twice with saturated aqueous 
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NaHCO3. The combined organic layers were dried, filtered and concentrated. 
The glycoside was isolated by silica gel column chromatography 
hexane/dichloromethane/ethyl acetate (1:1:2) as a white foam in an 
approximately 1:1 mixture of diastereomers (473 mg, 43%): 1H NMR (400 MHz, 
CDCl3) δ  7.35 (t, J = 8.0 Hz, 2 × 2H), 7.22 (t, J = 7.6 Hz, 2 × 1H), 7.12 (d, J = 6.4 
Hz, 2 × 2H), 5.74-5.98 (m, 2 × 2H) 5.18-5.40 (m, 2 × 3H), 5.04 (t, J = 9.6 Hz, 2 × 
1H), 4.74 (t, J = 8.0 Hz, 2 × 1H), 4.02-4.28 (m, 2 × 4H), 3.86 (q, J = 8.8, J = 17.8 
Hz, 2 × 1H), 3.82-3.66 (m, 2 × 2H), 2.04 (s, 2 × 3H), 2.00 (s, 2 × 6H), 1.92 (s, 2 × 
3H),13C NMR (100 MHz, CDCl3) δ 171.1, 171.0, 170.6, 169.6, 151.2, 134.0, 
133.8, 129.8, 126.5, 121.5, 119.1, 119.0, 101.4,100.7, 72.4, 72.1, 71.6, 70.4, 
68.8, 62.2, 54.8, 54.6, 48.9, 48.2, 23.6, 23.5, 20,9, 20.8, ESIHRMS calcd for 
C25H31NO11SNa [M + Na]+ 576.1516, found 576.1516. 
2-(2-Pyridyldisulfanyl)-3-enyl-2-acetamido-2-deoxy-β-D-glucopyranoside 91. 
Compound 91 was obtained from 90 according to procedure A in 60% yield over 
two steps. Compound 91 was eluting from silica gel chromatography with 
dichloromethane/methanol (25:1) and isolated as a white foam in a 1:1 mixture of 
diastereomers: 1H NMR (400 MHz, CD3OD) δ 8.36 (s, 2 × 1H), 7.94-7.78 (m, 2 × 
2H), 7.21 (t, J = 5.6 Hz, 2 × 1H), 5.87-5.67 (m, 2× 1H), 5.19 ( dd, J = 4.8, J = 16.8 
Hz, 2 × 1H), 5.11 (d, J = 10.4 Hz, 2 × 1H), 4.47-4.39 (m, 2 × 1H), 4.16-4.50 (m, 2 
× 1H), 3.86 ( dd, J = 5.6, J = 9.6, Hz, 2 × 1H), 3.82-3.75 (m, 2 × 1H), 3.74-3.63 
(m, 2 × 4H), 3.50-3.42 (m, 2 × 1H), 3.36-3.23 (m, 2 × 4H), 1.98 (s, 2 × 3H), 13C 
NMR (100 MHz, CD3OD) δ 172.5, 160.5, 148.9, 148.8, 138.1, 138.0, 134.2, 
133,8, 121.1, 121,0, 120.2, 121.1, 118.4, 118.3, 116.9, 102.1, 101.7, 76.9, 76.7, 
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74.8, 74.7, 74.6, 71.4, 70.9, 69.9, 69.8, 61.6, 61.5, 56.1, 56.0, 54.4, 54.1, 22.1, 
2.0, ESIHRMS calcd for C17H24N2O6S2Na [M + Na]+ 439.0974, found 439.0978. 
Methyl 2-acetamido-6-S-acetyl-2-deoxy-6-deoxy-β-D-glucopyranoside 94. 
Diizopropyl azodicarboxylate (0.25 mL, 1.22 mmol) was added dropwise at 0 ºC 
to a stirred solution of triphenylphosphine (326 mg, 1.24 mmol) in 
dimethylformamide (2 mL). The mixture was stirred at 0 ºC for 1 h and gave a 
light yellow precipitate. A solution of deprotected compound 93 (240 mg, 1.02 
mmol) and thiolacetic acid (0.09 mL, 1.22 mmol) in dimethylformamide (1.7 mL) 
was added dropwise at 0 ºC and the resulting mixture was stirred for 20 h at 
room temperature, resulting in a clear yellow solution. The mixture was 
concentrated in vaccuo and the residue was purified by silica gel 
chromatography (eluting with dichloromethane/methanol 15:1) to give the desired 
acetylthio compound 94 as a white solid (176 mg, 59%) mp 108 ºC, [α]RTD + 36.8 
(c MeOH), 1H NMR (300 MHz, CD3OD) δ 4.26 (d, J = 8.7 Hz, 1H), 3.66-3.55 (m, 
2H), 3.48-3.38 (m, 4H), 3.38-3.26 (m, 4H), 3.20 (t, J = 9 Hz, 1H), 2.80 (dd, J = 
8.1, J = 8.7 Hz, 1H), 2.32 (s, 3H), 1.94 (s, 3H), 13C NMR (75 MHz, CD3OD ) δ 
195.8, 172.6, 102.2, 75.0, 74.6, 73.9, 56.0, 55.7, 30.9, 29.2, 21.8, ESIHRMS 
calcd for C11H19NO6S Na [M + Na]+ 316.0831, found 316.0849.  
Methyl 6-[4-(2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-2E-butenyl]thio-
2- acetamido-2-deoxy-β-D-glucopyranoside 97. 
Compound 97 was prepared according to general procedures H and similarly 
was subjected to the silver nitrate rearrangement (cf. compound 106) and 
isolated as a white foam eluting from silica gel in dichloromethane/methanol 
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(20:1) in 82% (Ph3P) and 68% yields (AgNO3): [α]RT D + 41.0 (c 0.5, MeOH); 1H 
NMR (400 MHz, CD3OD) δ 5.80 = 5.60 (m, 2H), 4.40 (d, J = 8.0 Hz, 1H), 4.32 (d, 
J = 8.8 Hz, 1H), 4.27 (d, J = 8.8 Hz, 1H), 4.09 (dd, J = 5.2, J = 12.8 Hz, 1H), 3.88 
(d, J = 12.0 Hz, 1H), 3.72-3.61 (m, 4H), 3.48-3.20 (m, 12H), 2.94 (d, J = 13.6 Hz, 
1H), 2.62 (dd, J = 8.0 Hz, J = 14.4 Hz, 1H), 1.98 (s, 3H), 1.97 (s, 3H), 13C NMR 
(100 MHz, CD3OD) δ 172.6, 129.6, 128.8, 102.4, 102.3, 100.6, 77.0, 76.8, 74.9, 
74.8, 73.6, 70.9, 68.7, 61.6, 56.1, 56.0, 55.9, 34.0, 32.1, 21.9, 21.8, ESIHRMS 
calcd for C21H36N2O11SNa [M + Na]+ 547.1938, found 547.1942. 
Phenyl 2-azido-2-deoxy-3,4,6-tri-O-(p-methoxybenzyl)-1-thio-β-D-
glucopyranoside 122.  
To a stirred solution of thioglycoside 121 (800 mg, 2.7 mmol) in 
dimethylformamide (6.4 mL) was added, portion-wise, at 0 ºC sodium hydride 
(542 mg, 16.1 mmol) The resulting mixture was stirred for 0.5 h at 0 ºC before p-
methoxybenzylchloride (2.2 mL, 16.1 mmol) was added dropwise. The resulting 
mixture was allowed to warm to room temperature and stirred for 2 h then 
quenched by addition of methanol. The mixture was concentrated and purified by 
silica gel column chromatography 0.5% Et3N hexane/ethyl acetate (4:1) gave 
compound 122 (1.6 g, 92%) as a light yellow solid: mp, [α]RTD – 45.8 (c 1.0, 
CHCl3), 1H NMR (400 MHz, CDCl3) δ 7.60 (dd, J = 7.2, J = 8.0 Hz, 2H), 7.32-7.24 
(m, 7H), 7.12 (d, J = 8.8 Hz, 2H), 6.92-6.82 (m, 2H), 4.78 (s, 2H), 4.72 (d, J = 
10.4 Hz, 1H), 4.56 (d, J = 11.2 Hz, 1H), 4.52-4.46 (m, 2H), 4.40 (d, J = 9.6 Hz, 
1H), 3.80 (s, 9H), 3.76-3.66 (m, 2H), 3.58-3.42 (m, 3H), 3.32 (t, J = 9.6 Hz, 1H), 
13C NMR (100 MHz, CDCl3) δ 159.7, 159.6, 159.4, 133.8, 131.5, 130.5, 130.3, 
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130.1, 130.0, 129.8, 129.6, 129.2, 128.5, 114.2, 114.1, 114.0, 86.1, 85.0, 79.6, 
76.9, 75.7, 74.9, 73.3, 65.6, 65.3, 55.5, ESIHRMS calcd for C36H39N3O7S [M + 
Na]+ 680.2406, found 680.2404. 
Phenyl 2-azido-2-deoxy-3,4,6-tri-O-(p-methoxybenzyl)-1-thio-β-D-
glucopyranoside-S-Oxide 112. 
Compound 112 was obtained in a diastereomeric mixture and 92% yield 
according to general procedure E. Purification by silica gel chromatography in 
0.5% Et3N hexane/ethyl acetate (4:1) afforded 112 as a white solid: 1H NMR (400 
MHz, CDCl3) δ 7.71-7.63 (m, 2H), 7.51 (d, J = 4.8 Hz, 2H), 7.45 (dd, J = 2.4, J = 
3.2 Hz, 2H), 7.32 (d, J = 8.4 Hz, 3H), 7.25 (t, J = 8.0 Hz, 3H), 7.10 (d, J = 8.0 Hz, 
1H), 6.92-6.81 (m, 4H), 4.83 (d, J = 1.6 Hz, 1H), 4.89-4.65 (m, 3H), 4.48 (dd, J = 
7.2, J = 8.0 Hz, 3H), 4.31 (d, J = 11.6 Hz, 1H), 4.17 (dd, J = 9.6, J = 12.0 Hz, 
1H), 3.86-3.3.77 (m, 13H), 3.74-3.67 (m, 2H), 3.66-3.57 (m, 1H), 3.56-3.45 (m, 
4H), 13C NMR (100 MHz, CDCl3) δ 159.7, 159.6, 140.3, 139.4, 131.6, 131.5, 
130.1, 130.0, 129.9, 129.7, 129.6, 129.3, 129.2, 125.6, 124.9, 114.2, 114.1, 
114.0, 113.9, 94.5, 91.8, 84.8, 84.7, 80.9, 80.4, 75.8, 75.7, 74.9, 73.5, 73.4, 68.4, 
68.3, 61.0, 60.2, 55.5, ESIHRMS calcd for C36H39N3O8SNa [M + Na]+ 696.2356, 
found 696.2359. 
Phenyl 2-Azido-2-deoxy-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-1-thio-β-D-
glucopyranoside 113.  
Title compound 113 was obtained from compound 121 in 83% yield according to 
general procedure B. Compound 113 was isolated as a white solid and eluted 
from silica gel chromatography with hexane/ethyl acetate (2:1):  mp 110 ºC; [α]RT 
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D + 47.3 (c 1.0, CDCl3) 1H NMR (400 MHz, CDCl3) δ 7.55 (dd, J = 2.4, J = 5.6 Hz, 
2H), 7.37-7.30 (m, 3H), 4.40 (d, J = 9.6 Hz, 1H), 3.92-3.83 (m, 1H), 3.77-3.68 (m, 
2H), 3.63 (t, J = 9.6 Hz, 1H), 3.54-3.49 (m, 1H), 3.39 (t, J = 9.6 Hz, 1H), 3.33 (s, 
3H), 3.28 (d, J = 5.6 Hz, 1H), 3.23 (s, 3H), 194 (dd, J = 5.6 Hz, J = 7.2 Hz, 1H), 
1.33 (s, 3H), 1.27 (s, 3H), 13C NMR (100 MHz, CDCl3) δ 134.1, 129.4, 128.9, 
100.4, 99.9, 86.3, 78.3, 73.2, 65.8, 61.7, 61.5, 48.3, 48.3, 17.8, 17.7, ESIHRMS 
calcd for C18H25N3O6SNa [M + Na]+ 434.1362, found 434.1354. 
Phenyl 2-Azido-2-deoxy-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-1-thio-2’-
azido-2’-deoxy-3’,4’,6’-tri-O-(p-methoxybenzyl)]-β-D-gentiobioside 123. 
Glycosyl sulfoxide 112 (1.2 g, 1.78 mmol) was premixed with glycosyl acceptor 
113 (880 mg, 2.14 mmol), 2,4,6-tri-tert-butylpyrimidine (TTBP*) (886 mg, 3.57 
mmol) and activated 4Å powdered molecular sieves in 
dichloromethane/acetonitrile (4:3) (3.6 mL) and the resulting mixture was stirred 
at room temperature for 0.5 h then cooled at -80 ºC before 
trifluoromethanesulfonic anhydride (0.33 mL, 1.96 mmol) was added dropwise. 
The reaction mixture was stirred at - 80 ºC for 1.5 h, quenched by addition of 
aqueous saturated NaHCO3 and then allowed to warm to room temperature. The 
aqueous phase was extracted twice with dichloromethane. The organic layers 
were combined, dried, filtered and concentrated in vaccuo. Purification by silica 
gel column chromatography in 0.5% Et3N hexane/ethyl acetate (4:1 to 2.5:1) 
gave the resulting disaccharide (1.05 g, 62%) as a white foam: 1H NMR (400 
MHz, CDCl3) δ 7.61-7.53 (m, 2H), 7.36-7.27 (m, 5H), 7.27-7.22 (m, 3H), 7.07 (d, 
J = 8.0 Hz, 2H), 6.89 (d, J = 8.8 Hz, 2H), 6.83 (dd, J = 5.6, J = 8.8 Hz, 3H), 4.83-
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4.69 (m, 3H), 4.58-4.37 (m, 3H), 4.14 (d, J = 10.8 Hz, 1H), 3.90-3.46 (m, 16H), 
3.44-3.19 (m, 11H), 1.32 (s, 3H), 1.27 (s, 3H), 13C NMR (100 MHz, CDCl3) δ 
159.6, 159.5, 134.1, 133.8, 130.4, 130.0, 129.8, 129.3, 128.6, 114.1, 114.0, 
102.4, 100.4, 100.0, 86.4, 83.1, 78.2, 75.9, 75.8, 75.5, 75.2, 74.9, 74.7, 73.4, 
72.2, 71.2, 68.4, 68.1, 66.6, 66.3, 65.6, 61.7, 60.2, 55.5, 55.4, 48.3, 17.8, 17.7, 
ESIHRMS calcd for C48H58N6O13Na [M + Na]+ 981.3680, found 981.3682. 
Phenyl 2-Azido-2-deoxy-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-1-thio-[2’-
azido-2’-deoxy-3’,4’,6’-tri-O-(p-methoxybenzyl)]-β-D-gentiobioside-S-Oxide 
109.  
Title compound 109 was isolated as a white foam in 88% yield and in an 
approximately 1:1 mixture of diastereomers. Compound 53 was prepared from 
compound 52 according to general procedure E and eluted from silica gel in 
0.5% Et3N hexane/ethyl acetate (3:1): 1H NMR (400 MHz, CDCl3) δ 7.68-7.60 (m, 
2 × 2H), 7.55-7.45 (m, 2 × 3H), 7.33-7.20 (m, 2 × 4H), 7.12-7.02 (m, 2 × 2H), 
6.91-6.79 (m, 2 × 6H), 4.80-4.66 (m, 2 × 3H), 4.54 (dd, J = 9.6, J = 10.8 Hz, 1 × 
1H), 4.48-4.38 (m, 2 × 2H), 4.21 (dd, J = 5.6, J = 9.6 Hz, 1 × 1H), 4.02-3.84 (m, 2 
× 3H), 3.83-3.73 (m, 2 × 10H), 3.73-3.44 (m, 2 × 6H), 3.43-3.14 (m, 2 × 9H), 1.34 
(s, 2 × 3H), 1.26 (s, 2 × 3H), 13C NMR (100 MHz, CDCl3) δ 159.6, 139.1, 131.7, 
131.4, 130.3, 130.0, 129.9, 129.8, 129.7, 129.6, 129.4, 129.3, 125.4, 124.7, 
114.2, 114.1, 114.0, 102.9, 102.1, 100.5, 100.1, 95.2, 91.7, 91.4, 82.7, 79.8, 
78.8, 77.5, 75.4, 75.3, 75.0, 74.9, 74.8, 73.5, 73.4, 73.1, 68.5, 68.2, 67.7, 66.4, 
66.1, 65.8, 57.7, 55.5, 55.4, 48.4, 48.3, 17.8, 17.7; ESIHRMS calcd for 
C48H58N6O14SNa [M + Na]+ 997.3629, found 997.3614 
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2-(Phenyloxycarbonylthioxy)-3-butenyl-2-azido-2-deoxy-3,4-O-(2,3-
dimethoxy-butane-2,3-diyl)-[2’-azido-2’deoxy-3’,4’,6’-tri-O-(p-
methoxybenzyl)]-β-D-gentiobioside 124.  
Disaccharide glycosyl sulfoxide 109 (560 mg, 0.57 mmol) was premixed with 2-
(Phenoxycarbonylthioxy)-3-butenol 82 (266 mg, 1.20 mmol), 2,4,6-tri-tert-
butylpyrimidine (TTBP*) (314 mg, 1.26 mmol) and activated 4Å powdered 
molecular sieves in dichloromethane/acetonitrile (4:3) (2 mL) and the resulting 
mixture was stirred at room temperature for 0.5 h then cooled at -60 ºC before 
trifluoromethanesulfonic anhydride (0.15 mL, 0.86 mmol) was added dropwise. 
The reaction mixture was stirred at -60 ºC for 8 h. The reaction mixture was then 
cooled to -80 ºC, quenched by addition of aqueous saturated NaHCO3 and then 
allowed to warm to room temperature. The aqueous phase was extracted twice 
with dichloromethane. The organic layers were combined, dried, filtered and 
concentrated in vaccuo. Purification by silica gel column chromatography 0.5% 
Et3N hexane/ethyl acetate (6:1 to 3:1) gave the coupling product (390 mg, 63%) 
as a white foam, in an approximately 1:1 mixture of diastereomers: 1H NMR (400 
MHz, CDCl3) δ  7.41-7.11 (m, 2 ×10H), 7.17-7.10 (m, 2 ×2H), 7.45 (d, J = 7.2 Hz, 
2 × 2H), 6.90-6.79 (m, 2 ×3H), 6.03-5.92 (m, 2 ×1H) 5.43 (d, J = 16.8 Hz, 2 × 
1H), 5.25 (d, J = 9.6 Hz, 2 × 1H), 4.80-4.67 (m, 2 ×4H), 4.55 (dd, J = 7.2, J = 11.6 
Hz, 2 × 1H), 4.47-4.35 (m, 2 ×3H), 4.29-4.17 (m, 2 ×3H), 3.92-3.81 (m, 2 ×1H), 
3.79 (s, 2 × 6H), 3.78 (s, 2 × 3H), 3.73-4.49 (m, 2 ×7H), 3.49-3.19 (m, 2 ×10H), 
1.33 (s, 2 × 3H), 1.27 (s, 2 × 3H); 13C NMR (100 MHz, CDCl3) δ  169.3, 169.2, 
169.0, 159.6, 159.5, 159.4, 156.6, 151.4, 134.2, 134.1, 130.3, 130.2, 130.0, 
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130.0, 129.9, 129.8, 129.7, 126.4, 126.3, 124.7, 121.7, 121.6, 121.5, 120.3, 
118.9, 115.7, 114.2, 114.1, 114.0, 103.0, 102.9, 102.8, 102.7, 100.2, 100.0, 83.2, 
83.0, 75.4, 75.2, 74.9, 74.6, 73.4, 73.3, 71.4, 71.2, 70.8, 70.1, 70.0, 68.4, 67.1, 
66.5, 63.2, 55.5, 55.4, 48.7, 48.3, 45.9, 18.0, 17.9, 17.8, 17.7; ESIHRMS calcd 
for C53H64N6O16SNa 1095.3997, found 1095.4004. 
2-(Phenyloxycarbonylthioxy)but-3-enyl 2,2’-diazido-2,2’-dideoxy-β-D-
gentiobioside 125.  
The title compound 125 was obtained from compound 124 according to general 
procedure G as a white foam eluted from silica gel with 
dichloromethane/methanol (20:1) in approximately a 1:1 mixture of 
diastereomers and 67% yield: 1H NMR (400 MHz, CDCl3) δ 7.40 (t, J = 7.3 Hz, 2 
× 2H), 7.26 (t, J = 7.2 Hz, 2 × 1H), 7.15 (d, J = 9.2 Hz, 2 × 2H), 6.06-5.95 (m, 2 × 
1H), 5.41 (d, J = 15.2 Hz, 2 × 1H), 5.23 (d, J = 10.8 Hz, 2 × 1H), 4.48 (dd, J = 
7.3, J = 8.8 Hz, 2 × 1H), 4.41 (d, J = 8.0 Hz, 2 × 1H), 4.28-4.18 (m, 2 × 3H), 3.93-
3.60 (m, 2 × 7H), 3.47 (dd, J = 6.4, J = 8.0 Hz, 2 × 1H), 3.34-3.06 (m, 2 × 9H), 
13C NMR (100 MHz, CDCl3) δ 164.0, 134.9, 129.5, 126.2, 121.3, 117.7, 117.6, 
102.7, 102.3, 102.1, 101.9, 94.7, 76.8, 76.2, 75.1, 75.0, 70.7, 70.6, 70.3, 69.0, 
67.1, 61.3, 48.6, ESIHRMS calcd for C23H30N6O11SNa [M + Na]+ 621.1591, found 
621.1593. 
2-(Pyridyldithio)but-3-enyl-2,2’-diazido-2,2’-dideoxy-β-D-gentiobioside 107.  
The title compound 107 was obtained according to general procedure A as a 
white foam eluting from silica gel in dichloromethane/methanol (20:1) in 
approximately a 1:1 mixture of diastereomers and in 65% yield over two steps: 
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1H NMR (400 MHz, CD3OD) δ 8.37 (d, J = 4.0 Hz, 2 × 1H), 8.75 (dd, J = 4.0, J = 
8.4 Hz, 2 × 1H), 7.83-7.77 (m, 2 × 1H), 7.21 (dd, J = 4.8, J = 7.2 Hz, 2 × 1H), 
5.90-5.78 (m, 2 × 1H), 5.30-5.21 (m, 2 × 1H), 5.15 (d, J = 10.8 Hz, 2 × 1H), 4.96-
4.85 (m, 2 × 1H), 4.47-4.32 (m, 2 × 2H), 4.24-3.98 (m, 2 × 3H), 3.91-3.64 (m, 2 × 
7H), 4.48-3.05 (m, 2 × 9H); 13C NMR (100 MHz, CD3OD) δ 148.9, 137.9, 133.9, 
121.1, 120.3, 120.2, 118.4, 102.7, 101.8, 76.8, 76.2, 75.1, 74.9, 70.6, 70.4, 69.8, 
69.0, 67.0, 61.4, 53.8; ESIHRMS calcd for C21H29N7O9S2Na [M + Na]+  610.1366, 
found 1379. 
Phenyl 2-Azido-2-deoxy-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-1-thio-6-O-p-
toluenesulfonyl-β-D-glucopyranoside 126.  
The title compound 126 was obtained according to general procedure C as a 
white solid in a quantitatif yield, by elution from silica gel with hexane/ethyl 
acetate (3:1): mp 134 ºC; [α]RTD + 12.3 (c 1.0, CDCl3), 1H NMR (400 MHz, CDCl3) 
δ 7.80 (d, J = 8.8 Hz, 2H), 7.64 (d, J = 8.0 Hz, 1H), 7.46 (d, J = 7.6 Hz, 2H), 7.34-
7.25 (m, 4H), 4.29 (t, J = 10.4 Hz, 2H), 4.21 (dd, J = 4.0, J = 10.8 Hz, 1H), 3.67-
3.53 (m, 3H), 3.31 (d, J = 9.6 Hz, 1H), 3.28 (s, 3H), 3.23 (d, J = 7.6 Hz, 1H), 3.20 
(s, 3H), 2.67 (s, 3H), 1.29 (s, 3H), 1.25 (s, 3H), 13C NMR (100 MHz, CDCl3) δ 
145.2, 134.4, 133.0, 130.3, 130.1, 129.3, 129.0, 128.2, 100.5, 100.1, 86.1, 77.6, 
75.4, 73.0, 67.3, 65.3, 61.1, 48.6, 48.4, 21.9, 17.8, 17.7, ESIHRMS calcd for 
C25H31N3O8S2Na [M + Na]+ 588.1450, found 588.1440. 
Phenyl 2-Azido-2-deoxy-6-acetylthio-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-
1-thio-β-D-glucopyranoside 127.  
! 165!
The title compound 127 was prepared according to general procedure D and 
isolated as a light yellow foam eluted from silica gel with hexane/ethyl acetate 
(6:1) in 78% yield: [α]RT D + 132.1 (c 1.0, CDCl3), 1H NMR (400 MHz, CDCl3) δ 
7.57 (dd, J = 6.4, J = 7.2 Hz, 2H), 7.35-7.30 (m, 3H), 4.35 (d, J = 9.6 Hz, 1H), 
3.67 (t, J = 9.6 Hz, 1H), 3.62-3.55 (m 1H), 3.51-3.43 (m, 2H), 3.30 (s, 3H), 3.22 
9s, 3H), 3.07 (q, J = 7.2, J= 14 Hz, 1H), 2.35 (s, 3H), 1.31 (s, 3H), 1.28 (s, 3H), 
13C NMR (100 MHz, CDCl3) δ 194.9, 134.5, 133.2, 130.7, 129.2, 129.1, 128.9, 
100.4, 100.13, 86.2, 76.7, 73.0, 68.6, 61.5, 48.4, 48.3, 30.7, 30.1, 17.8, 17.7, 
ESIHRMS calcd for C20H27N3O6Na [M + Na]+492.1239, found 492.1245. 
Phenyl 6-Acetylthio-2-azido-2-deoxy-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-
1-thio-β-D-glucopyranoside-S-Oxide 110.  
Compound 110 was prepared according to general procedure E and isolated as 
a white solid eluted from silica gel in hexane/ethyl acetate (4:1) in 70% yield: mp 
125 ºC; [α]RT D – 12.3 (c 1.0, CDCl3); 1H NMR (400 MHz, CDCl3) δ 7.62-7.58 (m, 
2H), 7.55-7.51 (m, 3H), 4.01 (dd, J = 9.6, J = 10.8 Hz, 1H), 3.83 (t, J = 9.6 Hz, 
1H), 3.72 (d, J = 9.6 Hz, 1H), 3.54 (d, J = 9.6 Hz), 3.43-3.31 (m, 5H), 3.20 (s, 
3H), 2.83 (dd, J = 8.0, J = 14.0 Hz, 1H), 2.19 (s, 3H), 1.27 (s, 3H), 13C NMR (100 
MHz, CDCl3) δ 194.7, 139.1, 131.5, 129.2, 125.6, 100.5, 100.2, 91.9, 77.8, 73.3, 
68.8, 57.6, 48.4, 48.3, 30.6, 29.8, 17.8, 17.7, ESIHRMS calcd for 
C20H27N3O7S2Na [M + Na]+ 508.1188, found 508.1183. 
Methyl 2-Azido-2-deoxy-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-β-D-
glucopyranoside 111.  
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Compound 111 was obtained as a white foam according to general procedure B 
and isolated from silica gel with hexane/ethyl acetate (2:1) in 81% yield: [α]RTD =  
+ 70.3 (c 1.0, CDCl3) 1H NMR (400 MHz, CDCl3) δ 4.2 (d, J = 8 Hz, 1H), 3.88-
3.80 (m, 1H), 3.76-3.66 (m, 2H), 3.60 (dd, J = 9.6, J = 10.8 Hz, 1H), 3.53 (s, 3H), 
3.48-3.42 (m, 1H), 3.39 (dd, J = 7.2, J = 8.4 Hz, 1H), 3.28 (s, 3H), 3.23 (s, 3H), 
2.50 (dd, J = 5.6, J = 8.0 Hz, 1H), 1.31 (s, 3H), 1.26 (s, 3H), 13C NMR (100 MHz, 
CDCl3) δ 103.6, 100.3, 99.9, 76.9, 74.2, 71.0, 66.0, 62.9, 61.2, 57.6, 48.3, 17.8, 
17.7, ESIHRMS calcd for C13H23N3O7Na [M + Na]+ 365.1434, found 365.1432. 
Methyl 2,2’-Diazido-2,2’-dideoxy-6’- acetylthio-β-D-gentiobioside 131.  
Glycosyl sulfoxide 110 (340mg, 0.70 mmol) was premixed with 2,4,6-tri-tert-
butylpyrimidine (TTBP*) (244 mg, 0.98 mmol) and activated 4Å powdered 
molecular sieves in dichloromethane/acetonitrile (3:1) (2.6 mL) and the resulting 
mixture was stirred at room temperature for 0.5 h then cooled at -65 ºC before 
trifluoromethanesulfonic anhydride (0.14 mL, 0.84 mmol) was added dropwise. 
The glycoside sulfoxide was preactivated for 10 min before a solution of the 
glycosyl acceptor 111 (466 mg, 1.4 mmol) in dichloromethane (0.8 mL) was 
added. The resulting mixture was stirred for 8 h at -65 ºC quenched by addition of 
aqueous saturated NaHCO3 and then allowed to warm to room temperature. The 
aqueous phase was extracted twice with dichloromethane. The organic layers 
were combined, dried, filtered and concentrated in vaccuo. The crude protected 
disaccharide was taken to the acid hydrolysis step without further purification to 
give compound 131 as a white foam eluted from silica gel with 
dichloromethane/methanol (20:1) in 64% yield: [α]RT D + 18.5 (c 1.0, MeOH) NMR 
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(400 MHz, CDCl3) δ  4.42 (d, J = 7.8 Hz, 1H), 4.24 (d, J = 7.8 Hz, 1H), 4.16 (dd, J 
= 1.8, J = 11.4 Hz, 1H), 3.70 (dd, J = 6.9 Hz, J = 11.7 Hz, 1H), 3.60-3.51 (m, 1H), 
3.46 ( dd, J = 7.2, J = 8.1 Hz, 1H), 3.35 (s, 1H), 3.32-3.24 (m 8H), 3.23-3.08 ( m, 
4H), 2.98 (dd, J = 8.1, J = 14.1 Hz, 1H), 2.33 (s, 3H), 13C NMR (100 MHz, CDCl3) 
δ  195.7, 102.9, 102.6, 75.9, 75.2, 75.0, 74.7, 73.4, 70.6, 69.1, 67.0, 48.7, 47.0, 
30.6, 29.2, ESIHRMS calcd for C15H24N6O9SNa [M + Na]+ 487.1223, found 
487.1232. 
Methyl 6-[4-O-(2,2’-Azido-2,2’-dideoxy-β-D-gentiobiosyloxy)but-2E-enyl]-
thio-2,2’-azido-2,2’- 6-thio-α-D-gentiobioside 106.  
Thiol precursor 108 (40 mg, 0.09 mmol) was dissolved in dimethylformamide (0.8 
mL) at room temperature and hydrazine acetate (12 mg, 0.13 mmol) was added. 
The resulting mixture was stirred for 0.75 h and directly transferred to a stirred 
solution of sulfenyl donor 107 (56 mg, 0.1 mmol) in methanol (1mL). The 
resulting mixture was stirred until TLC showed complete consumption of the free 
thiol compound (18 h). Silver nitrate (26 mg, 0.20 mmol) was then added and the 
resulting mixture was stirred at room temperature, under light exclusion, for an 
additional 36 h. The resulting mixture was filtered through a patch of celite and 
silica and concentrated. Purification by silica gel chromatography 
dichloromethane/methanol (15:1) afforded the desired compound as a white 
foam in 52% yield: [α]RT D + 65.8 (c 1.0, CHCl3); 1H NMR (400 MHz, CD3OD) δ 
5.84-5.67 (m, 2H), 4.62 (s, 2H), 5.52-4.36 (m, 5H), 4.23 (dd, J = 9.5, J = 12.0 Hz, 
5H), 3.87 (d, J = 12.0 Hz, 2H), 3.83-3.62 (m, 5H), 3.56 (s, 3H), 3.54-3.43 (m, 5H), 
3.42-3.05 (m, 15H), 2.95 (d, J = 15.0 Hz, 1H), 2.63 (q, J = 7.0 Hz, 1H); 13C NMR 
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(100 MHz, CD3OD) δ 130.4, 128.6, 102.9, 102.6, 100.6, 77.2, 76.8, 76.1, 75.9, 
75.2, 75.1, 74.8, 72.9, 70.6, 70.5, 70.3, 69.1, 69.0, 68.9, 67.0, 66.9, 61.3, 56.2, 
33.9, 31.4; ESIHRMS calcd for C29H46Cl3N12O17SNa [M + Na]+ 889.2722, found 
889.2736. 
Phenyl 3,4,6-Tri-O-acetyl- 2-deoxy-1-thio-2-(2,2,2-trichloroethoxycarbonyl-
amino)-β-D-glucopyranoside 142. 
To a stirred solution of compound 141 (10 g, 19.2 mmol) in dichloromethane (100 
mL) was added respectively at room temperature, trimethylsilyl 
trifluoromethanesulfonate (TMSOTf) (4.2 mL, 23 mmol) and benzenethiol (2.4 
mL, 23 mmol). The resulting mixture was stirred for 4 h then, neutralized by 
addition of triethylamine and concentrated. Purification by silica gel column 
chromatography (hexane/ethyl acetate 3:1) afforded compound 142 (9.2 g, 84%) 
as a light yellow solid: mp 87 ºC; [α]RT D + 18.5 (c 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.49 (dd, J = 3.2, J = 4.0 Hz, 2H), 7.29 (dd, J = 2.0, J = 3.2 Hz, 
3H), 4.95 (d, J = 9.6 Hz, 1H), 5.27 (t, J = 9.6 Hz, 1H), 5.01 (t, J = 9.6 Hz, 1H), 
4.85 (d, J = 10.8 Hz, 1H), 4.74 (ddd, J = 12.0, J = 16 Hz, 2H), 4.24-4.412 (m, 
2H), 3.76-3.66 (m, 2H), 2.06 (s, 3H), 1.99 (s, 3H), 1.97 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 170.9, 169.7, 154.2, 133.1, 132.3, 129.2, 128.5, 119.2, 86.8, 77.6, 
75.9, 74.7, 73.4, 68.8, 62.6, 55.2, 21.0, 20.9, 20.8; ESIHRMS calcd for 
C21H24Cl3NO9SNa  [M + Na]+ 594.0135, found 594.0112. 
Phenyl 3,4,6-O-Acetyl-2-deoxy-1-thio-2-(2,2,2-trichloroethoxycarbonyl-
amino)-β-D-glucopyranoside-S-Oxide 138.  
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The title compound 138 was prepared according to general procedure E, eluting 
from silica gel chromatography with hexane/ethyl acetate (2:1) and isolated as a 
white foam in 88% yield: mp 134 ºC; [α]RT D + 31.0 (c 1.0, CDCl3) 1H NMR (400 
MHz, CDCl3) δ 7.71 (dd, J = 2.5, J = 3.2 Hz, 2H), 7.52 (dd, J = 2.4, J = 3.2 Hz, 
3H), 5.68 (d, J = 8.8 Hz, 1H), 5.44 (t, J = 9.6 Hz, 1H), 4.92 (t, J = 9.6 Hz, 1H), 
4.80 (d, J = 10.4 Hz, 1H), 4.62 (d, J = 12.4 Hz, 1H), 4.44 (d, J = 12 Hz, 1H), 4.16 
(m, 2H), 3.86 (dd, J = 9.6, J = 10.8 Hz, 1H), 3.78 (m, 1H), 2.00 (s, 9H), 13C NMR 
(100 MHz, CDCl3) δ 170.7, 170.6, 169.6, 153.9, 138.8, 131.6, 129.1, 125.9, 95.3, 
93.3, 76.4, 74.6, 72.6, 68.1, 61.7, 51.7, 20.9, 20.8, ESIHRMS calcd for 
C21H24Cl3NO10SNa [M + Na]+ 610.0084, found 610.0067. 
Phenyl 2-deoxy-3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-1-thio-2-(2,2,2-
trichloroethoxycarbonyl-amino)-β-D-glucopyranoside 139.  
To a stirred solution of thioglycoside 142 (1g, 1.65 mmol) in MeOH (8.8 mL) was 
added a catalytic amount of 25% sodium hydroxide in MeOH (0.18 mmol) at 
room temperature. The resulting mixture was stirred for 1 h, neutralized by 
addition of Amberlyst IR 120 resin, filtered and concentrated to give phenyl 2-
(2,2,2-trichloroethoxycarbonylamino)-1-thio-β-D-glucopyranoside 143, which was 
subjected to general protocol B directly, giving the title compound as a white 
foam, eluted from silica gel with hexane/ethyl acetate (1.5:1) in 72% yield: mp; 
[α]RT D + 54.5 (c 1.0, CDCl3) 1H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 2.4, J = 
4.0 Hz, 2H), 7.31 (dd, J = 2.4, J = 4.4 Hz, 3H), 5.10 (d, J = 8.8 Hz, 2H), 4.75 (s, 
2H) 4.10 (dd, J = 7.2, J = 9.6 Hz, 1H), 3.93-3.85 (m, 1H), 3.77-3.70 (m, 1H), 3.66 
(t, J = 9.6 Hz, 1H), 3.62-3.56 (m, 1H), 3.41 (brs, 1H), 3.10 (dd, J = 4.4, J = 5.6 
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Hz, 1H), 3.24 (s, 3H), 3.21 (s, 3H), 1.91 (dd, J = 5.6, J = 7.6 Hz, 2H), 1.27 (s, 
6H), 13C NMR (100 MHz, CDCl3) δ 153.8, 133.0, 132.0, 129.4, 129.3, 128.4, 
100.3, 99.8, 86.1, 78.1, 77.4, 74.7, 70.1, 67.0, 61.7, 54.7, 48.2, 48.1, 17.8, 17.8, 
ESIHRMS calcd for C21H28Cl3NO8SNa [M + Na]+ 582.0449, found 582.0494. 
Phenyl 3’,4’,6’-Tri-O-acetyl-2,2’-dideoxy-3,4-O-(2,3-dimethoxybutan-2,3-
diyl)- 1-thio-2,2’-bis(2,2,2-trichloroethoxycarbonylamino)-β-D-gentiobioside 
144.  
Glycosyl sulfoxide 138 (310 mg, 0.53 mmol) was stirred in dichloromethane (1.6 
mL) and in presence of activated 4Å powdered molecular sieves at room 
temperature for 0.5 h. The resulting mixture was cooled at at -65 ºC before 
trifluoromethanesulfonic anhydride (0.10 mL, 0.58 mmol) was added dropwise. 
The glycoside sulfoxide was preactivated for 10 min before a solution of the 
glycosyl acceptor 139 (350 mg, 0.62 mmol) in dichloromethane (0.4 mL) was 
added. The resulting mixture was stirred for 7 h at -65 ºC quenched by addition of 
aqueous saturated NaHCO3 and then allowed to warm to room temperature. The 
aqueous phase was extracted twice with dichloromethane. The organic layers 
were combined, dried, filtered and concentrated in vaccuo. Purification by silica 
gel column chromatography hexane/ethyl acetate (5:1 to 2:1) gave the resulting 
disaccharide as a white foam (230 mg, 43%): [α]RT D + 44.2 (c 1.0, CDCl3) 1H 
NMR (500 MHz, CDCl3) δ 7.52 (d, J = 7.2 Hz, 2H), 7.43-7.33 (m, 3H), 5.36-5.06 
(m, 2H), 5.00 (d, J = 7.6 Hz, 2H), 4.81-4.69 (m, 3H), 4.64 (dd, J = 8.8, J = 12.0 
Hz, 1H), 4.52 (d, J = 8.0 Hz, 1H), 4.28-4.21 (m, 2H), 4.15-4.02 (m, 3H), 3.75-3.52 
(m, 4H), 3.39 (t, J = 9.6 Hz, 2H), 3.20 (s, 3H), 3.17 (s, 3H), 2.07 (s, 3H), 2.03 (s, 
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3H), 2.01 (s, 3H), 1.26, (s, 3H), 1.24 (s, 3H), 13C NMR (125 MHz, CDCl3) δ 169.7, 
169.3, 168.4, 153.1, 152.5, 132.2, 128.5, 127.7, 100.2, 99.0, 98.7, 94.5, 84.9, 
78.1, 75.7, 73.5, 71.2, 70.5, 67.7, 67.3, 66.6, 66.3, 60.9, 54.9, 53.4, 47.0, 46.9, 
19.7, 19.6, 16.6, 16.5, ESIHRMS calcd for C36H46Cl6N2O17SNa 1043.0549, found 
1043.0546. 
Phenyl 3’,4’,6’Tri-O-acetyl-2,2’-dideoxy-3,4-O-(2,3-dimethoxybutan-2,3-diyl)- 
1-thio-2,2’-bis(2,2,2-trichloroethoxycarbonyl-amino)-β-D-gentiobioside-S-
Oxide 135.  
The title compound 135 was obtained as a white foam by general procedure E 
from 144 and eluted from silica gel in hexane/ethyl acetate (2:1) in 88% yield: mp 
134 ºC; [α]RT D + 31.0 (c 1.0, CDCl3) 1H NMR (400 MHz, CDCl3) δ 7.71 (dd, J = 
2.5, J = 3.2 Hz, 2H), 7.52 (dd, J = 2.4, J = 3.2 Hz, 3H), 5.68 (d, J = 8.8 Hz, 1H), 
5.44 (t, J = 9.6 Hz, 1H), 4.92 (t, J = 9.6 Hz, 1H), 4.80 (d, J = 10.4 Hz, 1H), 4.62 
(d, J = 12.4 Hz, 1H), 4.44 (d, J = 12 Hz, 1H), 4.16 (m, 2H), 3.86 (dd, J = 9.6, J = 
10.8 Hz, 1H), 3.78 (m, 1H), 2.00 (s, 9H), 13C NMR (100 MHz, CDCl3) δ 170.7, 
170.6, 169.6, 153.9, 138.8, 131.6, 129.1, 125.9, 95.3, 93.3, 76.4, 74.6, 72.6, 
68.1, 61.7, 51.7, 20.9, 20.8, ESIHRMS calcd for C21H24Cl3NO10SNa [M + Na]+ 
610.0084, found 610.0067. 
2-(Phenyloxycarbonylthioxy)but-3-enyl 3’,4’,6’-Tri-O-acetyl-2,2’-dideoxy-3,4-
O-(2,3-dimethoxybutan-2,3-diyl)-2,2-bis-(2’,2’,2’-trichloroethoxycarbonyl-
amino) β-D-gentiobioside 145.  
Disaccharide glycosyl sulfoxide donor 135 (280 mg, 0.27 mmol) was mixed with 
acceptor 82 (120 mg, 0.54 mmol) and activated 4Å powdered molecular sieves in 
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dichloromethane (1.2 mL) and the resulting mixture was stirred at room 
temperature for 0.5 h then cooled at -60 ºC before trifluoromethanesulfonic 
anhydride (0.07 mL, 0.40 mmol) was added dropwise. The reaction mixture was 
stirred at -60 ºC for 12 h. The reaction mixture was then cooled to -75 ºC, 
quenched by addition of aqueous saturated NaHCO3 and then allowed to warm 
to room temperature. The aqueous phase was extracted twice with 
dichloromethane. The organic layers were combined, dried, filtered and 
concentrated in vaccuo. Purification by silica gel column chromatography 
hexane/ethyl acetate (4:1 to 2:1) gave the coupling product as a white foam, in 
an approximately 1:1 mixture of diastereomers (202 mg, 40% over two steps): 1H 
NMR (400 MHz, CDCl3) δ 7.36 (t, J = 7.2 Hz, 2 × 2H), 7.25-7.13 (m, 2 × 3H), 6.1-
5.85 (m, 2 × 1H), 5.40 (d, J = 16.8 Hz, 2 × 1H), 5.35-5.20 (m, 2 × 3H), 5.05 (dd, J 
= 8.8, J = 9.6 Hz, 2 × 2H), 4.85-4.65 (m, 2 × 6H), 3.90-3.80 (m, 2 × 1H), 3.75-
3.50 (m, 2 × 5H), 3.45 (dd, J = 8.0, J = 10.0 Hz, 2 × 1H), 3.25 (s, 2 × 3H), 2.08 (s, 
2 × 3H), 1.98 (s, 2 × 6H), 1.28 (s, 2 × 3H), 1.24 (s, 2 × 3H), 13C NMR (100 MHz, 
CDCl3) δ 170.9, 170.6, 169.7, 154.2, 151.3, 134.1, 133.8, 129.7, 126.4, 121.6, 
121.5, 119.2, 119.1, 101.1, 100.1, 99.9, 95.7, 76.9, 74.7, 72.2, 71.9, 71.6, 70.2, 
68.8, 68.6, 68.3, 67.7, 62.2, 62.1, 56.5. 55.7, 55.4, 49.0, 48.6, 48.2, 48.1, 29.9, 
21.0, 20.8, 17.9, 17.8, ESIHRMS calcd for C41H52Cl6N2O20SNa [M + Na]+ 
1157.0885, found 1157.0890. 
2-(Phenyloxycarbonylthioxy)but-3-enyl 3’,4’,6’-Tri-O-acetyl-2,2’-dideoxy-
2,2’-bis(2,2,2-trichloroethoxycarbony-lamino)-β-D-gentiobioside 146.  
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Hydrolysis of the bis(acetal) group was carried out according to general 
procedure G. The title compound 146 was isolated as a white foam from silica 
gel eluted with hexane/ethyl acetate 1:1 to 1:3 as an approximately 1:1 mixture of 
diastereomers in 68% yield NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 7.2, J = 8.4 
Hz, 2 × 2H), 7.28-7.21 (m, 2 × 1H), 7.16 (dd, J = 8.4 Hz, 2 × 2H), 6.00-6.57 (m, 2 
× 1H), 5.55-5.45 (d, J = 16.8 Hz, 2 × 1H), 5.40 (d, J = 16.8 Hz, 2 × 1H), 5.25 (d, J 
= 10.4 Hz, 2 × 1H), 5.25-5.20 (m, 2 × 1H), 5.05 (t, J = 9.6 Hz, 2 × 1H), 4.80-4.65 
(m, 2 × 4H), 4.55 (bs, 2 × 1H), 4.30-4.05 (m, 2 × 5H), 3.90-3.60 (m, 2 × 6H), 
3.60-3.30 (m, 2 × 4H), 2.10 (s, 2 × 3H), 2.03 (s, 2 × 6H), 13C NMR (100 MHz, 
CDCl3) δ 171.1, 171.0, 169.7, 155.3, 154.6, 151.3, 134.1, 133.8, 129.8, 126.5, 
121.6, 121.5, 119.4, 119.3, 101.5, 95.5, 77.0, 75.1, 75.0, 74.8, 74.7, 74.3, 72.2, 
71.5, 69.3, 68.7, 62.1, 58.3, 58.1, 56.4, 48.8, 48.4, 29.9, 21.1, 20.8, ESIHRMS 
calcd for C35H42Cl6N2O18SNa [M + Na]+ 1043.0182, found 1043.0209. 
2-(2-Pyridyldithio)but-3-enyl 2,2’-dideoxy-2,2’-(2,2,2-
trichloroethoxycarbonyl-amino)-β-D-gentiobioside 133.  
Installation of the disulfide moiety on 146 was undergone under general 
procedure A. The title compound 133 was isolated as a white foam eluting from 
silica gel in dichloromethane/methanol (20:1) as an approximately 1:1 mixture of 
diastereomers in 62% yield over two steps: 1H NMR (400 MHz, CD3OD) δ  8.36 
(d, J = 4.8 Hz, 2 × 1H), 7.91 (dd, J = 7.2, J = 8.4 Hz, 2 × 1H), 7.87-7.79 (m, 2 × 
1H), 7.20 dd, J = 4.8, J = 7.2 Hz, 2 × 1H), 5.90-5.74 (m, 2 × 1H), 5.15 (dd, J = 
9.6, J = 16.8 Hz, 2 × 2H), 4.85-4.64 (m, 2 × 10H), 4.53-4.33 (m, 2 × 2H), 4.21-
4.00 (m, 2 × 2H), 3.88 (d, J = 12.0 Hz, 2 × 1H), 3.82-3.59 (m, 2 × 4H), 3.50-3.21 
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(m, 2 × 9H), 13C NMR (100 MHz, CD3OD) δ 155.8, 149.1, 148.8, 138.1, 134.1, 
133.8, 122.2, 121.0, 120.3, 118.6, 118.3, 102.1, 101.8, 101.7, 76.8, 75.8, 74.6, 
74.5, 74.4, 71.1, 70.9, 70.0, 69.8, 69.0, 61.6, 58.0, 57.8, 54.4, 54.3, 29.6, 
ESIHRMS calcd for C27H35Cl6N3O13S2Na [M + Na]+ 905.9637, found 905.9640. 
Methyl 3,4,6-Tri-O-acetyl-2-(2,2,2-trichloroethoxycarbonyl-amino)-2-deoxy-
β-D-glucopyranoside 147.  
The title compound 147 was prepared according general procedure F and 
isolated in 94% yield as a white solid eluted from silica gel with hexane/ethyl 
acetate (2:1): mp 115 ºC; [α]RT D + 12.5 (c 1.0, CDCl3), 1H NMR (400 MHz, 
CDCl3) δ 5.30 (dd, J = 9.2, J = 10.4 Hz, 1H), 5.20 (bs, 1H), 5.07 (dd, J = 8.8, J = 
10.0 Hz, 1H), 4.80 (d, J = 11.2 Hz, 1H), 4.65 (d, J = 12 Hz, 1H), 4.54 (d, J = 7.6 
Hz, 1H), 4.28 (dd, J = 4, J = 4.8 Hz, 1H), 4.15 (d, J = 10.0 Hz, 1H), 3.72 (d, J = 
7.2 Hz, 1H), 3.64 (ddd, J= 8.8, J = 17,6 Hz, 1H), 3.52 (s, 3H), 2.03 (s, 6H), 2.09 
(s, 3H), 13C NMR (100 MHz, CDCl3) δ 170.9, 169.7, 154.3, 119.2, 102.0, 74.7, 
72.0, 68.9, 62.2, 57.4, 56.4, 55.1, 21.0, 20.8, ESIHRMS calcd for 
C16H22Cl3NO10Na [M + Na]+ 516.0207, found 516.0211. 
Methyl 3,4-O-(2,3-dimethoxy-butane-2,3-diyl)-2-(2,2,2-
trichloroethoxycarbonyl-amino)-2-deoxy-β-D-glucopyranoside 137.  
Compound 147 (600 mg, 1.66 mmol) was dissolved in MeOH (8.3 mL) at room 
temperature and a catalytic amount of 25% NaOMe in MeOH (0.16 mmol) was 
added. The resulting mixture was stirred for 1h before the pH of the solution was 
adjusted to 7 by addition of Amberlyst IR 120 resin. The resulting mixture was 
filtered and concentrated and dried under vacuo to give compound 148, which 
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was treated according to general procedure B and eluted from silica gel with 
hexane/ethyl acetate (1:1) in 72% yield as a white solid: mp 105 ºC; [α]RT D + 
123.0 (c 1.0, CDCl3), 1H NMR (400 MHz, CDCl3) δ 5.20 (s, 1H), 4.72 (dd, J = 
12.4, J = 18 Hz, 3H), 4.10 (dd, J = 7.2, J = 9.2 Hz, 1H), 3.92-3.84 (m, 1H), 3.80-
3.74 (m,1H), 3.69 (t, J = 10.0 Hz, 1H), 3.58-3.53 (m, 1H), 3.50 (s, 3H), 3.40-3.28 
(m, 1H), 3.25 (s, 3H), 3.21 (s, 3H), 2.01 (dd, J = 4.8, J = 8.0 Hz, 1H), 1.28 (s, 
6H), 13C NMR (100 MHz, CDCl3) δ 119.2, 119.1, 102.2, 100.2, 99.8, 74.6, 74.1, 
68.3, 67.2, 61.4, 57.2, 56.0, 48.2, 48.1, 17.9, 17.8, ESIHRMS calcd for 
C16H26Cl3NO9Na [M + Na]+ 504.0571, found 504.0572. 
Phenyl 2-deoxy-3,4-O-(2,3-dimethoxybutane-2,3-diyl)-1-thio-6-O-p-
toluenesulfonyl-2-(2,2,2-trichloroethoxycarbonyl-amino)-β-D-
glucopyranoside 136.  
The title compound 136 was prepared following general procedure C, eluted from 
silica gel with hexane/ethyl acetate (3:1) and isolated in a quantitatif yield as a 
white solid: mp 144 ºC; [α]RT D + 84.2 (c 1.0, CDCl3), 1H NMR (400 MHz, CDCl3) δ 
7.81 (d, J = 7.2 Hz, 2H), 7.41 (d, J = 8.0 Hz, 2H), 7.34-7.20 (m, 5H), 5.03 (dd, J = 
6.4, J = 10.0 Hz, 2H), 4.73 (s, 2H), 4.30 (d, J = 10.8 Hz, 1H), 4.23 (dd, J = 4.0 
Hz, J = 10.8 Hz, 1H), 4.07 (dd, J = 10.0, J = 11.2 Hz, 1H), 3.67 (dd, J = 2.4, J = 
3.2 Hz, 1H), 3.59 (t, J = 9.6 Hz, 1H), 3.31-3.23 (m, 1H), 3.29 (s, 3H), 3.18 (s, 3H), 
2.40 (s, 3H), 1.25 (s, 6H), 13C NMR (100 MHz, CDCl3) δ 145.1, 133.3, 130.1, 
129.2, 128.5, 128.2, 100.4, 100.0, 85.6, 77.6, 75.4, 74.6, 69.7, 67.7, 66.5, 54.3, 
48.5, 48.2, 21.9, 17.9, 17.7, ESIHRMS calcd for C28H34Cl3NO10Na [M + 
Na]+736.0587, found 736.0594. 
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Methyl 2,2’-dideoxy-3,4;3’,4’-di-O-(2,3-dimethoxy-butan-2,3-diyl)-2,2’-
bis(2,2,2-trichloroethoxycarbonyl-amino)-6-O-p-toluenesulfonyl-β-D-
gentiobioside 149. 
 The title compound 149 was prepared according to general procedure F and 
isolated as a white foam eluted from silica gel with hexane/ethyl acetate (5:1 to 
3:1) in 89% yield: mp, [α]23 D = + 72.7 (c 1.0, CDCl3), 1H NMR (400 MHz, CDCl3) 
δ 7.82 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 5.10 (bs, 2H), 4.88 (bs, 1H), 
4.80-4.62 (m, 5H), 4.31 (d, J = 10.8 Hz, 1H), 4.16 (dd, J = 5.6, J = 10.8 Hz, 1H), 
4.12-3.97 (m, 3H), 3.68 (dd, J = 6.4, J = 8.8 Hz, 3H), 3.59-3.45 (m, 5H), 3.40-
3.12 (m, 14H), 2.45 (s, 3H), 1.28 (s, 6H), 1.25 (s, 6H), 13C NMR (100 MHz, 
CDCl3) δ 154.6, 154.1, 145.2, 132.9, 130.1, 128.4, 128.2, 101.9, 101.6, 100.2, 
99.8, 95.8, 95.7, 74.8, 74.5, 73.8, 73.6, 72.3, 71.7, 69.7, 69.2, 68.5, 67.7, 67.0, 
57.3, 57.2, 56.5, 55.7, 55.6, 48.5, 48.4, 48.2, 48.1, 29.9, 21.9, 18.9, 17.8, 
ESIHRMS calcd for C38H54Cl6N2O19SNa [M + Na]+1107.1070, found 1107.1086. 
Methyl 6’-Acetylthio-2,2’-dideoxy-3,4;3’,4’-di-O-(2,3-dimethoxy-butane-2,3-
diyl)-2,2’-bis(2,2,2-trichloroethoxycarbonyl-amino)]-β-D-gentiobioside 150. 
The title compound 150 was obtained following general procedure D as a light 
yellow foam by elution from silica gel chromatography with hexane/ethyl acetate 
(6:1) in 71% yield: [α]RT D + 82.3 (c 1.0, CDCl3), 1H NMR (400 MHz, CDCl3) δ 
5.16-5.0 (m, 1H), 4.92-4.83 (m, 1H), 4.78-4.63 (m, 5H), 4.12-3.99 (m, 3H), 3.74-
3.65 (m, 2H), 3.64-3.56 (m, 1H), 3.53-3.42 (m, 6H), 3.33 (dd, J = 5.2, J = 7.2 Hz, 
3H), 3.23 (s, 3H), 3.21 (s, 3H), 3.20 (s, 3H), 3.18 (s, 3H), 3.04 (q, J = 10.0 Hz, J = 
18.8 Hz, 1H), 2.33 (s, 3H), 1.29 (s, 3H), 1.27 (s, 3H), 13C NMR (100 MHz, CDCl3) 
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δ 195.1,  154.6 154.0, 129.2, 128.8, 101.8, 101.6, 100.1, 100.0, 99.8, 95.8, 77.6, 
75.9, 74.8, 74.6, 74.2, 74.1, 72.7, 72.5, 70.1, 68.4, 67.8, 57.6, 57.3, 55.9, 48.5, 
48.3, 48.1, 30.7, 30.2, 19.0, 17.9, 17.8, ESIHRMS calcd for C33H50Cl6N2O17SNa 
[M + Na]+1011.0859, found 1011.0869. 
Methyl 2,2’-dideoxy-2,2’-bis(2,2,2-trichloroethoxycarbonyl-amino)-6’-
acetylthio-β-D-gentiobioside 151.  
The title compound 151 was prepared from 150 following general procedure G 
and eluted from silica gel with dichloromethane/methanol (20:1) as a white foam 
in 68% yield: [α]RTD – 6.0 (c 1.0, CHCl3) NMR (400 MHz, CDCl3) δ 4.84-4.69 (m, 
6H), 4.60 (s, 1H), 4.45 (d, J = 7.6 Hz, 1H), 4.29 (d, J = 8.8 Hz, 1H), 4.11 (d, J = 
10.4 Hz, 1H), 3.72-3.56 (m, 2H), 3.45-3.29 (m, 7H), 3.21 (dd, J = 8.8, J = 9.4 Hz, 
3H), 2.90 (dd, J = 7.2, J = 13.6 Hz, 1H), 2.34 (s, 3H), 13C NMR (100 MHz, CDCl3) 
δ 196.0, 155.9, 102.4, 102.1, 91.5, 75.6, 75.0, 74.6, 74.4, 74.2, 74.1, 74.0, 72.1, 
71.4, 69.5, 48.5, 47.4, 30.8, 29.3, 25.6, 19.8, ESIHRMS calcd for 
C21H30Cl6N2O13SNa [M + Na]+ 782.9497, found 782.9501. 
Methyl 6-S-[4-O-(2,2’-dideoxy-2,2’-(2,2,2-trichloroethoxycarbonylamino)-β-D-
gentiobiosyloxy)but-2E-enyl]-2,2’-dideoxy-(2,2,2-trichloroethoxycarbonyl-
amino-6-thio-α-D-gentiobioside 132.  
Methyl 2,2’-dideoxy-2,2’-bis(2,2,2-trichloroethoxycarbonyl-amino)-6’-S-acetyl-β-D-
gentiobioside 151 (30 mg, 0.04 mmol) was dissolved in dimethylformamide (0.5 
mL) at room temperature and hydrazine acetate (12 mg, 0.13 mmol) was added. 
The resulting mixture was stirred for 1.25 h and directly transferred to a stirred 
solution of disaccharide sulfenyl donor 133 (42 mg, 0.05 mmol) in methanol (0.8 
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mL). The resulting mixture was stirred until TLC showed complete consumption 
of the free thiol compound (20 h). Triphenyl phosphine (13 mg, 0.05 mmol) was 
then added and the resulting mixture was stirred at room temperature for an 
additional 40 h. The resulting mixture was filtered through a patch of celite and 
silica and concentrated. Purification by silica gel chromatography 
dichloromethane/methanol (15:1) afforded the desired compound 132 as a white 
foam eluting from silica gel in dichloromethane/methanol (15:1) and in 54% yield: 
[α]RT D + 72.6  (c 1.0, CHCl3); 1H NMR (400 MHz, CD3OD) δ 5,85-5.58 (m, 2H), 
4.92 (d, J = 4.1 Hz, 3H), 4.93-4.86 (m, 12H), 4.85 (d, J = 4.0 Hz, 2H), 4.80 (d, J = 
12.1 Hz, 2H), 4.73 (dd, J = 9.7, J = 12.2, 3Hz), 4.62 (dd, J = 8.9, J = 11.3, 2Hz), 
4.54-4.37 (m, 2H), 4.36-4.24 (m, 2H), 4.19 (d, J = 4.0 Hz, 2H), 4.13-4.01 (m, 1H), 
3.89 (d, J = 11.3, 1H), 3.77-3.59 (m, 4H), 3.53-3.18 (m, 18H), 2.96 (d, J = 13.0 
Hz, 1H), 2.63 (dd, J= 5.7, J = 8.1 Hz, 1H), 13C NMR (100 MHz, CD3OD) δ 153.8, 
153.6, 130.4,128.7, 102.8, 102.5, 100.7, 78.2, 77.7, 76.2, 75.9, 75.8, 75.3, 75.2, 
74.9, 72.5, 72.3, 70.7, 70.6, 70.4, 69.2, 69.0, 68.6, 67.5, 67.3, 61.5, 56.3, 33.9, 
32.2. 
2,3-O-Di-benzyl-4,6-O-benzylidene -1-allyl-1-deoxy-β-D-mannopyranose 193. 
Compound 193 was prepared by the general glycosylation procedure I and 
obtained in 57 to 60% yield as a white solid: mp = 80.9 – 90.5 °C, [ α]RTD - 26.0 (c 
= 1.0 M, CHCl3); 1H NMR (500 MHz, CDCl3)  δ 7.52 (dd, J = 1.5, 7.5 Hz, 2H), 
7.42 – 7.29 (m, 13H), 5.72 – 5.63 (m, 2H), 5.10 -5.02 (m, 3H), 4.93 (d, J = 12.0 
Hz, 1H), 4.77 (d, J = 12.5 Hz, 1H), 4.70 (d, J = 11.5 Hz, 1H), 4.30 – 4.24 (m, 2H), 
3.86 (t, J = 10.0 Hz, 1) 3.81 (d, J = 2.0 Hz, 1H), 3.74 (dd, J = 2.5, 9.5 Hz, 1H), 
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3.46 (t, J = 7.0 Hz, 1H), 3.39 (dt, J = 5.0, 10.0 Hz, 1H), 2.47 (dt, J = 6.5, 14.0 Hz, 
1H), 2.26 (dt, J = 7.0, 14.0 Hz, 1H), 13C NMR (125 MHz, CDCl3) δ 138.6, 138.4, 
137.7, 134.3, 128.8, 128.5, 128.4, 128.3, 128.2, 127.7, 127.6, 127.5, 126.0, 
117.5, 101.3, 80.7, 79.6, 79.5, 76.3, 75.0, 73.1, 72.0, 68.7, 35.5, 29.7, ESIHRMS 
calcd for C30H32O5Na [M + Na]+ 495.2147, found 495.2142. 
2,3-Di-O-benzyl-4,6-O-benzylidene-1-deoxy-1-(2-oxo-2-phenylethyl)-β-D-
mannopyranose 196. 
Compound 196 was prepared by the general glycosylation procedure I and 
obtained in 76% yield as a colorless oil: [ α]RTD – 10.4 (c = 0.75 M, CHCl3); 1H 
NMR (500 MHz, CDCl3)  δ 7.82 (d, J = 7.0 Hz, 2H), 7.59 – 7.51 (m, 3H), 7.46 - 
7.34 (m, 8H), 7.32 – 7.25 (m, 4H), 7.17 – 7.09 (m, 3H), 5.65 (s, 1H), 5.02 (d, J = 
11.5 Hz, 1H), 4.96 (d, J = 12.5 Hz, 1H), 4.81 (d, J = 12.5 Hz, 1H), 4.61 (d, J = 
12.0 Hz, 1H), 4.26 (ddt, J = 1.5, 6.5, 9.5, 2H), 4.15 (t, J = 6.0 Hz, 1H), 4.05 (d, J = 
1.5 Hz, 1H), 3.88 (dd, J = 3.0, 9.5 Hz, 1H), 3.83 (t, J = 10.0 Hz, 1H), 3.48 (dt, J = 
5.0, 10.0 Hz, 1H), 3.24 (dd, J = 5.5, 17.5 Hz, 1H), 3.13 (dd, J =7.5, 17.5 Hz, 1H), 
13C NMR (125 MHz, CDCl3) δ 197.2, 138.5, 138.0, 137.7, 136.5, 133.3, 120.9, 
128.8, 128.5, 128.4, 128.3, 128.2, 128.1, 127.8, 127.7, 127.6, 126.1, 101.4, 80.4, 
79.4, 75.9, 75.6, 75.0, 73.3, 71.8, 68.6, 39.6, ESIHRMS calcd for C35H34O6Na [M 
+ Na]+ 573.2252, found 573.2255. 
2,3-O-Di-benzyl-4,6-O-benzylidene -1-allyl-1-deoxy-α-D-glucopyranose 197. 
Compound 197 was prepared by the general glycosylation procedure I and 
obtained in 56 to 58% yield as a white solid: mp = 90.8 – 91.2 °C, d[ α]RTD– 0.9 (c 
= 0.75 M, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.50 (dd, J = 1.5, 8.0 Hz, 2H), 
! 180!
7.41 – 7.27 (m, 13H), 5.81 – 5.73 (m, 1H), 5.13 (dd, J = 1.5, 17.0 Hz, 1H), 5.09 
(d, J = 10.0 Hz, 1H), 4.92 (d, J = 11.0 Hz, 1H), 4.78 (d, J = 12.0 Hz, 1H), 4.64 (d, 
J = 11.5 Hz, 1H), 4.26 – 4.21 (m, 1H), 4.08 (dd, J = 5.5, 8.0 Hz, 1H), 3.90 – 3.86 
(m, 1H), 3.76 (dd, J = 5.5, 8.5 Hz, 1H), 3.70 – 3.64 (m, 3H), 2.54 (t, J = 7.5 Hz, 
2H), 13C NMR (125 MHz, CDCl3) δ 138.6, 138.1, 137.4, 134.3, 128.4, 128.3, 
128.2, 127.9, 127.8, 127.7, 127.6, 126.0, 117.2, 101.1, 82.7, 79.4, 78.7, 74.9, 
74.8, 73.6, 69.4, 63.4, 30.7, ESIHRMS calcd for C30H32O5Na [M + Na]+ 495.2147, 
found 495.2138 
2,3-Di-O-benzyl-4,6-O-benzylidene-1-(2-oxo-2-phenylethyl)-α-D-
glucopyranose 198 and [(1R)-2-Oxo-1,2-diphenyl-1-(phenylthiomethyl)ethyl] 
2,3-Di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside 199. 
Compounds 198 and 199 were obtained by the general glycosylation procedure 
I. Purification by column chromatography eluting with hexanes/ethyl acetate 4:1 
gave a 1:1 mixture of C- and O-glucosides in 80% yield. 
198: isolated as a colorless oil, [ α]RTD + 17.6 (c = 0.75 M, CHCl3);1H NMR (500 
MHz, CDCl3)δ 7.90 (d, J = 7.5 Hz, 2H), 7.56 (dd, J = 7.0, 8.0 Hz, 1H), 7.51 – 7.43 
(m, 4H), 7.40 – 7.35 (m, 5H), 7.34 – 7.26 (m, 8H), 5.57 (s, 1H), 4.96 – 4.93 (m, 
2H), 4.82 (d, J = 12.0 Hz, 1H), 4.73 (d, J = 11.5 Hz, 1H), 4.63 (d, J = 17.6 Hz, 
1H), 4.21 (dd, J = 3.0, 9.5 Hz, 1H), 3.91 – 3.83 (m, 2H), 3.72 – 3.64 (m, 3H), 3.50 
– 3.46 (m, 1H), 3.29 (dd, J = 7.5, 16 Hz, 1H), 13C NMR (125 MHz, CDCl3) δ 
197.2, 138.5, 137.7, 137.3, 137.0, 133.2, 128.9, 128.6, 128.4, 128.3, 128.2, 
128.1, 128.0, 127.9, 127.8, 127.7, 126.0, 101.2, 82.4, 78.8, 78.7, 74.8, 73.8, 
! 181!
72.0, 69.3, 64.7, 36.0, ESIHRMS calcd for C35H34O6Na [M + Na]+ 573.2253, 
found 573.2251. 
199: isolated as a colorless oil, [ α]RTD + 28.0 (c = 0.25 M, CHCl3);1H NMR (500 
MHz, CDCl3)δ 7.87 (d, J = 7.0 Hz, 2H), 7.57 – 7.15 (m, 27H), 7.05 (t, J = 7.5 Hz, 
1H), 5.46 (s, 1H), 5.08 (d, J = 3.5 Hz, 1H), 4.84 (d, J = 11.5, 1H), 4.74 (d, J = 
11.0 Hz, 1H), 4.62 (d, J = 11.5 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 4.18 – 4.11 (m, 
2H), 4.01 (d, J = 8.0 Hz, 1H), 3.98 (d, J = 12.0 Hz, 1H), 3.88 – 3.82 (m, 2H), 3.70 
(d, J = 14.0 Hz, 1H), 3.50 – 3.43 (m, 2H), 3.67 (dd, J = 3.5, 9.5 Hz, 1H), 13C NMR 
(125 MHz, CDCl3) δ 195.8, 141.3, 138.9, 138.2, 137.6, 137.5, 137.1, 133.0, 
129.5, 128.9, 128.6, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.6, 127.5, 
127.4, 127.2, 126.1, 126.0, 101.2, 93.9, 82.7, 82.5, 79.6, 78.4, 75.2, 73.8, 68.9, 
63.2, 45.9, 43.1, 29.7, ESIHRMS calcd for C49H46O7SNa [M + Na]+ 801.2862, 
found 801.2852. 
2-O-Benzyl-4,6-O-benzylidene-1-allyl-1,3-dideoxy- β-D-mannopyranose 200. 
Compound 200 was prepared from 192 by the general glycosylation procedure I 
and obtained in 52 to 59% yield as a colorless oil: [ α]RTD + 1.7 (c = 0.75 M, 
CHCl3); 1H NMR (500 MHz, CDCl3)  δ 7.49 (dd, J = 2.0, 8.0 Hz, 2H), 7.40 - 7.28 
(m, 8H), 5.76 – 5.67 (m, 1H), 5.57 (s, 1H), 5.05 (ddd, J = 1.5, 10.0, 17.0 Hz, 2H), 
4.74 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 1H), 4.27 (dd, J = 5.0, 10.5 Hz, 
1H), 3.98 (m, 1H), 3.81 (t, J = 10.5 Hz, 1H), 3.65 (d, J = 1.0 Hz, 1H), 3.53 (dt, J = 
1.5, 7.0 Hz, 1H), 3.44 (dt, J = 5.0, 10.0 Hz, 1H), 2.54 – 2.45 (m, 2H), 2.35 (dt, J = 
7.5, 14.5 Hz, 1H), 1.67 (dt, J = 3.0, 13.5 Hz, 1H), 13C NMR (125 MHz, CDCl3) δ 
137.9, 137.6, 134.4, 129.0, 128.4, 128.3, 128.1, 127.8, 126.1,117.3, 101.9, 80.1, 
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74.5, 74.1, 73.8, 71.2, 69.2, 35.5, 32.0, 29.7, ESIHRMS calcd for C23H26O4Na [M 
+ Na]+ 389.1731, found 389.1733. 
S-Phenyl 2-O-Benzyl-4,6-O-benzylidene-3-deoxy-α-D-thio-mannopyranoside 
192-α. 
192-α: isolated as a colorless oil, [ α]RTD – 34.1 (c = 1.0 M, CHCl3), 1H NMR (500 
MHz, CDCl3)  δ 7.41 (dd, J = 1.5, 8.0 Hz, 2H), 7.38 (dd, J = 1.5, 8.0 Hz, 2H), 7.32 
- 7.20 (m, 11 H), 5.53 (s, 1H), 5.49 (s, 1H), 4.54 (dd, J = 12.0, J = 17.5 Hz, 2H), 
4.26 (dt, J = 5.0, J = 10.0 Hz, 1H), 4.13 (dd, J = 5.0, J = 10.0 Hz, 1H), 4.07 – 4.02 
(m, 1H), 3.93 (brs, 1H), 3.77 (t, J = 10.5 Hz, 1H), 2.82 – 2.38 (m, 1H), 1.96 (dt, J 
= 2.0, J = 13.0 Hz, 1H), 13C NMR (125 MHz, CDCl3) δ 137.6, 137.2, 134.1, 131.5, 
129.1, 128.5, 128.3, 128.0, 127.7, 127.5, 126.2, 102.3, 86.2, 76.5, 74.3, 71.2, 
69.0, 69.1, 30.7, ESIHRMS calcd for C26H26O4SNa [M + Na]+ 457.1450, found 
457.1433. 
2-O-Benzyl-4,6-O-benzylidene-1,3-dideoxy-1-(2-oxo-2-phenylethyl)- β-D-
mannopyranose 201. 
Compound 201 was prepared from compound 192 by the general glycosylation 
procedure I and obtained in 75% yield in a mixture  α/β > 1:20. The β anomer 
was isolated as a colorless oil: [ α]RTD - 21.7 (c = 0.75 M, CHCl3);1H NMR (500 
MHz, CDCl3)  δ 7.90 (dd, J 1.5, 8.5 Hz, 2H), 7.58 (t, J = 7.0 Hz, 1H), 7.50 (dd, J = 
2.0, 8.0 Hz, 2H), 7.39 – 7.34 (m, 4H), 7.26 – 7.24 (m, 1H), 7.22 – 7.18 (m, 3H), 
5.59 (s, 1H), 4.72 (d, J = 12.0 Hz, 1H), 4.35 (d, J = 12.0 Hz, 1H), 4.26 (dd, J = 
3.0, 4.5 Hz, 2H), 3.98 (ddd, J = 4.5, 9.5, 13.5 Hz, 1H), 3.85 (t, J = 3.0 Hz, 1H), 
3.78 (t, J = 10.5 Hz, 1H), 3.53 (ddd, J =5.0, 9.0, 10.5 Hz, 1H), 3.30 (d, J = 7.0 Hz, 
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2H), 2.53 (dt, J = 3.5, 14.0 Hz, 1H), 1.84 – 1.78 (m, 1H), 13C NMR (125 MHz, 
CDCl3) δ 197.6, 137.6, 136.8, 133.3, 129.0, 128.8, 128.5, 128.4, 128.3, 128.2, 
128.1, 128.0, 127.9, 127.7, 126.1, 102,0, 76.2, 74.4, 74.0, 73.7, 71.2, 69.1, 39.6, 
31.8, 29.7, ESIHRMS calcd for C28H28O5Na [M + Na]+ 467.1834, found 467.1830. 
2-O-Benzyl-4,6-O-benzylidene-1-allyl-1,3-dideoxy-α-D-glucopyranose 202. 
Compound 202 was prepared from compound 190 by the general glycosylation 
procedure and obtained in 60 to 63% yield as a white solid: mp = 101.2 – 101.8 
°C, [ α]RTD + 30.2 (c = 0.75 M, CHCl3); 1H NMR (500 MHz, CDCl3)  δ 7.49 (dd, J = 
2.0, 8.0 Hz, 2H), 7.40 – 7.30 (m, 8H), 5.89 -5.81 (m, 1H), 5.52 (s, 1H), 5.17 (dd, J 
= 9.0, 10.0 Hz, 2H), 4.58 (q, J = 12.0 Hz, 2H), 4.22 (dd, J = 4.3, 9.9 Hz, 1H), 4.12 
(ddd, J = 3.8, 5.5, 7.3 Hz, 1H), 3.85 (ddd, J = 4.7, 5.5, 11.6 Hz, 1H), 3.63 (dd, J = 
9.5, 10.5 Hz, 1H), 3.58 – 3.49 (m, 2H), 2.71 – 2.64 (m, 1H), 2.47 – 2.43 (m, 1H), 
2.37 (dt, J = 4.3, 11.7 Hz, 1H), 1.85 (q, J = 1.6 Hz, 1H), 13C NMR (125 MHz, 
CDCl3)δ 138.0, 137.4, 134.5, 129.1, 128.5, 128.4, 127.8, 127.5, 126.1, 117.2, 
101.7, 74.6, 74.0, 71.0, 69.7, 64.9, 30.8, 29.7, 28.9; ESIHRMS calcd for 
C23H26O4Na [M + Na]+ 389.1729, found 389.1725. 
2-O-Benzyl-4,6-O-benzylidene-3-deoxy-1-(2-oxo-2-phenylethyl)-α-D-
glucopyranose 203 and [(1R)-2-Oxo-1,2-diphenyl-1-(phenylthiomethyl)ethyl] 
2-O-Benzyl-4,6-O-benzylidene-3-deoxy-α-D-glucopyranoside 204. 
Compounds 203 and 204 were obtained by the general glycosylation procedure I 
from compound 190. Purification by column chromatography eluting with 
hexanes/ethyl acetate 4:1 gave a 1.8:2 mixture of C- and O-glucosides in 71% 
yield. 
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203: isolated as a white solid, mp = 90.8 – 91.2 °C [ α]RTD + 32.4 (c = 0.5 M, 
CHCl3); 1H NMR (500 MHz, CDCl3)δ 7.96 (d, J = 7.5 Hz, 2H), 7.57 (t, J = 7.5 Hz, 
1H), 7.48 – 7.45 (m, 4), 7.39 – 7.27 (m, 8H), 5.50 (s, 1H), 4.98 – 4.94 (m, 1H), 
4.55 (s, 2H), 4.17 (, 1H), 3.89 (dt, J = 5.0, J = 12.5 Hz, 1H), 3.63 – 3.50 (m, 3H), 
4.70 (d, J = 4.5 Hz, 1H), 3.37 (dd, J = 8.0, 16.5, 1H), 2.41 (dt, J = 4.0, 12.0, 1H), 
1.85 (q, J = 12.0, 1H), 13C NMR (125 MHz, CDCl3) δ 197.6, 137.7, 137.3, 137.2, 
133.1, 129.1, 128.6, 128.5, 128.4, 128.2, 127.8, 127.6, 126.1, 101.7, 73.3, 71.6, 
71.2, 69.7, 66.2, 34.5, 31.4, 29.7, ESIHRMS calcd for C28H28O5Na [M + Na]+ 
467.1834, found 467,1831. 
204: isolated as a colorless oil; [ α]RTD + 57.6 (c = 0.5 M, CHCl3); 1H NMR (500 
MHz, CDCl3)δ 7.86 (d, J = 7.5 Hz, 2H), 7.58 – 7.53 (m, 3H), 7.48 (dd, J = 2.0, 8.0 
Hz, 2H), 7.42 (t, J = 8.0 Hz, 2H), 7.39 – 7.18 (m, 15H), 7.09 (t, J = 7.5 Hz, 1H), 
5.39 (s, 1H), 5.05 (d, J = 3.5 Hz, 1H), 4.04 (s, 2H), 4.17 (d, J = 18.5 Hz, 1H), 4.07 
– 4.00 (m, 3H), 3.76 (dd, J = 5.0, 15.0 Hz, 1H), 3.72 (d, J = 13.5 Hz, 1H), 3.43 – 
3.34 (m, 3H), 2.19 – 2.16 (m, 1H), 1.97 (q, J = 12.0 Hz, 1H), 13C NMR (125 MHz, 
CDCl3) δ 195.8, 141.7, 138.0, 137.5, 137.4, 137.0, 133.0, 129.6, 129.1, 128.8, 
128.6, 128.4, 128.3, 128.1, 127.9, 127.8, 127.7, 127.4, 127.2, 126.3, 125.9, 
101.8, 92.5, 82.2, 76.9, 74.6, 71.0, 69.1, 64.8, 46.1, 43.1, 29.8, ESIHRMS calcd 
for C42H40O6SNa [M + Na]+ 695.2443, found 695.2449. 
Methyl 4-O-Benzyl-2,3-di-O-methyl-α-D-galactopyranoside 250. 
To a vigorously stirred solution of compound 249 (4g, 12.9 mmol) in 
dichloromethane (116 mL) was added at room temperature BH3.THF (64 mL, 
64.5 mmol). The resulting mixture was stirred for 0.75 h then scandium triflate 
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Sc(OTf)3 ( 950 mg, 1.9 mmol) was added portion-wise. The mixture was stirred 
for 5 h then quenched by sequential additions of methanol and triethylamine and 
concentrated in vaccuo. The resulting residue was purified by silica gel 
chromatography (eluting with hexanes/ethyl acetate 1:2) to give the desired 
primary alcohol 250 as a colorless oil (3.87 g, 96%): [α]RTD + 108.8  (c 1.0, 
CHCl3), 1H NMR (400 MHz, CDCl3) δ 7.38 - 7.30 (m, 5H), 4.94 (d, J = 12.0 Hz, 
1H), 4.91 (d, J = 4.0 Hz, 1H), 4.61 (d, J = 12.4 Hz, 1H), 3.91 (d, J = 2.8 Hz, 1H), 
3.78-3.70 (m, 3H), 3.58 (dd, J = 2.4, J = 3.2 Hz, 1H), 3.55 - 3.49 (m, 7H), 3.40 (s, 
3H), 1.80 (dd, J = 3.2, 7.2 Hz, 1H), 13C NMR (100 MHz, CDCl3) δ 138.4, 128.8, 
128.7, 128.3, 98.2, 81.1, 78.2, 74.7, 73.8, 70.5, 62.6, 59.1, 58.8, 55.6, ESIHRMS 
calcd for C16H24O6Na [M + Na]+ 335.1471, found 335.1461. 
(6-R) Methyl 6-C-Allyl-4-O-benzyl-2,3-di-O-methyl-α-D-galactopyranoside 
251R and (6-S) Methyl 6-C-Allyl-4-O-benzyl-2,3-di-O-methyl-α-D-
galactopyranoside 251S. 
To a stirred solution of oxalyl chloride (6.0 mL, 69.1 mmol) in dichloromethane 
(220 mL) was added at – 78 ºC dimethyl sulfoxide (9.9 mL, 0.13 mol). The 
resulting mixture was stirred for 0.75 h before a solution of 250 (5.4 g, 17.2 
mmol) in dichloromethane (104 mL) was added. The resulting mixture was stirred 
for 2.5 h then triethylamine (100 mL, 0.34 mol) was added and the mixture stirred 
for an additional hour at – 78 ºC before it was allowed to warm up to 0 ºC and 
then stirred for 1h. The temperature was allowed to warm to room temperature 
and the mixture was stirred for one more hour. The resulting mixture was washed 
once with a 1 M solution of HCl. The aqueous phase was extracted twice with 
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dichloromethane. The combined organic layers were dried, filtered and 
concentrated in vaccuo. The crude aldehyde (5.3 g, 17.3 mmol) was dissolved in 
tetrahydrofuran (76 mL). The resulting mixture was cooled to – 30 ºC then 
allylmagnesium bromide 1 M solution in diethyl ether (68 mL) was slowly added. 
The resulting mixture was stirred for 5 h then poured into a 1 M solution of HCl. 
The aqueous phase was extracted twice with dichloromethane. The combined 
organic layers were dried, filtered and concentrated. Purification by silica gel 
chromatography (eluting with hexanes/ethyl acetate 2:3) gave the desired 
compounds 251R (2.8 g) and 251S (1.5 g) in a 2:1 ratio as a colorless oil and a 
white solid respectively. 
251R: [α]RT D + 190 (c =1.5 M, CHCl3), 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 
6.4 Hz, 2H), 7.37 - 7.26 (m, 3H), 5.87 - 5.76 (m, 1H), 5.12 (dd, J = 7.2, 10.8 Hz, 
2H), 4.96 (d, J = 11.2 Hz, 1H), 4.89 (d, J = 4.0 Hz, 1H), 4.68 (d, J = 12.4 Hz, 1H), 
4.16 (d, J = 2.4 Hz, 1H), 3.82 - 3.75 (m, 2H), 3.60 - 3.47 (m, 8H), 3.43 - 3.39 (m, 
4H), 2.58 - 2.53 (m, 1H), 2.12 - 2.04 (m, 1H), 1.54 (d, J = 4.8 Hz, 1H), 13C NMR 
(100 MHz, CDCl3) δ 138.8, 134.7, 128.7, 128.5, 128.2, 118.7, 98.3, 81.1, 78.1, 
74.7, 72.7, 72.4, 68.4, 59.1, 58.6, 55.6, 38.6, ESIHRMS calcd for C19H28O6Na [M 
+ Na]+ 375.1784, found 375.1782. 
251S: mp 83 – 85 °C, [α]RT D + 39.4 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, 
CDCl3) δ 7.35 - 7.25 (m, 5H), 5.85 - 5.74 (m, 1H), 5.08 - 5.02 (m, 3H), 4.96 (dd, J 
= 2.4, 3.2 Hz, 1H), 4.64 (d, J = 11.2 Hz, 1H), 3.97 (s, 1H), 3.89 (dd, J = 4.2, 10.4 
Hz, 1H), 3.80 - 3.76 (m, 1H), 3.61 - 3.48 (m, 9H), 3.44 - 3.40 (m, 3H), 3.23 (s, 
1H), 2.17 (t, J = 6.4 Hz, 1H), 13C NMR (100 MHz, CDCl3) δ 138.1, 134.7, 128.8, 
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128.6, 128.2, 117.6, 98.3, 81.4, 78.1, 75.8, 74.7, 71.5, 71.2, 59.1, 59.0, 55.7, 
37.5, ESIHRMS calcd for C19H28O6Na [M + Na]+ 375.1784, found 375.1778. 
(6-R) Methyl 6-C-Allyl-4-O-benzyl-2,3,6-tri-O-methyl-α-D-galactopyranoside 
252R and (6-S) Methyl 6-C-Allyl-4-O-benzyl-2,3,6-tri-O-methyl-α-D-
galactopyranoside 252S. 
To a stirred solution of compound 251 (3 g, 8.5 mmol) in dimethylformamide (21 
mL) was added portion-wise at 0 ºC NaH (430 mg, 12.8 mmol). The resulting 
mixture was stirred for 0.5 h at 0 ºC before iodomethane (2.1 mL, 34.1 mmol) 
was added dropwise. The temperature was allowed to warm up to room 
temperature then stirred for 5 h and quenched by addition of methanol. The 
mixture was concentrated and purified by silica gel column chromatography 
(eluting with hexanes/ethyl acetate 1:2) to give compounds 252R (2.9 g, 92%) as 
a colorless oil and 252S (2.7 g, 87%) as a white solid. 
252R: [α]RT D + 124.4 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, CDCl3) δ 7.39 (d, J 
= 8.4 Hz, 2H), 7.32 (t, J = 7.4 Hz, 2H), 7.25 (d, J = 6.4 Hz, 1H), 5.94 - 5.82 (m, 
1H), 5.12 (dd, J = 10.4, 17.2 Hz, 2H), 5.00 (d, J = 11.6 Hz, 1H), 4.87 (d, J = 4.0 
Hz, 1H), 4.58 (d, J = 11.2 Hz, 1H), 4.15 (s, 1H), 3.76 (dd, J = 4.0, 10.0 Hz, 1H), 
3.59 - 3.54 (m, 3H), 3.54 - 3.46 (m, 6H), 3.41 (s, 3H), 3.28 (s, 3H), 2.66 - 2.59 (m, 
1H), 2.39 - 2.29 (m, 1H), 13C NMR (100 MHz, CDCl3) δ 139.2, 134.0, 128.5, 
128.2, 127.7, 117.8, 98.5, 81.2, 77.9, 77.2, 74.8, 73.4, 70.7, 59.0, 58.3, 57.0, 
55.9, 33.4, ESIHRMS calcd for C20H30O6Na [M + Na]+ 389.1940, found 389.1949. 
252S: mp 86 – 88 °C, [α]RT D + 157.2 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, 
CDCl3) δ 7.38 - 7.32 (m, 4H), 7.30 - 7.26 (m, 1H), 5.84 - 5.74 (m, 1H), 5.06 - 5.00 
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(m, 2H), 4.94 (dd, J = 3.2, 8.8 Hz, 2H), 4.60 (d, J = 11.2 Hz, 1H), 3.89 (d, J = 2.4 
Hz, 1H), 3.78 (dd, J = 3.2, 9.2 Hz, 1H), 3.59 - 3.50 (m, 8H), 3.49 - 3.44 (m, 4H), 
3.42 (s, 3H), 2.19 - 2.12 (m 1H), 1.94 - 1.87 (m, 1H), 13C NMR (100 MHz, CDCl3) 
δ 138.8, 134.5, 128.6, 128.4, 128.0, 117.3, 97.6, 81.9, 80.2, 78.3, 74.4, 74.1, 
74.0, 60.1, 59.0, 58.9, 55.2, 35.2, ESIHRMS calcd for C20H30O6Na [M + Na]+ 
389.1940, found 389.1942. 
Methyl 4-O-Benzyl-7-deoxy-2,3-di-O-methyl-α-D-glycero-D-galacto-
octopyranoside 253R and 254S. 
Ozone was purged at – 70 ºC to a stirred solution of compound 252 (2 g, 5.5 
mmol) in a 7:1 mixture dichloromethane/methanol (260 mL) until the color of the 
solution became persistent blue. O2 was purged for a few minutes then NaBH4 
(900 mg, 24 mmol) was added under Argon and the resulting mixture allowed to 
warm up to room temperature. The mixture was stirred for 10 h then 
concentrated in vacuuo. The residue was taken up in ethyl acetate and washed 
once with HCl 1 M. The aqueous phase was extracted twice with 
dichloromethane. The combined organic layers were dried, filtered and 
concentrated. Purification by silica gel chromatography (eluting with 
hexanes/ethyl acetate 1:2) gave the desired compounds 253R (1.47 g, 73% over 
two steps) and 253S (1.35 g, 68% over two steps) as a white solid and a 
colorless oil respectively. 
253R: mp 82 – 84 °C, [α]RT D + 100.1 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, 
CDCl3) δ 7.38 (d, J = 8.4 Hz, 2H), 7.35 - 7.30 (m, 2H), 7.27 - 7.23 (m, 1H), 5.03 
(d, J = 10.4 Hz, 1H), 4.87 (d, J = 3.2 Hz, 1H), 4.56 (d, J = 11.2 Hz, 1H), 4.14 (s, 
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1H), 3.85 - 3.69 (m, 3H), 3.68 - 3.55 (m, 3H), 3.54 - 3.44 (m, 6H), 3.41 (s, 3H), 
3.29 (s, 3H), 2.35 (brs, 1H), 2.10 - 2.03 (m, 1H), 1.86 - 1.77 (m, 1H), 13C NMR 
(100 MHz, CDCl3) δ  139.0, 128.7, 128.5, 128.1, 127.7, 98.5, 81.3, 78.0, 77.6, 
74.7, 73.5, 71.2, 60.1, 59.1, 58.5, 57.6, 56.1, 32.1, ESIHRMS calcd for 
C19H30O7Na [M + Na]+ 393.1889, found 393.1899. 
253S: [α]RT D  + 68.4 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, CDCl3) δ 7.35 - 7.25 
(m, 5H), 4.98 (d, J = 12.4 Hz, 1H), 4.91 (d, J = 3.2 Hz, 1H), 4.56 (d, J = 12.0 Hz, 
1H), 3.83 (brs, 1H), 3.76 (dd, J = 3.2, 10.0 Hz, 1H), 3.64 - 3.39 (m, 15H), 3.40 (s, 
3H), 1.43 - 1.33 (m, 1H), 1.32 - 1.21 (m, 1H), 13C NMR (100 MHz, CDCl3) δ  
138.7, 130.1, 128.7, 128.6, 128.1, 97.7, 81.7, 80.7, 78.3, 74.8, 74.3, 73.8, 60.8, 
60.7, 59.0, 58.9, 55.3, 33.0, ESIHRMS calcd for C19H30O7Na [M + Na]+ 393.1889, 
found 393.1883. 
Methyl 4-O-Benzyl-7-deoxy-2,3-di-O-methyl-8-O-p-toluenesulfonyl-α-D-
glycero-D-galacto-octopyranoside 253-1-R. 
To a stirred solution of compound 253R (1.4 g, 3.8 mmol) in acetonitrile (38 mL) 
was added at room temperature tosyl chloride (1.45 g, 7.6 mmol) and 
tetramethylethylenediamine (1.20 mL, 7.6 mmol) respectively. The resulting 
mixture was stirred for 2.5 h then, poured into ice and extracted twice with 
dichloromethane. The combined organic layers were dried, filtered and 
concentrated in vaccuo. The residue was purified by silica gel chromatography 
hexanes/ethyl acetate (1:1) and gave 253-1-R (1.82 g, 92%) as a colorless oil: 
[α]RT D + 65.9 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, CDCl3) δ  7.76 (d, J = 8.0 
Hz, 2H), 7.38 - 7.26 (m, 6H), 4.99 (d, J = 11.6 Hz, 1H), 4.78 (d. J = 4.0 Hz, 1H), 
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4.53 (d, J = 10.8 Hz, 1H), 4.20 - 4.13 (m, 1H), 4.12 - 4.04 (m, 2H), 3.71 (dd, J = 
3.2, 9.6 Hz, 1H), 3.55 - 3.50 (m, 8H), 3.44 (d, J = 8.8 Hz, 1H), 3.28 (s, 3H), 3.18 
(s, 3H), 2.42 (s, 3H), 2.18 - 2.09 (m, 1H), 1.95 - 1.86 (m, 1H), 13C NMR (100 
MHz, CDCl3) δ  144.9, 138.9, 133.3, 130.0, 128.6, 128.2, 127.8, 98.4, 81.3, 77.9, 
75.2, 74.6, 73.5, 71.4, 67.3, 59.1, 58.5, 57.6, 55.8, 29.7, 21.7, ESIHRMS calcd 
for C26H36O9SNa [M + Na]+ 547.1978, found 547.1973. 
Methyl 4-O-Benzyl-7-deoxy-2,3-di-O-methyl-8-O-p-toluenesulfonyl-β-L-
glycero-D-galacto-octopyranoside 253-1-S. 
Compound 253-1-S was obtained under the same conditions as compound 253-
1-R, as a white solid (92%): mp 87-89 °C, [α]RT D + 59.9 (c = 1.0 M, CHCl3), 1H 
NMR (400 MHz, CDCl3) δ  7.75 (d, J = 8.0 Hz, 1H), 7.38 - 7.25  (m, 6H), 4.98 (d, 
J = 11.2 Hz, 1H), 4.88 (d, J = 4.0 Hz, 1H), 4.55 (d, J = 11.2 Hz, 1H), 4.09 - 4.03 ( 
m, 2H), 3.84 (d, J = 1.6 Hz, 1H), 3.75 (dd, J = 4.4, 10.8 Hz, 1H), 3.55 - 3.45 (m, 
9H), 3.37 (s, 3H), 3.34 (s, 3H), 2.41 (s, 3H), 1.71 - 1.63 (m, 1H), 1.51 - 1.42 (m, 
1H), 13C NMR (100 MHz, CDCl3) δ  145.0, 138.4, 133.2, 130.1, 128.8, 128.7, 
128.2, 128.1, 97.7, 81.7, 78.2, 77.6, 74.5, 74.5, 73.8, 67.0, 60.7, 59.1, 58.9, 55.2, 
30.5, 21.9, ESIHRMS calcd for C26H36O9SNa [M + Na]+ 547.1978, found 
547.1982. 
Methyl 7-deoxy-2,3-di-O-methyl-8-O-p-toluenesulfonyl-α-D-glycero-D-
galacto-octopyranoside 253-2-R. 
To a solution of tosylate 253-1-R (1.6 g, 3.5 mmol) in a 10:1 mixture 
methanol/ethyl acetate (26 mL) was added palladium on charcoal (10%, 650 
mg). The hydrogenolysis was performed using a hydrogenation apparatus under 
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40 psi H2 and the reaction was run for 4 h. The resulting mixture was filtered 
through celite and concentrated in vaccuo. Purification by silica gel 
chromatography hexanes/ethyl acetate (1:2) afforded compounds 253-2-R (1.15 
mg, 86%) as a colorless oil:  [α]RT D + 81.0 (c = 1.0 M, CHCl3), 1H NMR (400 
MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.81 (d, J = 4.0 
Hz, 1H), 4.24 - 4.12 (m, 3H), 3.62 - 3.52 (m, 2H), 3.51 - 3.41 (m, 8H), 3.39 (s, 
3H), 3.33 (s, 3H), 2.41 (s, 4H), 2.21 - 2.12 (m, 1H), 1.81 - 1.73 (m, 1H), 13C NMR 
(100 MHz, CDCl3) δ 145.0, 133.2, 130.0, 128.2, 98.1, 79.5, 77.4, 75.8, 70.8, 67.3, 
65.7, 59.6, 59.2, 58.0, 55.7, 31.5, 21.9, ESIHRMS calcd for C19H30O9SNa [M + 
Na]+ 457.1508, found 457.1497. 
Methyl 7-deoxy-2,3-di-O-methyl-8-O-p-toluenesulfonyl-β-L-glycero-D-
galacto-octopyranoside 253-2-S.  
Compound 253-2-S was obtained under the same conditions as compound 253-
2-R, as a white solid (78%): mp 85 – 87 °C, [α]RT D + 68.7 (c = 1.0 M, CHCl3), 1H 
NMR (400 MHz, CDCl3) δ 7.80 - 7.78 (m, 2H), 7.33 (d, J = 6.4 Hz, 2H), 4.87 (d, J 
= 3.2 Hz, 1H), 4.22 - 4.14 (m, 2H), 3.61 - 3.52 (m, 3H), 3.50 - 3.43 (m, 7H), 3.42 - 
2.35 (m, 7H), 2.58 (brs, 1H), 2.43 (s, 3H), 2.12 - 2.02 (m, 1H), 1.85 - 1.76 (m, 
1H), 13C NMR (100 MHz, CDCl3) δ 145.0, 133.2, 130.1, 128.1, 97.8, 79.4, 77.8, 
77.6, 72.3, 67.1, 67.0, 60.0, 59.2, 58.0, 55.5, 30.5, 21.9, ESIHRMS calcd for 
C19H30O9SNa [M + Na]+ 457.1508, found 457.1515. 
Methyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-α-D-glycero-D-galacto-
octopyranoside 254R. 
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To a stirred solution of alcohol 253-2-R (1.1 g, 2.5 mmol) in dimethylformamide 
(25 mL) at room temperature were added NaH (102 mg, 3.0 mmol) and NaI (304 
mg, 2.0 mmol) respectively. The resulting mixture was stirred for 1 h, quenched 
by addition of methanol and concentrated in vacuo. Purification by silica gel 
chromatography hexanes/ethyl acetate (1:1) afforded compound 254R (582 mg, 
88%) as a white solid: mp 58 – 60 °C, [α]RT D + 198.0 (c  = 1.0 M, CHCl3), 1H 
NMR (500 MHz, CDCl3) δ 4.96 (d, J = 3.0 Hz, 1H), 4.14 (dd, J = 4.5, 12.0 Hz, 
1H), 4.05 (d, J = 3.0 Hz, 1H), 3.71 - 3.67 (m, 2H), 3.55 ( dd, J = 3.5, J = 10.5 Hz, 
1H), 3.52 (s, 1H), 3.50 (s, 3H), 3.48 (s, 3H), 3.44 - 3.38 (m, 4H), 3.35 (dt, J = 3.8, 
11.7 Hz, 1H), 1.98 (dq, J = 4.7, 12.5 Hz, 1H), 1.75 (dd, J = 4.5, 12.5 Hz, 1H), 13C 
NMR (125 MHz, CDCl3) δ 98.8, 78.7, 78.0, 74.2, 66.4, 64.3, 59.7, 58.4, 56.0, 
55.8, 29.9, 26.8, ESIHRMS calcd for C12H22O6Na [M + Na]+ 285.1314, found 
282.1313. 
Methyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-β-L-glycero-D-galacto-
octopyranoside 254S. 
Compound 254S was obtained under the same conditions as compound 254R, 
as a colorless oil (90%): [α]RT D + 225.4 (c = 1.0 M, CHCl3), 1H NMR (500 MHz, 
CDCl3) δ 4.85 (d, 4.0 Hz, 1H), 3.98 (d, J = 3.0 Hz, 1H), 3.82 (dd, J = 5.5, 11.5 Hz, 
1H), 3.70 - 3.63 (m, 2H), 3.59 (d, J = 3.0 Hz, 1H), 3.50 - 3.49 (m, 4H), 3.45 (s, 
4H), 3.40 (s, 3H), 3.38 (s, 3H), 1.98 (m, 1H), 1.63 (d, J = 11.2 Hz, 1H), 13C NMR 
(125 MHz, CDCl3) δ 98.7, 78.5, 77.8, 74.4, 70.0, 64.9, 62.6, 59.6, 57.8, 56.9, 
55.6, 25.3, ESIHRMS calcd for C12H22O6Na [M + Na]+ 285.1314, found 282.1320. 
2,4-Dinitrophenyl 2,3,4,6-Tetra-O-methyl-α-D-galactopyranoside 255. 
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To a stirred solution of 247 (2.5 g, 10.0 mmol) in acetic anhydride (29 mL) was 
added at room temperature aqueous HClO4 (70%, 80 µL). The resulting mixture 
was stirred for 0.25 h then quenched by addition of a solution of saturated 
NaHCO3 (140 mL). After 2.5 h stirring at room temperature, the mixture was 
neutralized with solid NaHCO3. The aqueous solution was extracted three times 
with dichloromethane. The combined organic layers were dried, filtered and 
concentrated in vaccuo. The residue was purified by silica gel chromatography 
hexanes/ethyl acetate (1:1) and gave a mixture of the corresponding anomeric 
acetate compound (2.20 g, 79%) in a 5:1 α/β mixture as a colorless oil: 1H NMR 
(400 MHz, CDCl3) (major anomer, α) δ 6.32 (d, J = 4.0 Hz, 1H), 3.90 (dd, J = 6.0, 
J = 7.6 Hz, 1H), 3.73 - 3.60 (m, 2H), 3.53 - 3.51 (m, 8H), 3.42 (s, 3H), 3.34 (s, 
3H), 13C NMR (100 MHz, CDCl3) δ 169.7, 90.2, 80.0, 77.0, 75.5, 71.6, 70.8, 61.5, 
59.4, 59.2, 58.2, 21.3, ESIHRMS calcd for C12H22O7Na [M + Na]+ 301.1263, 
found 301.1261. 
To a solution of the anomeric acetate mixture (2.1 g, 7.55 mmol) in methanol (37 
mL) was added hydrazine acetate (835 mg, 9 mmol) at room temperature. The 
resulting mixture was stirred for 1 h and concentrated. The crude residue was 
taken up in dimethylformamide (42 mL) then DABCO (2.9 g, 25 mmol) and DNFB  
(1.1 mL, 8.81 mmol) were respectively added. The resulting mixture was stirred 
for 6 h and concentrated in vaccuo. The residue was taken up in 
dichloromethane the organic phase was washed with water, dried over Na2SO4 
and concentrated. The residue was recrystallized in ether/hexane to give 15 
(45% over 2 steps) as a light yellow foam: [α]RT D – 16.4 (c = 1.0 M, CHCl3), 1H 
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NMR (400 MHz, CDCl3) δ 8.72 (s, 1H), 8.38 (dd, J = 2.8, 9.2 Hz, 1H), 7.38 (d, J = 
9.2 Hz, 1H), 5.04 (d, J = 7.2 Hz, 1H), 3.74 - 3.66 (m, 3H), 3.62 - 3.53 (m, 8H), 
3.37 (s, 3H), 3.27 (dd, J = 2.4, 9.6 Hz), 13C NMR (100 MHz, CDCl3) δ 154.8, 
141.4, 128.9, 121.8, 117.5, 101.4, 83.8, 79.9, 74.8, 74.7, 71.0, 61.7, 61.6, 59.6, 
58.9, ESIHRMS calcd for C16H22N2O10Na [M + Na]+ 425.1172 found, 425.1175. 
2,4-Dinitrophenyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-α-D-glycero-D-
galacto-octopyranoside 256R. 
To a stirred solution of 254R (640 mg, 2.4 mmol) in acetic anhydride (7.4 mL) 
was added at room temperature aqueous HClO4 (70%, 20 µL). The resulting 
mixture was stirred for 0.25 h then quenched by addition of saturated NaHCO3 
(40 mL). After 2.5 h stirring at room temperature, the mixture was neutralized 
with solid NaHCO3. The aqueous solution was extracted three times with 
dichloromethane. The combined organic layers were dried, filtered and 
concentrated in vaccuo and purified by silica gel column chromatography!
hexanes/ethyl acetate (1:1). To a stirred solution of the resulting compound (400 
mg, 1.38 mmol) in methanol (7.0 mL) was added a freshly prepared solution of 
1M NaOH in methanol (0.14 mmol). After complete consumption of the starting 
material, the reaction mixture was neutralized by addition of Amberlyst resin IR 
120 and concentrated in vaccuo. The resulting crude compound was dissolved in 
dimethylformamide (8.0 mL) then was added at room temperature DABCO (472 
mg, 4.80 mmol) and dinitrofluorobenzene (DNFB) (0.20 mL, 1.64 mmol) 
respectively. The resulting mixture was stirred for 5 h and concentrated. The 
residue was taken up in ethyl acetate and washed twice with water. The aqueous 
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solution was extracted twice times with ethyl acetate. The combined organic 
layers were dried, filtered and concentrated in vaccuo. The residue was purified 
by silica gel chromatography hexanes/ethyl acetate (1:1 to 1:2) and gave 
compound 256R as a light yellow foam (352 mg, 62% over two steps): [α]RT D  - 
16.2 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, CDCl3 δ 8.72 (d, J = 3.2 Hz, 1H), 
8.39 (dd, J = 2.4, 10.0 Hz, 1H), 7.44 (d, J = 8.8 Hz, 1H), 5.03 (d, J = 7.2 Hz, 1H), 
4.16 (dd, J = 4.0, 11.6 Hz, 1H), 3.82 (s, 1H), 3.77 - 3.72 (m, 2H), 3.63 (s, 3H), 
3.54 (s, 3H), 3.46 - 3.41 (m, 5H), 3.27 (dd, J = 3.2, 9.6 Hz, 1H), 2.03 - 1.91 (m, 
1H), 1.82 - 1.74 (m, 1H), 13C NMR (125 MHz, CDCl3) δ 155.2, 141.4, 139.7, 
129.1, 121.8, 117.8, 102.1, 81.9, 79.7, 77.2, 72.9, 70.2, 66.5, 61.6, 58.6, 56.1, 
26.4, ESIHRMS calcd for C17H22N2O10Na [M + Na]+ 437.1272, found 4378. 
2,4-Dinitrophenyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-β-L-glycero-D-
galacto-octopyranoside 256S. 
Compound 256S was obtained under the same conditions as compound 256R, 
as a light yellow solid (67% over 2 steps): mp 58 – 60 °C, [α]RT D + 23.4 (c = 1.0 
M, CHCl3), 1H NMR (500 MHz, CDCl3) δ  8.75 (d, J = 3.0 Hz, 1H), 8.43 - 8.41 (m, 
1H), 7.36 (dd, J = 3.5, 9.0 Hz, 1H), 5.09 (d, J = 7.5 Hz, 1H), 4.06 (s, 1H), 3.88 
(dd, J = 4.0, 11.0 Hz, 1H), 3.78 - 3.71 (m, 2H), 3.64 (s, 3H), 3.57 - 3.53 (m, 5H), 
3.43 (s, 3H), 3.27 - 3.24 (m, 1H), 2.04 - 1.96 (m, 1H), 1.67 (d, J = 14.5, 1H), 13C 
NMR (125 MHz, CDCl3) δ  154.7, 141.3, 139.7, 128.6, 121.7, 117.3, 101.6, 81.5, 
79.2, 73.7, 70.1, 68.5, 62.5, 61.4, 57.9, 56.8, 24.6, ESIHRMS calcd for 
C17H22N2O10Na [M + Na]+ 437.1272, found 4369 
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Phenyl 4,6-O-Benzylidene-2,3 -di-O-methyl-1-thio-β-D-galactopyranoside 
260. 
To a solution of phenyl 4,6-O-benzylidene-1-thio-β-D-galactopyranoside (5.0 g, 
13.9 mmol) in dimethyformamide (32 mL) was added at 0 ºC NaH (1.8 g, 55.5 
mol). The resulting mixture was stirred for 0.5 h then iodomethane (3.5 mL, 55.5 
mol) was added dropwise and the temperature allowed to warm up to room 
temperature. The resulting mixture was stirred for 2 h then quenched by addition 
of methanol and concentrated in vaccuo. The residue was taken up in 
dichloromethane and the organic phase washed twice with water, dried over 
Na2SO4 and concentrated.  Purification by silica gel chromatography 
hexanes/ethyl acetate (5:2) afforded compound 260 (5.0 g, 93%) as a white 
solid: mp 122-124 °C, [α]RT D  + 15.2 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, 
CDCl3) δ 7.71 - 7.69 (m, 2H), 7.49 - 7.46 (m, 2H), 7.38 - 7.35 (m, 3H), 7.26 - 7.23 
(m, 3H), 5.52 (d, J = 4.8 Hz, 1H), 4.50 (dd, J = 4.0, 9.6 Hz, 1H), 4.40 - 4.30 (m, 
2H), 3.55 - 3.44 (m, 8H), 3.32 (dd, J = 4.0, 9.6 Hz, 1H), 2.95 - 2.87 (m,1H), 13C 
NMR (100 MHz, CDCl3) δ 138.0, 133.2, 129.6, 129.0, 128.4, 127.7, 126.9, 101.7, 
86.6, 83.7, 77.6, 73.3, 70.1, 69.7, 61.2, 58.0, ESIHRMS calcd for C21H24O5SNa 
[M + Na]+ 411.1142 found, 411.1145. 
Phenyl 2,3-Di-O-methyl-4,6-methylidene-1-thio-β-D-galactopyranoside 261. 
To a stirred solution of compound 260 (5 g, 12.9 mmol) in methanol (126 mL) 
was added at room temperature p-toluenesulfonic acid (245 mg, 1.29 mmol). The 
resulting mixture was stirred for 9 h, neutralized by addition of triethylamine and 
concentrated in vaccuo. Purification by silica gel chromatography hexanes/ethyl 
! 197!
acetate 1:2 afforded phenyl 2,3-di-O-methyl-1-thio-β-D-galactopyranoside! (3.7 g, 
97%) as a colorless oil: [α]RT D  - 7.3 (c = 1.0 M, CHCl3), 1H NMR (400 MHz, 
CDCl3) δ 7.51 (d, J = 6.4 Hz, 2H), 7.29 - 7.19 (m, 3H), 4.52 (d, J = 9.6 Hz, 1H), 
4.09 (s, 1H), 3.93 - 3.87 (m, 1H), 3.81 - 3.75 (m, 1H), 3.54 (s, 3H), 3.49 - 3.43 (m, 
4H), 3.34 (dd, J = 8.8, 9.6 Hz, 1H), 3.20 (dd, J = 8.8, 3.2 Hz, 1H), 2.94 - 2.84 (m, 
2H), 13C NMR (100 MHz, CDCl3) δ 133.9, 131.8, 129.6, 127.6, 87.5, 84.8, 78.7, 
78.2, 66.6, 62.7, 61.4, 57.9, ESIHRMS calcd for C14H20O5SNa [M + Na]+ 
323.0929 found, 323.0917. 
To a stirred solution of phenyl 2,3-di-O-methyl-1-thio-β-D-galactopyranoside (2.8 
g, 9.33 mmol), in acetonitrile (47 mL), was added camphore sulfonic acid (220 
mg, 0.93 mmol) and formaldehyde dimethyl acetal (2.0 mL, 22.4 mmol) 
respectively. The resulting mixture was heated at 40 ºC for 48 h, neutralized by 
addition of triethylamine and concentrated in vaccuo. Purification by silica gel 
chromatography hexanes/ethyl acetate 1:2 afforded compound 22 (1.20 g, 41%) 
as a white solid: mp 118 – 120 °C, [α]RT D – 2.0 (c = 1.0 M, CHCl3), 1H NMR (400 
MHz, CDCl3) δ 7.58 (d, J = 6.4 Hz, 2H), 7.28 - 7.18 (m, 3H), 5.14 (d, J = 5.6 Hz, 
1H), 4.68 (d, J = 6.8 Hz, 1H), 4.48 (d, J = 9.6 Hz, 1H), 4.12 (d, J = 12.0 Hz, 1H), 
3.52 (s, 3H), 3.48 (s, 3H), 3.44 (dd, J = 12.4, 9.6 Hz, 1H), 3.33 (s, 1H), 3.20 (d, J 
= 8.8 Hz, 1H), 13C NMR (100 MHz, CDCl3) δ 133.7, 132.5, 129.1, 127.7, 93.7, 
87.5, 83.4, 77.8, 72.8, 70.6, 69.0, 61.3, 58.3, ESIHRMS calcd for C15H20O5Na [M 
+ Na]+ 335.0929 found, 335.0917 
2,4-Dinitrophenyl 2,3-Di-O-methyl-4,6-methylidene-β- D-galactopyranoside 
263. 
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To a stirred solution of compound 261 (320 mg, 1.02 mmol) in chloroform (6.4 
mL) was added at room temperature NIS (278 mg, 1.18 mmol) and dry glacial 
acetic acid (0.12 mL, 2.05 mmol) respectively. The resulting mixture was stirred 
for 2 h and quenched by addition of a 10% aqueous solution of Na2S2O3.  The 
aqueous solution was extracted twice with dichloromethane. The combined 
organic layers were dried, filtered and concentrated in vaccuo. The residue was 
purified by silica gel chromatography hexanes/ethyl acetate (1:1) and gave 2,3-
di-O-methyl-4,6-methylidene-1-thio-α-D-galactopyranoside acetate (142 mg, 
52%) 2,3-di-O-methyl-4,6-methylidene-1-thio-β-D-galactopyranoside acetate (28 
mg, 18%). 
2,3-Di-O-Methyl-4,6-methylidene-1-thio-α -D-galactopyranoside Acetate 
(major anomer): white solid, mp 165 – 168 °C, [α]RT D  + 151.3 (c = 0.15 M, 
CHCl3), 1H NMR (500 MHz, CDCl3) δ 6.49 (d, J = 3.0 Hz, 1H), 5.20 (d, J = 6.5 Hz, 
1H), 4.75 (d, J = 6.5 Hz, 1H), 4.17 – 4.11 (m, 2H), 3.86 – 3.80 (m, 2H), 3.86 – 
3.80 (m, 2H), 3.73 (s, 1H), 3.59 (dd, J = 3.0, J = 10.0 Hz, 1H), 3.55 (s, 3H), 3.49 
(s, 3H), 2.14 (s, 3H), 13C NMR (125 MHz, CDCl3) δ 169.3, 93.5, 90.4, 77.3, 76.3, 
72.7, 68.6, 65.4, 59.2, 58.1, 21.1, ESIHRMS calcd for C11H18O7Na [M + Na]+ 
285.0950, found 285.0948. 
2,3-Di-O-Methyl-4,6-methylidene-1-thio-β -D-galactopyranoside Acetate 
(minor anomer): colorless oil, [α]RT D  + 91.2 (c = 0.50 M, CHCl3), 1H NMR (400 
MHz, CDCl3) δ 5.48 (d, J = 8.8 Hz, 1H), 5.19 (d, J = 6.4 Hz, 1H), 4.73 (d, J = 5.6 
Hz, 1H), 4.15 (d, J = 13.2 Hz, 1H), 4.06 (d, J = 3.6 Hz, 1H), 3.78 (d, J = 15.0 Hz, 
1H), 3.61 – 3.48 (m, 8H), 3.27 (dd, J = 3.2, J = 9.6 Hz, 1H), 2.16 (s, 3H), 13C 
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NMR (100 MHz, CDCl3) δ 169.8, 94.2, 93.8, 81.6, 78.6, 72.5, 68.6, 68.0, 61.2, 
58.5, 21.4, ESIHRMS calcd for C11H18O7Na [M + Na]+ 285.0950, found 285.0955. !
To a stirred solution of! 2,3-di-O-methyl-4,6-methylidene-1-thio- D-
galactopyranoside!acetate (290 mg, 1.11 mmol) in methanol (5.5 mL) was added 
a freshly prepared solution of 1 M NaOH in methanol (0.11 mmol). After complete 
consumption of the starting material, the reaction mixture was neutralized by 
addition of Amberlyst resin IR 120 and concentrated in vaccuo. The resulting 
crude compound was dissolved in dimethylformamide (6.4 mL) then was added 
at room temperature DABCO (380 mg, 3.86 mmol) and dinitrofluorobenzene 
(0.17 mL, 1.32 mmol) respectively. The resulting mixture was stirred for 5 h and 
concentrated. The residue was taken up in ethyl acetate and washed twice with 
water. The aqueous solution was extracted twice times with ethyl acetate. The 
combined organic layers were dried, filtered and concentrated in vaccuo. The 
residue was purified by silica gel chromatography hexanes/ethyl acetate (1:1 to 
1:2) and gave compound 263 as a light yellow foam (171 mg, 40% over 2 steps): 
[α]RT D  – 2.1 (c = 0.75 M, CHCl3), 1H NMR (500 MHz, CDCl3) δ 8.76 (d, J = 2.5 
Hz, 1H), 8.40 (dd, J = 2.5, 9.0 Hz, 1H), 7.37 (d, J = 9.5 Hz, 1), 5.22 (d, J = 6.5 
Hz, 1H), 5.15 (d, J = 7.5 Hz, 1H), 4.78 (d, J = 6.0 Hz, 1H), 4.19 (d, J = 12.5 Hz, 
1H), 4.16 (d, J = 3.5 Hz, 1H), 3.90 (dd, J = 1.5, 13.0 Hz, 1H), 3.84 (dd, J = 7.5, 
9.5 Hz, 1H), 3.68 (s, 3H), 3.63 (s, 1H), 3.59 (s, 3H), 3.55 (dd, J = 3.0, 9.5 Hz, 
1H), 13C NMR (125 MHz, CDCl3) δ 154.5, 141.3, 139.6, 128.6, 121.8, 117.1, 
101.0, 93.6, 80.9, 78.8, 72.0, 68.3, 68.0, 61.4, 58.6, ESIHRMS calcd for 
C15H18N2O10Na [M + Na]+ 409.0859 found, 409.0862. 
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APPENDIX 
Plots for the acid catalyzed hydrolysis of methyl α-D-galactopyranosides 247, 
254R and 254S (T 82 ºC, [HClO4] = 2.0 M). 
Methyl 2,3,4,6-tetra-O-methyl-α-D-galatopyranoside 247. 
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Methyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-α-D-glycero-D-galacto-
octopyranoside 254R. 
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Methyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-β-L-glycero-D-galacto-
octopyranoside 254S. 
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Plots for the spontaneous hydrolysis of 2,4-DNP galactopyranosides 255, 256R, 
256S and 263 (phosphate buffered saline solution: pH = 6.5, C = 25 mM, [KCl] = 
0.4 M).  
Only one plot (T = 75 ºC) is represented for each of these four compounds since 
all the plots are similar at any temperature.  
 
2,4-Dinitrophenyl 2,3,4,6-Tetra-O-methyl-α-D-galactopyranoside 255. 
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2,4-Dinitrophenyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-α-D-glycero-D-
galacto-octopyranoside 256R. 
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2,4-Dinitrophenyl 4,8-Anhydro-7-deoxy-2,3,6-tri-O-methyl-β-L-glycero-D-
galacto-octopyranoside 256S. 
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2,4-Dinitrophenyl 2,3-Di-O-methyl-4,6-methylidene-β- D-galactopyranoside 
263. 
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ABSTRACT 
SYNTHESIS OF OLIGOSACCHARIDE MIMETICS BY THE DESULFURATIVE 
REARRANGEMENT OF ALLYLIC DISULFIDES AND STEREOELECTRONIC 
INFLUENCE OF C-O BONDS ON C- AND O-GLYCOSYLATION  
 
by 
MYRIAME MOUME-PYMBOCK 
May 2013 
Advisor:  Dr David Crich 
Major: Chemistry 
Degree:  Doctor of Philosophy 
 This dissertation focuses on two different problems. The first part of this 
manuscript presents the application of a novel methodology to access the 
synthesis of oligosaccharide mimetics while the second part focuses on the study 
of the stereoelectronic effects of proximal C-O bonds in C- and O-glycosylation 
reactions. 
 The first chapter provides a brief overview of the important roles that 
oligosaccharides and glycoconjugates play in biological processes and sets out 
the major advances that have been made in the past few decades in the 
synthesis of such complex structures while bringing out the ongoing challenges 
and the limitations that impede the development of general methods with broad 
applicability. 
 In chapter two, the emphasis is placed on a new thioligation reaction 
developed in the Crich laboratory as a means for the chemical synthesis of linear 
mimetics of an important bacterial motif, the β-(1→6)-N-acetyl glucosamine 
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polymer. Small, protecting group-free, pre-assembled sugar units are linked 
together into larger oligosaccharide chains by the desulfurative rearrangement of 
allylic disulfides.  
The first part of chapter three presents the general mechanistic aspects of 
O-glycosylation reactions, before detailing them further in the context of 
glycosylation reactions using 4,6-O-benzylidene-protected donors. The second 
part covers underlying principles of protecting group reactivity and their affects on 
glycosylation reaction. 
Chapter four looks into the stereoelectronic influence of the C3-O3 bond in 
4,6-O-benzylidene protected gluco- and mannopyranoside donors. The 
stereoselective formation of C-glycosides in the 3-deoxy mannose and glucose 
series is compared to that in the more usual 3-OBn series. The results of this 
study provided complementary insights into the determining elements controlling 
the stereoselective formation of C-glycosides.    
In chapter five, the influence of the 4,6-O-benzylidene group on reactivity 
is investigated in the galactose series by probing the disarming influence of the tg 
conformation of the C5-C6 bonds. Kinetic studies on 4,6-O-alkylidene 
galactoside derivatives and their carba-analogs revealed that, similarly to the 
glucose series, 4,6-O-acetals also exert a disarming effect on 
galactopyranosides reactivity. 
 This manuscript ends with an overall conclusion presented in chapter six. 
All compounds characterizations and data plots are presented in chapter seven, 
in the experimental section. 
! 228!
AUTOBIOGRAPHICAL STATEMENT 
 
Education 
2007 – 2012: Ph.D in Organic Chemistry, Wayne State University, MI 
Research advisor: Pr David Crich 
 
2004 – 2006: M.Sc in Applied and Fundamental Chemistry, Université Pierre et 
Marie Curie, Paris VI, France 
Thesis: “Synthesis of Glycosidase Inhibitors” 
Research advisor: Pr Pierre Sinaÿ 
 
Thesis: “Synthesis of Glycomimetic Inhibitors of the Adhesion of Pseudomonas 
aeruginosa to the Pulmonary Mucus of Patients with Cystic Fibrosis” 
Research advisor: Pr René Roy 
 
2001 – 2004: B.Sc in Biochemistry, Université Pierre et Marie Curie, Paris VI, 
France 
 
Publications 
1. “Probing the Influence of 4,6-O-Acetal on the Reactivity of Galactopyranosyl 
Donors: Verification of the Disarming Influence of the Trans-Gauche 
Conformation of C5-C6 Bonds” Moume-Pymbock, M.; Crich, D. (Manuscript in 
preparation) 
 
2. “Stereoselective C-Glycoside Formation with 2-O-Benzyl-4,6-O-Benzylidene 
Protected 3-Deoxy Gluco- and Mannopyranoside Donors: Comparison with O-
Glycoside Formation” Moume-Pymbock, M.; Crich, D. J. Org.Chem, 2012, 
77(20), 8905-8912. 
 
3. Protecting Group-Free Glycoligation by the Desulfurative Rearrangement of 
Allylic Disulfides as a Means of Assembly of Oligosaccharide Mimetics” 
Venkataraman, S.; Moume-Pymbock, M.; Hu, T.; Crich, D. J. Org.Chem, 2011, 
76(10), 3691-3709. 
 
4. “X-Ray Structures and Thermodynamics of the Interaction of PA-IIL from 
Pseudomonas aeruginosa with Disaccharide Derivatives” Marotte, K.; Sabin, C.; 
Preville, C.; Moume-Pymbock, M.; Wimmerova, M.; Mitchell, E. P.; Imberty, A.; 
Roy, R. ChemMedChem, 2007, 2(9), 1328-1338. 
 
5. “Synthesis and Biding Properties of Divalent and Trivalent Clusters of the 
Lewis a Disaccharide Moities to Pseudomonas aeruginosa Lectin PA-IIL” 
Marotte, K.; Preville, C.; Sabin, C.; Moume-Pymbock, M.; Imberty, A.; Roy, R. 
Organic & Biomolecular Chemistry, 2007, 5(18), 2953-2961. 
 
